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1 Summary 
 
RNAi interference (RNAi) is a highly conserved regulatory mechanism employed by almost 
all Eukaryotes. With RNAi organisms can modulate the expression of endogenous genes and 
protect the integrity and identity of their genomes. All RNAi-based processes depend on a 
complex containing small non-coding RNAs (sRNA) associated with Argonaute proteins. In 
this sRNA-Argonaute complex, sRNA recognizes its sequence-specific target messenger 
RNA (mRNA) via a base-pairing interaction, and directs the Argonaute protein to it. Upon 
binding, the Argonaute protein can repress target gene expression at different stages.  
In the case of the most studied class of sRNAs, the microRNAs, the repression of gene 
expression occurs at the post-transcriptional level. MicroRNAs inhibit the translation of 
target mRNAs and promote their degradation in the cytoplasm of a cell. In contrast, nuclear 
RNAi-based processes have been implicated in directing chromatin modifications and 
repressing gene activity at the transcriptional level. RNAi-mediated chromatin modifications 
have been linked to epigenetic gene silencing across kingdoms but the mechanistic details of 
the small RNA-dependent transgenerational silencing remain uncovered. One of the obstacles 
in the way to understanding these regulatory processes is the fact that attempts to stably 
silence genes by ectopic small RNA mediated, locus-independent heterochromatin formation, 
have proven to be inherently difficult.   
By performing a mutagenesis screen we identified the highly conserved RNA Polymerase 
II-associated factor 1 (Paf1) complex as a repressor of sRNA-directed heterochromatin 
formation in the fission yeast Schizosaccharomyces pombe. We showed that small RNAs 
produced from a hairpin construct effectively silenced the expression of the target gene in 
trans, if the function of Paf1 complex was impaired. The induced repression was locus- and 
sequence-independent, and involved de novo formation of a functional heterochromatic 
domain. Importantly, we observed that the silent state could be transmitted through meiosis 
and was subsequently inherited through tens of generations, even in the absence of the 
primary siRNAs source. Thus, the Paf1 complex represses sRNA-induced heterochromatin 
formation in an epigenetic fashion [1]. By performing a genetic analysis, we found that the 
Paf1 complex represses sRNA-mediated heterochromatin formation by contributing to 
efficient transcription termination and nascent transcript release. Thereby, we demonstrate 
that defective transcription termination exposes genes to sRNA-mediated repression.  
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The findings described in this dissertation are not only an advancement to the mechanistic 
research on sRNA-directed transgenerational gene silencing. The ability to stably repress 
gene activity without changing the underlying DNA sequence may also provide important 
technological implications, in particular in plant biotechnology.  
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2 Contributions 
 
Results presented in this dissertation were obtained in a collaborative effort and published in 
the following article: 
 
This work was published as a co-authorship with Yukiko Shimada, to whom I am immensely 
grateful for sharing the project with me. The manuscript and the comment article [2], [3] can 
be found in the Section 10. 
Experiments described in the section 7 were performed by me, Yukiko Shimada and Valentin 
Flury, with the help of Julia Batki.  
I reconstituted identified point mutations and created strains for validation of the screen 
results, as well as the control strains (Figures: 10A, 10B); performed the H3K9me2, 
H3K36me3 and RNA PolII ChIP experiments (Figures: 12, 19 22B, 22C); prepared and 
analyzed genome-wide data sets for RNA expression profiling and small-RNA expression 
profiling (Figures: 6A, 6B, 10C, 15, 16A, 17, 18); prepared the ribozyme strains and 
performed the silencing assays presented in the Figure 23; made the cross from Figure 21B. 
Yukiko Shimada performed the screen together with all the control experiments and analyzed 
the hits (Figures: 5B, 6C, 6D, 8); performed crosses and tetrad dissections presented in 
Figures 20C, 20D, 21A; prepared and performed the silencing assays presented in the Figures 
11, 13, 16B. 
Yukiko Shimada and Valentin Flury prepared the set of deletions and mutations presented in 
the Figure 22D. Valentin Flury performed the establishment and maintenance scoring assay 
(Figure 22E). Yukiko Shimada, with the help of Julia Batki, prepared the set of deletions of 
RNAi and heterochromatin factors (Figure 14). I, with the help of Julia Batki, performed the 
establishment and maintenance scoring assays (Figures: 20A, 20B). 
Katarzyna Maria Kowalik*, Yukiko Shimada*, Valentin Flury, Michael Beda Stadler, 
Julia Batki, Marc Bühler The Paf1 complex represses small-RNA-mediated epigenetic 
gene silencing. Nature 2015 Apr 9;520(7546):248-52. 
 
Highlited in: Mikel Zaratiegui Molecular Biology: RNAi hangs by a thread. Nature 2015 
Apr 9;520(7546): 162-4. 
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Michael Stadler designed and performed the computational analysis of the mutant genome 
resequencing data.   
I wrote all the sections of this dissertation independently, with the exception of the 
description of the Figure 9. Figures were prepared by Marc Bühler, me, and Michael Stadler 
(Figure 9). Marc Bühler critically read the manuscript of this dissertation.  
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3 Introduction 
3.1 RNAi-mediated regulatory mechanisms 
3.1.1 RNAi phenomenon 
 
RNAi interference (RNAi) is a highly conserved regulatory phenomenon employed by almost 
all eukaryotic organisms to modulate expression of endogenous genes and protect integrity or 
identity of their genomes. RNAi was first described as a gene silencing mechanism mediated 
by double stranded RNA (dsRNA) in the nematode C. elegans [4]. Soon after this finding had 
been published, it became evident that other known gene silencing effects, like 
co-suppression in plants or quelling in the fungus Neurospora crassa, were also examples of 
the RNAi-based regulatory processes [5], [6].  
 
As it was first shown in plants, RNAi-mediated silencing occurs through small interfering 
RNAs [7]. In the cell, siRNAs form effector complexes with small-RNA-binding proteins of 
the Argonaute family. What is common to all RNAi-based processes is that recognition of 
RNAi target sequences occurs via complementarity-based interaction with siRNAs [8], [9]. 
Thereby, these relatively short (20-30 nucleotides) RNA molecules serve as an address tag 
for the Argonaute-containing effector complexes and can be specifically directed to virtually 
any target RNA sequence. Importantly, since it is a variable siRNA sequence that directs the 
recruitment of universal proteins, RNAi-based mechanisms can always adapt to novel, 
exogenous targets. Bacteria also adapted the mechanism of RNA-based target recognition in 
the CRISPR-Cas9 system, which is an independently evolved concept similar to RNAi, 
where an RNA-guided DNA nuclease protects the bacterial genome from exogenous genetic 
elements [10]. 
 
3.1.2 RNAi-mediated Post-Transcriptional Gene Silencing 
 
RNAi-based regulatory mechanisms are traditionally categorized into post-transcriptional 
gene silencing (PTGS) and transcriptional gene silencing (TGS). During PTGS, recognition 
of a target sequence by the siRNA leads to a direct cleavage and degradation or 
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destabilization of the target RNA molecule by the effector complex called RNA-induced 
Silencing Complex (RISC) [11]. Thus, in a classic PTGS, small RNA-mediated repression 
affects cellular levels of a target RNA without affecting its transcription. Micro RNAs 
(miRNAs) and small interfering RNAs (siRNAs) are two examples of small RNA groups 
mediating PTGS. 
 
miRNA-mediated gene silencing 
 
miRNAs constitute a class of small RNAs, approximately 22 nt long, which are commonly 
produced in plants and animals. Generally, miRNAs originate from precursor miRNA 
transcripts (pri-miRNAs), which are encoded in the genome in a form of microRNA genes 
and are transcribed by RNA Polymerase II (PolII) [12], [13]. Alternatively, many miRNA 
precursors can be also encoded within introns of protein coding genes [14], [15]. Maturation 
of miRNAs involves recognition of the pri-miRNA transcripts by the RNA binding protein 
DGCR8 and subsequent cleavage by the ribonuclease (RNAse) III-type endonuclease Drosha 
[16]. The cleavage event takes place in the nucleus and produces ~70 nt long hairpin 
structures termed pre-miRNAs. Pre-miRNAs are then transported to the cytoplasm with the 
help of the shuttling protein Exportin-5 [17]. In the cytoplasm, pre-miRNAs are further 
processed by another RNAse III-type endonuclease, Dicer, into 22-nucleotide long miRNA 
duplexes [18]. In the plant miRNA biogenesis pathway both of these processing steps are 
performed in the nucleus by one enzyme - Dicer homolog DCL1 (Dicer-like 1) [19]. Dicer 
processing is coupled to loading of one of the strands of the miRNA duplex onto the RISC 
effector complex [20].  
The key factor of the RISC complex is the aforementioned Argonaute protein, which is 
directly binding the single stranded miRNA [18]. In animals, miRNAs commonly show a 
limited complementarity to their targets, which is the highest in the so-called ‘seed region’ in 
the 5’ end of the small RNA sequence [21], [22]. This imperfect binding implies that one 
miRNA can regulate many different cellular transcripts. It is generally believed that imperfect 
binding between the target RNA and the miRNA-loaded RISC induces translational 
repression of the target mRNA, followed by the transcript deadenylation and degradation 
[23], [24]. 
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In plants, miRNAs exhibit almost perfect complementarity to the target mRNAs and 
therefore can induce a direct cleavage of their targets, like typical siRNAs (see below). 
However, regulation by translational repression is also frequently observed in plants [25].  
  
siRNA-mediated silencing 
 
Small interfering RNAs (siRNAs) constitute another class of small RNAs. siRNAs are 21-24 
nt long and they are usually produced from exogenous, long, linear dsRNAs by the 
endonuclease Dicer [9]. Commonly, in the natural environment such dsRNA arrives to the 
cell for instance through a viral infection or it is transcribed in the cell after transposon 
invasion or derepression. Upon Dicer cleavage, the siRNA duplex is loaded onto the 
Argonaute protein, but only one siRNA strand is retained while the other is destroyed [26], 
[27]. Such a minimal siRNA-Ago complex is capable of recognition, binding and repression 
of a target RNA molecule. Importantly, siRNAs bind their targets with full complementarity. 
Such binding results in destruction of the target RNA through a direct endonucleolytic 
cleavage by the ‘slicer’ activity of the Argonaute protein [28]. Mismatches in the 
siRNA-target RNA duplex around the cleavage site prevent the ‘slicer’ activity and abolish 
direct degradation of the target [26]. Importantly, siRNA-triggered PTGS can be very potent 
due to the siRNA amplification mechanism that exists in some organisms. In such an 
amplification loop, dsRNA induces the generation of secondary siRNAs through the activity 
of RNA-dependent RNA polymerase (RdRP) [29].   
In addition to the RNAi triggered by exogenous dsRNA, multiple cases of siRNA production 
from endogenous dsRNA were reported in animals [30]. Probably the most striking example 
of endogenous siRNA function is the siRNA-dependent silencing of endogenous transposable 
elements (TE) in Drosophila somatic cells that lack the piRNA pathway [31] (see below). 
Other reported sources of endogenous siRNAs include overlapping antisense transcripts, 
inverted repeats or bi-directionally transcribed pseudogenes [30].  
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3.1.3 RNAi-mediated CDGS and heterochromatin assembly in fission yeast 
 
In S. pombe, the RNAi pathway is involved in formation of heterochromatin. Classically, the 
term heterochromatin refers to the more compact, inaccessible and transcriptionally inactive 
form of DNA in the nucleus [32]. Several chromatin modifications like histone marks or 
DNA methylation play a cooperative role in order to convey this silent state. Most notably for 
the study presented in this dissertation, in S. pombe heterochromatin is identified as the 
chromatin regions rich in methylation of histone H3 lysine 9 (H3K9) [32]. Di- and 
trimethylated H3K9 is recognized by chromodomains of the conserved Heterochromatin 
Protein 1 (HP1) proteins [33]. By binding to the methylated H3K9, HP1 proteins contribute 
to maintaining the silent chromatin.  
Heterochromatin assembly in fission yeast was the most extensively studied example of small 
RNA-mediated Transcriptional Gene Silencing (TGS). In the classical understanding of 
siRNA-mediated TGS, siRNA-directed chromatin modifications repress target genes by 
drastically reducing their transcriptional activity and making the chromatin inaccessible to the 
transcriptional machinery. An important feature of siRNA-mediated TGS emerges here - it 
should occur on chromatin, as the TGS-associated chromatin modifications must be localized 
and directed towards the right loci that are ‘addressed’ by siRNAs. Therefore, it is believed 
that siRNAs recruit the effector complexes to their target genes by interactions with nascent 
transcripts that are still associated with chromatin and RNA Polymerase [34].  
Contrary to the traditional understanding of RNAi-mediated chromatin repression by TGS, it 
quickly became evident that heterochromatin is not completely devoid of active transcription 
[34] (See below). It was proposed that the RNAi machinery confers the silent chromatin state 
by directing transcriptional silencing, as well as by mediating on-chromatin degradation of 
nascent heterochromatic transcripts [35], [36]. Thus, RNAi-mediated repression of 
heterochromatin is a combined effect of TGS and co-transcriptional gene silencing (CTGS), 
which can be together referred to as chromatin-dependent gene silencing (CDGS).  
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Figure 1. Model for RNAi-mediated heterochromatin formation at centromeric repeats in S. pombe. In 
S. pombe repression of centromeric repeats is an interplay between CTGS and TGS mechanisms and 
involves a self-reinforcing positive feedback loop coupling H3K9 methylation to small RNA production. 
The RITS complex is guided to the centromeric repeats by a base-pairing interaction with nascent 
centromeric transcripts. Upon binding of RITS, the nascent transcript becomes a template for dsRNA 
synthesis, which is performed by RNA-directed RNA polymerase-containing RDRC. Recruitment of RDRC 
is facilitated by a direct interaction with RITS. Dcr1 processes dsRNA into siRNA duplexes, which get 
loaded onto the Ago1 protein within the ARC complex. The Ago1-bound siRNA from the ARC complex 
undergoes transition into the RITS complex and can target nascent transcripts again. RITS complex recruits 
the H3K9 methyltransferase Clr4 associated within the CLRC complex. Clr4 methylates H3K9, which 
creates a binding platform for the HP1 proteins Swi6 and Chp2. The HP1 proteins promote recruitment of 
the Clr3 histone deacetylase present within the SHREC complex and deacetylation of histones restricts 
access to chromatin for RNA PolII. RITS binding to chromatin is enhanced by direct interaction with 
methylated H3K9 via Chp1. Recruitment of the CLRC complex to the chromatin is also enforced by direct 
binding of the H3K9-methylated nucleosomes by the chromodomain of the Clr4 methyltransferase.  
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RNAi-mediated heterochromatin formation in S. pombe 
 
In the S. pombe genome one can distinguish three regions of constitutive heterochromatin: 
centromeres, telomeres and the mating type locus [32]. Although in each of them the 
mechanism of silencing is slightly different, they all constitute repetitive regions and share 
homologous sequences called dg and dh repeats that can serve as heterochromatin nucleation 
centers. RNAi-mediated heterochromatin formation at S. pombe centromeres was extensively 
studied over the past years and the role of individual RNAi components in this process, in 
particular Dcr1, Ago1 and Rdp1, is very well established [37]  (Figure 1).  
Fission yeast centromeres consists of innermost repeats (imr), followed by outermost repeats 
(otr) located in a mirrored orientation on both sides of the chromosome center [32]. otr 
comprise the aforementioned dg and dh repeats, which contain regions homologous to the 
other constitutive heterochromatin loci. otr are bi-directionally transcribed by the RNA PolII 
[38], [39]. The product, long non-coding double-stranded transcripts are processed into 
siRNAs by the RNA endonuclease Dicer (Dcr1) [40]. Single stranded siRNAs are then 
loaded onto the RNA-Induced Transcriptional Silencing complex (RITS; consisting of the 
Argonaute protein Ago1, the chromodomain-containing protein Chp1 and Tas3, [41] through 
the intermediate Argonaute siRNA Chaperone complex (ARC; consisting of Ago1, Arb1 and 
Arb2 [42]). RITS is subsequently guided to chromatin by a base-pairing interaction between 
the Ago1-bound siRNA and the nascent transcript transcribed from the centromeric repeats 
[35], [41]. Upon establishment of this interaction, RITS recruits CLRC (Clr4-Rik1-Cul4 
Complex, including the Cullin-4 ubiquitin ligase), which brings the sole S. pombe H3K9 
methyltransferase Clr4 to the centromeric repeats [43]. Methylation of H3K9 by Clr4 
provides in turn a binding site for the HP1 homologues Swi6 and Chp2 [32].  
HP1 proteins bound to H3K9me serve as recruiting platforms for Histone Deacetylases 
(HDACs), and by this contribute to TGS. It was shown that Swi6 and Chp2 recruit two 
important complexes: the Snf2-HDAC-containg complex (SHREC; which consists of the 
Clr3 histone deacetylase and the Mit1 helicase) and the Clr6 deacetylase complex to the 
centromeric repeats [44]. Clr3 is responsible for deacetylation of histone H3 lysine 14 
(H3K14), whereas Clr6 is a histone deacetylase with broader specificity. These HDACs not 
only promote histone hypoacetylation, but also contribute to chromatin remodeling into a 
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more compact, repressive form [44], [45]. As a result, the access of RNA PolII to chromatin 
is restricted and transcription of centromeric repeats is limited.  
Recruitment of CLRC to heterochromatin is also reinforced by H3K9 methylation, as Clr4 
itself contains an H3K9me-binding chromodomain. The whole process is amplified through 
the activity of the RNA-directed RNA polymerase (Rdp1). Rdp1 mediates the synthesis of 
dsRNA that gets further processed by Dcr1 to enrich the pool of centromeric siRNAs [46]. 
Rdp1 is a part of the RNA-dependent RNA polymerase complex (RDRC), which consists of 
Rdp1, the polyA-polymerase Cid12 and the RNA helicase Hrr1. Importantly, not only 
deletions of the genes encoding for RNAi factors cause a decrease in H3K9 methylation at 
the centromeric repeats [47], but also loss of the H3K9 methyl mark causes a decrease in the 
small RNA pool [46], [48]. This interdependence can be explained by the fact that 
recruitment of RDRC is promoted by the RITS complex [49]. In turn, interaction of the RITS 
complex with heterochromatin is strengthened by the chromodomain-containing Chp1. In this 
way, the whole process is potentiated through a self-reinforcing loop, which couples siRNA 
biogenesis to high levels of histone methylation, and in consequence to CDGS.  
As mentioned above, centromeric silencing in S. pombe is a result of the cooperative action 
of CTGS and TGS, rather than a simple consequence of transcriptional shutdown. It was 
observed that loss of the SHREC complex results only in partial derepression of centromeric 
repeats, as compared to the complete loss of H3K9 methylation in the clr4Δ strain. However, 
the increase in PolII occupancy was comparable in both mutant situations [46]. This can be 
explained by the contribution of the RNAi machinery to degradation of a portion of 
centromeric transcripts directly on chromatin. In addition to the RNAi machinery, other 
factors are supposedly involved in the degradation of the nascent heterochromatic transcripts. 
In particular, the non-canonical polyA polymerase Cid14 was suggested to target the 
centromeric transcripts for degradation by the nuclear RNA surveillance machinery and the 
RNAi pathway as well [36].  
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3.1.4 Nuclear RNAi pathways and CDGS in other eukaryotes 
 
Nuclear RNAi mediates chromatin and DNA modifications also in higher eukaryotic 
organisms [37]. RNAi-mediated CDGS was first described in Arabidopsis thaliana, [50], 
[51], yet the role of nuclear RNAi in chromatin silencing was quickly expanded by examples 
from C. elegans, Drosophila and mammals [37].  
 
RNA-directed DNA methylation in plants 
 
In A. thaliana, siRNAs direct establishment and maintenance of DNA methylation [52], [53]. 
This process, called RNA-directed DNA methylation (RdDM) resembles in many aspects the 
RNAi-mediated TGS pathway from S. pombe. In Arabidopsis, 24nt long siRNAs that mediate 
RdDM usually derive from repetitive elements of viral or centromeric origin [52]. The 
silencing cycle is initiated by exogenous dsRNA molecules, or when the plant specific RNA 
PolII homologue RNA PolIV transcribes precursor RNAs, which are used as templates by the 
RdRP RDR2 and turned into dsRNA molecules [54]. dsRNAs are subsequently processed 
into siRNAs by Dicer-like 3 protein (DCL3) [55]. These siRNAs are then loaded onto the 
plant Argonaute proteins, including the Ago4 [56]. siRNA-loaded Ago4 is guided via 
base-pairing interactions to nascent transcripts produced by another homologue of PolII – 
RNA PolV [57]. The target recognition and binding is supported by a direct interaction 
between Ago4 and the GW repeats of the C-terminal domain of RNA PolV [58]. Ago4, 
through an interaction with the RDM1 protein recruits the de novo DNA methyltransferase 
DRM2 to the loci transcribed by RNA PolV, which leads to establishment of DNA 
methylation and CDGS [59]. 
It is believed that RdDM and TGS are also potentiated through a self-reinforcing loop that 
involves siRNAs, DNA methylation and H3K9 methylation [60]. Genomic regions 
undergoing RdDM in A. thaliana are also enriched with H3K9me marks [60]. 
siRNA-directed DNA methylation is required for recruitment of the plant H3K9 
methyltransferase SUVH4 (also known as KYP), and small RNAs were shown directly to be 
necessary for high levels of H3K9 methylation [61]. In turn, it was also suggested that 
SUVH4 and its homologues contribute to the maintenance of RdDM [60]. These findings 
suggest a complex interplay between the components of RdDM pathway, but also point 
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towards the importance of epigenetic feedback loops in maintenance of a heritable chromatin 
state.  
 
RNAi-mediated H3K9 methylation in somatic cells of C. elegans 
 
In somatic cells of C. elegans, exogenous dsRNA triggers a classical RNAi response, in 
which dsRNA is processed into primary siRNAs by the Dicer homologue Dcr-1 [62], [63]. 
Primary siRNA are bound by the Argonaute homolog RDE-1 and elicit siRNA-mediated 
PTGS (outlined in section 3.1.2). However, some of the RDE-1-bound siRNAs, with the help 
of the RdRP homologue RRF-1 induce generation of secondary siRNAs called 22G-RNAs 
[64]. In the cytoplasm, 22G-RNAs are then loaded on several Argonaute proteins and can 
further support PTGS initiated by the primary siRNAs. However, when a 22G-RNA gets 
loaded on the specific Argonaute homologue NRDE-3, it guides it to nascent transcripts, 
where they recruit the silencing factor NRDE-2 that promotes H3K9 methylation and inhibits 
transcription elongation [65]. This silencing pathway is known as the NRDE pathway. It was 
reported that transcriptional silencing by the NRDE pathway could be inherited through 
generations, yet the silent state was later described as not very stable [66], [67]. Much more 
evidence for stable epigenetic silencing mediated by small RNAs comes from the germline of 
C. elegans, where another class of small RNAs called piRNAs confers heritable TGS, sharing 
some nuclear components of the aforementioned NRDE pathway [67]. I will discuss germ 
line nuclear RNAi in C. elegans further in the Discussion.  
 
piRNA-mediated control of transposable elements  
 
piRNAs constitute a distinct class of small RNAs that play a key role in suppression of 
transposable elements (TE) during animal germline development. piRNAs are longer than 
other small RNAs, ~24-32 nt long. They are bound by a clade of Argonaute proteins called 
the PIWI proteins, and most importantly, they do not depend on the activity of Dicer 
nucleases for their biogenesis [68]. Our current understanding of the piRNA pathway comes 
from studies in Drosophila melanogaster and mice [69].  piRNA biogenesis begins with the 
production of primary piRNAs from long precursors that are transcribed from genomic loci 
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called piRNA clusters [70]. Primary piRNAs are antisense to the transcripts of TE and, upon 
loading on the PIWI proteins Aubergine (Aub) or Piwi, they can mediate cleavage of the 
transposons in a classic PTGS event. The initial cleavage event is not only destroying the 
active transposon, but also providing a sense transposon transcript for the so-called piRNA 
ping-pong cycle, in which the sense and antisense piRNAs can be amplified to potentiate the 
silencing response. The ping-pong cycle was first proposed based on extensive small RNA 
deep-sequencing experiments performed with Drosophila ovaries [70], [71]. In the 
Drosophila germline, the PIWI proteins Piwi and Aub associate predominantly with piRNAs 
antisense to TE, whereas the third PIWI protein, Ago3, is mainly loaded with sense piRNAs 
[70]. It was observed that sense and antisense piRNAs originating from the same TE overlap 
precisely by 10 nt. This position corresponds to the distance at which the target RNA 
molecules are cleaved by piRNA-loaded PIWI proteins. In the ping-pong cycle model, 
antisense piRNAs direct Aub to cleave the sense TE transcripts and the remaining cleavage 
products serve as the source of secondary, sense piRNAs. Sense piRNAs associate with Ago3 
and mediate the subsequent cleavage of antisense transcripts derived from piRNA clusters. 
Importantly, only piRNAs against actively transcribed transposons will trigger the ping-pong 
cycle to amplify the response [70]. However, since primary piRNAs are produced from 
piRNA clusters, the basic defense line is always present in the cell. Importantly, it was shown 
in Drosophila that, in addition to conferring the classical PTGS towards active transposons, 
piRNAs also target TE at the transcriptional level [72]. The piRNA-loaded Piwi protein 
directs the deposition of H3K9 trimethylation at the transposons in the genome. In turn, the 
HP1 homologue Rhino recognizes the H3K9 trimethylated loci and, together with the Cutoff 
protein, marks them as templates for the production of piRNA precursors [73]. The existence 
of the piRNA pathway has also been confirmed in zebrafish, Xenopus and mammals. 
Importantly, the role of piRNAs in transcriptional silencing of transposons via de novo DNA 
methylation was also confirmed in mice [71], [74]. Taken together, the piRNA pathway 
provides another great example of a positive feedback loop, which combines interdependent 
chromatin modifications and small RNA production to elicit efficient transposon silencing 
through a combination of TGS, CTGS and PTGS.  
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3.1.5 Inducible RNAi-mediated gene silencing in trans  
 
The phenomenon of RNAi is not only an interesting regulatory mechanism, but it has proven 
itself as a very powerful technology that advanced modern genetics. Shortly after the RNAi 
phenomenon was described, scientists learned how to use small RNAs to induce gene 
silencing at a post-transcriptional level with synthetic siRNAs [75]. However, in order to 
obtain a stable and heritable effect, this method requires constant supply of the small RNAs. 
To circumvent this problem, hairpin-expressing constructs were developed and became a 
tool, which until recently was the method of choice for long-term gene silencing [76], [77]. 
However, when using hairpin constructs, maintenance of the silent state relies on integration 
of the construct into the genome. Lately, more efficient alternatives have become available 
[78]. Genome-editing technology based on bacterial-origin TALENs (transcription activator-
like effectors nucleases) turned out to be a very feasible method to interfere with gene 
expression. TALENs can be engineered to bind almost any genomic sequence and mediate its 
cleavage, which can be subsequently repaired using a provided template DNA. As a result, 
one can generate gene knockouts, conditional alleles and tagged genes of choice in a 
relatively fast and efficient way. Most recently, a new genome-editing approach using the 
CRISPR-Cas9 system has been developed. CRISPR-Cas9 uses RNA molecules to target the 
desired sequence, so it is much easier to adapt for editing different genomic sequences and 
circumvents the need for designing and cloning new TALENs for every experiment. 
However, both of the approaches involve induction of permanent and irreversible changes in 
the sequence of the gene [78].  
Better understanding of the nuclear RNAi pathways in fission yeast and plants prompted the 
idea to use small RNAs to induce transcriptional gene silencing of desired genes. The 
obvious advantages of this system would be the heritability and reversibility of the 
repression, which could not be achieved by the approaches mentioned above. In S. pombe, 
the first attempts to use hairpins to induce gene silencing led to a conclusion that ectopic 
siRNAs can induce RNAi-mediated silencing of a euchromatic reporter, but at the 
post-transcriptional level [79]. Importantly, despite all the factors being present, the provided 
hairpin did not induce CDGS. The induced effects were not very strong, but it was an 
interesting observation as it showed that the yeast RNAi machinery can be programmed with 
any sequence to silence gene expression. However, the observations made by Zamore and 
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colleagues [79] could not be reproduced by other groups including ours (see the Results 
section and Figure 5 and 6). 
Later on it was shown that siRNA-mediated TGS of chosen genes is highly dependent on 
several conditions. At first, the ura4+-targeting hairpin was shown to induce silencing of the 
ura4+ gene, but only upon overexpression of the HP1 protein Swi6 [80]. Furthermore, it was 
observed that maintenance of the silent state required constant presence of the small RNA 
source. It was subsequently suggested that siRNA-mediated gene silencing in trans was 
under negative control of the small RNA nuclease Eri1, and could be enhanced when the 
eri1+ gene had been deleted [35]. Finally, a study by Allshire and colleagues suggested that 
siRNAs could induce gene silencing by H3K9 methylation in trans, but only at a small 
number of genomic loci and the silencing effect was weak and unstable [81]. The authors 
observed stronger silencing when the ura4+ gene was inserted in close proximity to 
constitutive heterochromatin and no silencing at all at the endogenous ura4+ locus. 
Importantly, all the studies mentioned above use the ura4+ gene as a reporter, and test the 
expression of this reporter with a silencing assay on medium containing 5-Fluoroorotic acid 
(5-FOA). 5-FOA is toxic to cells when the ura4+ gene is active, so performing a silencing 
assay by growing cells on the 5-FOA-containg plates may create selective pressure and give a 
false idea of the efficiency of the process.  
The potential of siRNAs to direct heritable heterochromatin states has also been tested in 
plants. With pathways executing siRNA-mediated DNA methylation and DNA 
methylation-dependent chromatin modifications, Arabidopsis seems to be a very promising 
model system to induce heritable TGS. Initial experiments confirmed that, by providing a 
promoter-targeting hairpin as a source of dsRNA, it was possible to induce DNA methylation 
of a provided transgene [82]. Subsequent studies provided more evidence for siRNA-directed 
DNA-methylation, yet it was shown that susceptibility of individual transgenes to such 
modifications depended on their pre-existing chromatin state [83]. The authors suggested that 
transgenes containing tandem repeats recruit the siRNA-producing machinery, but TGS 
might be only established once the target locus had already some pre-existing DNA 
methylation marks.  
Reports of siRNA-mediated TGS in mammalian cells have been rather ambiguous. Several 
groups tested the idea of siRNA-mediated programmable TGS by providing synthetic 
siRNAs targeting promoters of chosen genes, but the results they obtained were sometimes 
contradictory. It was shown that transient transfection with synthetic siRNAs can lead to 
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induction of low levels of H3K27 methylation and H3K9 methylation at the RASSF1A gene 
promoter [84]. The enrichment of histone marks correlated with an increased occupancy of 
Ago1 and the EZH2 histone methyltransferase, but no evidence was provided for the role of 
these chromatin modifications in gene repression. On the contrary, the authors observed that 
the siRNA-mediated repression was dependent on the TRBP2 protein, a component of the 
RISC complex from the canonical siRNA pathway (See section 3.1.2). The authors reported 
also an accumulation of low levels of DNA methylation, but only if the transient transfection 
was replaced by a stable integration of a hairpin construct expressing promoter siRNAs. 
Therefore, neither the contribution of TGS to the observed repression of the RASSF1A gene, 
nor the heritability of the induced state could be concluded from this study.  
On the other hand, other groups who also provided examples of siRNA-mediated repression 
of gene promoters observed opposite effects on DNA methylation [85]. Finally, the most 
recent studies support a different model of siRNA-mediated TGS, in which promoter-directed 
siRNAs induce gene repression by interfering with the assembly of the pre-initiation complex 
[86], [87].  
Taken together, despite our good understanding of siRNA-mediated regulation of gene 
expression, the efforts to apply this knowledge to induce stable and heritable repression of 
desired genes encountered some inherent difficulties.  
 
3.2 The Paf1 complex 
3.2.1 Discovery, composition and conservation of the Paf1 complex 
 
The Polymerase-Associated Factor 1 (Paf1) complex is a highly conserved protein complex 
associated with RNA PolII, which is believed to regulate multiple aspects of the PolII 
transcription cycle. The Paf1 complex was initially found in Saccharomyces cerevisiae 
through an affinity purification experiment that aimed at identification of general 
transcription factors associated with RNA PolII [88]. Initially, two subunits of the complex 
had been found – Paf1 and Cdc73. Subsequently, several groups showed that Paf1 forms a 
nuclear complex with four other proteins: Ctr9, Rtf1, Leo1 and Cdc73, and confirmed the 
association of the complex with PolII by biochemical and proteomic approaches [89–91].  
Importantly, a vast majority of the current knowledge about Paf1 complex composition and 
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function has been obtained from studies performed in budding yeast. These findings serve us 
as a starting point for our work on the Paf1 complex in S. pombe. 
The amino acid sequence of the Paf1 complex components, as well as the interactions 
between the Paf1 complex subunits are generally well conserved from yeast to higher 
eukaryotes, including humans [92], [93] However, some small differences in the composition 
of the complex were reported. The Rtf1 homolog was found to be rather loosely associated 
with the complex in higher eukaryotes including human, therefore it is not considered as the 
core component in these organisms [92–94]. Furthermore, an additional protein – Ski8 was 
reported to form the core human Paf1 (hPaf1) complex and to associate with Paf1 on 
chromatin [92]. Ski8 is also a component of the human SKI complex, which is involved in 3’ 
to 5’ end mRNA degradation events [95]. Identification of a stable association between the 
conserved Paf1 components and hSki8 implicated a role for the hPaf1 complex in RNA 
surveillance mechanism in the cellular nucleus [92].  
In fission yeast, the core Paf1 complex comprises Paf1, Leo1, Cdc73 and Tpr1 (homolog of 
S. cerevisiae Ctr9) [96]. Unlike in S. cerevisiae, the Rtf1 homolog (which in the fission yeast 
is called Prf1) does not form a stable association with the other four subunits [96]. This 
finding is consistent with the composition of the Paf1 complex in metazoans, arguing for S. 
pombe as a more suitable model organism to study functions of the Paf1 complex, if one 
wants to extend the findings and conclusions to the higher organisms.  
 
3.2.2 Interactions of Paf1 complex with RNA PolII and chromatin 
 
The Paf1 complex is physically associated with RNA PolII. It has been shown that the yeast 
Paf1 complex interacts with PolII through two subunits, Cdc73 and Rtf1 [90], [97]. Cdc73 is 
believed to serve as a direct contact point with the polymerase, whereas the interaction with 
Rtf1 probably occurs through Spt5, a component of the DSIF (DRB sensitivity inducing 
factor) transcription elongation factor [97]. Mutations of any of these two subunits result in 
dissociation of the complex from chromatin, however the remaining subunits are believed to 
remain in association with each other [89], [98]. For the hPaf1 complex, direct interactions 
with RNA PolII were reported for Paf1 and Leo1 [99] (See Figure 2).  
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Studies on single gene examples showed that the S. cerevisiae Paf1 complex associates 
together with PolII at the promoters, transcription start sites (TSS) and along the open reading 
frames (ORF) of active genes [100]. However, a genome-wide meta gene analysis revealed 
that the Paf1 distribution along the gene body resembles a typical elongation factor pattern – 
with high enrichment starting over 100 base pairs downstream to the TSS and dropping 
abruptly at the polyadenylation (polyA) site [101]. In contrast, RNA PolII continues 
downstream and remains associated with chromatin until the transcription termination signal. 
Importantly, as demonstrated by the same study, Paf1 chromatin occupancy correlates with 
profiles obtained for general transcription elongation factors on active genes, and the Paf1 
complex enrichment on chromatin is proportional to the activity of the gene [101]. In our lab, 
we also assayed genome-wide binding of the Paf1 complex to chromatin in fission yeast and 
mouse cells (Alex Tuck, personal communication) and obtained a similar profile of Paf1 
distribution along the genes. However, we still know little about recruitment of the Paf1 
complex in the fission yeast.  
 
3.2.3 Recruitment of the Paf1 complex 
 
In the budding yeast, recruitment of the Paf1 complex to chromatin is believed to occur 
through the yeast homolog of the pTEFb complex, comprising of the cyclin-dependent kinase 
Bur1 and its partner cyclin - Bur2 [102]. The Bur1 kinase has multiple substrates, including, 
most notably, the Rpb1 subunit of RNA PolII [103]. Bur1 is well known to be responsible for 
phosphorylation of Serine 2 (Ser-2) of the Rpb1 C-terminal domain (CTD), which is an 
important step in licensing RNA PolII for transition from transcription initiation to elongation 
[103]. Bur1-mediated phosphorylation of another important substrate – Spt5 – is necessary 
for recruitment of the Paf1 complex to chromatin [104], [105]. Spt5 together with Spt4 form 
the DSIF transcription elongation factor, which associates with PolII at the beginning of 
ORFs [104], [105]. The phosphorylated Spt5 is believed to mediate the interaction between 
RNA PolII and the Paf1 complex through its subunit Rtf1 [106]. This model is also consistent 
with observations made in higher eukaryotes. 
A second, possibly redundant mechanism of recruitment was recently postulated in S. pombe 
[96].  As mentioned above, in fission yeast the Prf1 (Rtf1) subunit is not stably associated 
with the rest of the complex. It was observed that phosphorylation of Spt5 by the Bur1 kinase 
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homolog Cdk9 is required for Prf1 recruitment to chromatin, but recruitment of the remaining 
components of the Paf1 complex is dependent on some other substrate of Cdk9, likely the 
CTD of Rpb1. Thus, according to this model, recruitment of the Paf1 complex to chromatin 
would occur in two steps. Different mechanistic requirements for the recruitment of Prf1 and 
the rest of the complex could have implications in distinct functions of this subunit in S. 
pombe.  
Several other recruitment models have been proposed for budding yeast and higher 
eukaryotes. Single locus studies and in vitro assays point at the role of phosphorylation status 
of Ser-2 and Ser-5 in the CTD of Rpb1 [107], as well as the Spt6 kinase [108], the 
components of the FACT chromatin remodeling complex [109], and the Not4 component of 
the Ccr4-Not complex [110]. 
Taken together, these and other evidence show that the exact recruitment mechanism of the 
Paf1 complex remains unclear and most likely, is a combinatorial effect of multiple steps and 
contact points between the Paf1 complex, transcription factors and the RNA PolII itself.  
 
3.2.4 Genetic properties of the Paf1 complex and intracomplex interactions  
 
Mutations causing deletions of individual components of the Paf1 complex are viable in both 
S. cerevisiae and S. pombe [96], [111]. In contrast, in higher eukaryotes Paf1 complex is 
essential for viability, as homozygous mutations of any of the Paf1 complex genes are lethal 
at an early embryonic stage [93], [112]. 
Although mutations of the individual components are viable, different mutant strains exhibit 
phenotypes of different strength in both fission and budding yeast. Notably, it was reported 
that deletions of Paf1 and Ctr9 in the budding yeast show the most severe growth phenotype 
under various growth conditions [111]. Curiously, certain double combinations of the severe 
paf1Δ or ctr9Δ mutations with the milder leo1Δ or rtf1Δ lead to partial rescue of growth 
sensitivity in stress conditions like DNA damage, heat shock, osmotic stress or 
caffeine-induced stress [89]. 
In S. cerevisiae it was shown that loss of individual components of the complex had a 
consequence on the cellular levels of the other subunits[113]. The authors performed a 
comprehensive analysis of these interdependencies at the protein level. Most notably, the 
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presence of Ctr9 is necessary for normal expression levels of all the other subunits, and the 
loss of Paf1 affects the levels of all other components except for the Leo1. These 
observations are consistent with the fact that the Ctr9 and Paf1 mutants exhibit the most 
severe growth phenotypes [111]. Presumably, in these mutants, the integrity of the complex 
is the most affected, whereas deletions of the other subunits still allow at least partial activity 
of the complex.  
Figure 2 illustrates a Paf1 complex interaction map created based on the data obtain for the 
yeast, Drosophila and human Paf1 complex [114]. Many of the depicted interactions are 
conserved in eukaryotes. Paf1 appears to be the most central subunit of the complex, as it 
interacts with PolII and all remaining subunits of the complex except for Ski8. Unfortunately, 
such a comprehensive study for the fission yeast Paf1 complex is not available. 
The phenotypic differences described above imply that the contribution of the individual 
components to the Paf1 complex activity might be different, or they may elicit additional 
roles in the cell. Although not much functional evidence has been acquired so far, both in the 
budding and fission yeast the Rtf1 homolog has been suggested to play a Paf1-independent 
role in chromatin remodeling and histone modifications [96], [115]. 
 
 
Figure 2. Summary of inter- and intracomplex interaction partners of the Paf1 complex identified in budding 
yeast, Drosophila and human. Recreated based on [112]. 
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3.2.5 Main molecular functions of the Paf1 complex 
 
The Paf1 complex serves multiple functions in contributing to the efficiency of transcription 
by Pol II and formation of the 3’end of cellular mRNAs. Many of these roles are conserved 
from yeast to human. In particular, gathered evidence strongly supports the role of the Paf1 
complex in facilitating transcription elongation, recruitment of chromatin modifiers 
responsible for transcription-coupled chromatin modifications, as well as efficient 
transcription termination and production of functional, stable mRNAs. Although connections 
of Paf1 complex to other cellular processes have been suggested [116], in this introduction I 
will focus only on the conserved molecular functions of the Paf1 complex that are related to 
transcription and general RNA expression.    
 
Role of the Paf1 complex in promoting CTD phosphorylation 
 
The C-terminal domain (CTD) of the large subunit of RNA Polymerase II – Rpb1 contains 
tandem repeats of a sequence of seven amino acids, which are modified in a specific order 
throughput the transcription cycle. When transcription begins, the CTD of a newly recruited 
Rpb2 is not phosphorylated. Upon transcription initiation, CTD repeats are phosphorylated 
on serine 5 (Ser-5) and serine 7 (Ser-7) and subsequent phosphorylation of serine 2 (Ser-2) 
residues contributes to regulation of the transcription cycle, and transition from the initiation 
to the elongation phase. A modified CTD serves as a platform for the recruitment of 
transcriptional regulators specific for different phases of the transcription cycle, thanks to the 
different specificities towards the CTD phosphorylation pattern. Paf1 complex has been 
shown to contribute to the proper levels of Ser-2 phosphorylation within the ORFs of actively 
transcribed genes [98], [113]. This, in turn, has consequences in recruitment of downstream 
factors that shape the proactive transcription environment, like in the case of the Set2 
methyltransferase, which governs methylation of histone H3 lysine 36 (H3K36) in the ORF 
of actively transcribed genes [117].  
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Contribution of the Paf1 complex to co-transcriptional chromatin modifications 
 
In the genomic context histone proteins that form nucleosomes are frequently modified on the 
post-translational level in patterns reflecting the transcriptional activity of the underlying 
genes [118]. Multiple studies linked the activity of the Paf1 complex to several of these 
histone modifications. Importantly, roles of the Paf1 complex in transcription-coupled 
chromatin modifications have been well established both in yeast and human cells, pointing 
towards high conservation of these molecular functions. In both budding yeast and human, 
the Paf1 complex has been shown to promote histone H2B lysine 123 monoubiquitination 
through recruitment of the ubiquitin-conjugating enzyme Rad6 and the ubiquitin ligase Bre1 
[119]. Importantly, monoubiquitination of this residue is necessary for another chromatin 
modification – Set1-mediated methylation of H3K4, which is enriched at gene promoters and 
5’ regions of CDS [120].  Stimulation of the H2BK123 ubiquitination by the Paf1 complex is 
also a prerequisite for H3K79 methylation [121]. The role of the Paf1 complex in deposition 
of both of these modifications is well described [122] and conservation of all of its molecular 
functions in governing these processes was shown in human cells [99], [109].   
Histone H3 K36 trimethylation, a chromatin mark located in the bodies of actively 
transcribed genes was also shown to be dependent on the Paf1 complex components Ctr9, 
Cdc73 and Paf1 in yeast [123]. However, the role of the Paf1 complex in this process is 
indirect, as it was shown that recruitment of the Set2 methyltransferase, which methylates 
H3K36, depends on Ser-2 phosphorylation [117] of the RNA Pol II CTD and the Paf1 
complex is necessary for the high levels of CTD phosphorylation at the actively transcribed 
genes [113].  
Taken together, the Paf1 complex seems to play a highly conserved role by having a direct 
and indirect influence on the status of chromatin at actively transcribed genes. Paf1 shapes 
the local chromatin landscape by supporting proper distribution of histone modifications. 
Histone marks contribute to an open chromatin structure by themselves, but they are also read 
by chromatin factors that recognize modification patterns and further facilitate gene 
transcription. Therefore, Paf1 plays an important role in creating a right transcription 
environment and ensuring the proper gene expression. Contribution of the Paf1 complex to 
correct patterns of histone modifications has also been confirmed in plants, where Paf1 was 
shown to be crucial for correct distribution of the H3K4 trimethylation and H3K36 
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dimethylation [124]. Effects of the Paf1 deficiency were especially prominent for highly 
transcribed genes like the family of FLC, whose expression is highly dependent on the Paf1 
complex. 
 
Role of the Paf1 complex in regulation of transcription elongation 
 
Although the Paf1 complex was initially identified as an elongation factor [125], its 
connection to transcription elongation is often based on co-purification studies, rather than on 
direct evidence. For example, the Paf1 complex was shown to associate with the FACT 
complex (Facilitates Chromatin Transcription), which is a highly conserved factor acting as a 
histone chaperone promoting transcription through nucleosomes in the chromatin 
environment [126]. It was suggested that the Paf1 complex contributed to the interaction 
between RNA PolII and FACT [93]. Furthermore, cooperative interaction between Paf1 
complex, PolII and DSIF (DRB Sensitivity Inducing Factor) was also reported [127]. DSIF is 
another conserved complex involved in regulation of the RNA PolII pausing at the transition 
from transcription initiation to elongation [103]. Finally, in the human cells a cooperative 
effect of Paf1 complex and the TFIIS elongation factor on transcription elongation was 
described.  
The reported physical interactions with the important elongation regulators like FACT in 
Drosophila, DSIF and TFIIS in human strongly suggest the involvement of the Paf1 complex 
in the regulation of transcription elongation in vivo. However, it is often difficult to 
distinguish between direct and indirect effects. For instance, it was suggested that Paf1 
contributed to transcription facilitation through the activity of FACT [93]. However, this 
function was dependent on the Paf1-mediated H2B ubiquitination which stimulates FACT 
(see above), rather than on the direct Paf1 activity [109]. 
Direct evidence for the involvement of the Paf1 complex in transcription elongation came 
from elegant in vitro studies. It was shown that the recombinant human Paf1 complex alone 
and in cooperation with another elongation factor Dst1 facilitate transcription in the in vitro 
transcription reconstitution assays with artificial templates [99]. Importantly, these 
experiments showed the activity of the Paf1 complex independently of any chromatin 
modifying activity and thanks to the use of the recombinant transcription complex with a 
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pre-initiated nascent transcript – that the Paf1 function is specific to the elongation phase of 
transcription.  
 
Role of the Paf1 complex in transcription termination and RNA 3’end formation 
 
Besides contribution to the transcription process itself, the Paf1 complex conveys interesting 
functions in transcription termination and processing of the 3’ end of the nascent transcript. 
In yeast, it was observed that deletion of the components of the Paf1 complex results in 
global reduction of the length of polyA tails of cellular mRNAs [113]. This is an interesting 
observation since it provides an alternative explanation for the curious fact, that despite the 
that Paf1 complex is a general transcription regulator, the Paf1 mutant yeast cells exhibit 
changes in RNA expression levels only for a relatively small subset of genes [128]. In turn, 
changes in the length of polyA tails could affect the stability for only some mRNAs and 
explain this modest effect. In addition to shortening of the polyA tails, alternative usage of 
the polyadenylation signals for several mRNAs was also reported [128]. The authors of this 
study show that, despite the established role in regulation of transcription, Paf1 complex 
contributes to the control of the RNA expression through ensuring the proper transcription 
termination independently of the RNA PolII. On the molecular level, this effect could be 
explained by the fact that the Paf1 complex mutants show decreased recruitment of the 
cleavage and polyadenylation factors Pcf1 and Ctf1 [98], [113]. Less evidence for the 
involvement of the human Paf1 complex in transcription termination is available. However, 
most importantly, interactions between the Paf1 complex and several components of the 
Cleavage and Polyadenylation Specificity Factors (CPSF) and Cleavage and stimulation 
Factor (CstF) complexes were reported in human cells [129]. In agreement with the studies 
done in yeast, upon depletion of the Paf1 complex components, decrease in chromatin 
association of the CPSF and CstF, as well as read-through transcription were also observed in 
human.  
Finally, in addition to the involvement in mRNA processing outlined above, the Paf1 
complex was also implicated in transcription termination and processing of the newly 
synthesized small nucleolar RNAs (snoRNAs), possibly through the recruitment of a known 
factor involved in snoRNA 3’-end formation, an RNA-binding protein Nrd1 [130]. As this 
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process is mechanistically distinct from 3’end formation of the mRNAs, this study provides 
an example of another molecular function of the Paf1 complex.  
 
3.2.6 Connections of the Paf1 complex to cancer 
 
Multiple mutations in the genes encoding for the Paf1 complex subunits were found to be 
associated with cancer. Interestingly, individual subunits of the Paf1 complex were shown to 
act as both tumor suppressors and oncogenes. This suggests that the role of Paf1 complex in 
human is quite complex, since the opposite effects of mutations of the Paf1 genes cannot 
always be explained simply by a loss the Paf1 complex activity in regulation of the 
transcriptional events.  
The subunit of the Paf1 complex most often associated with tumorigenesis is the homologue 
of the yeast Cdc73 protein called parafibromin in human [131]. Parafibromin, which is 
encoded by the CDC73 gene (also known as HRPT2), was described as a tumor suppressor  
 
Table 1. Mutations in the CDC73 gene found in the germline of cancer patients. Table was adapted from [132] 
Mutationa Codonb Predicted effectc Clinical manifestationd Reference 
3G>C 1 Met1 HPT-JT [133] 
12_31dup 11 Tyr11Cys, fs STOP 17 HPT-JT [133] 
20_24del, insCCCT 7 Val7Ala fs STOP15 HPT-JT [134] 
22delC 8 Leu8Arg fs STOP13 HPT-JT [135] 
25C>T* 9 Arg9STOP HPT-JT [132], [133], [136] 
30delG 10 Gln10His fs STOP11 HPT-JT [133] 
34_40del 12 Asn12Arg fs STOP7 HPT-JT [133] 
40delC* 14 Gln14Arg fs STOP7 HPT-JT [133] 
62_66del 21 Lys21Arg fs STOP43 FIHP [137] 
76delA* 26 Ile26Ser fs STOP11 HPT-JT [138] 
96G>A 32 Trp32STOP HPT-JT [139] 
127_128 insC 43 Trp43Ser fs STOP23 sporadic PTC [140] 
131+1G>A NA Splice [d] FIHP [141], [142] 
140_144del 47 Lys47Arg fs STOP17 FIHP [143], [144] 
162C>G* 54 Tyr54STOP sporadic PTA [145] 
165C>G 55 Tyr55STOP HPT-JT [133] 
176C>T 59 Ser59Phe # Sporadic PTC [146] 
188T>C 63 Leu63Pro FIHP, HPT-JT [132], [147] 
191T>C 64 Leu64Pro FIHP [138], [148] 
226C>T* 76 Arg76STOP HPT-JT [132] 
237+1G>C NA Splice [d] FIHP [148] 
238_1G>A NA Splice [a] HPT-JT [149] 
272G>C 91 Arg91Pro # sporadic PTA [145] 
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206_307 del 103 Ser103Asn fs Stop 5 HPT-JT [133] 
343G>T 115 Glu115STOP sporadic PTC, PTA [143], [150] 
356delA 119 Gln119Arg fs STOP 14 HPT-JT [133] 
375dupA 126 Arg126Thr fs STOP5 sporadic PTA [151] 
374_375 dup 126 Arg126Asn fs STOP8 FIHP [147] 
406A>T 136 Lys136STOP HPT-JT [133] 
415C>T 139 Arg139STOP HPT-JT [152] 
518_521del 174 Ser174Lys fs STOP27 sporadic PTC, FIHP [137], [150] 
639delT 213 Phe213Leu fs STOP6 HPT-JT [133] 
668_669delinsG 223 Asp223Gly fs STOP34 HPT-JT [153] 
679_680insAG 227 Asp227Lys fs STOP31 HPT-JT, sporadic PTC, FIHP [133], [151], [153], [154] 
685_688del 229 Arg229Tyr fs STOP27 FIHP [155] 
687_688del 229 Arg229Ser fs STOP37 HPT-JT [132], [138], [139], [156] 
692-693insT 231 Trp231Cys fs STOP36 sporadic PTC [146] 
700C>T 234 Arg234STOP HPT-JT, sporadic PTC [132], [142], [157] 
745dupA 249 Ile249Asn fs STOP18 FIHP HPT-JT [132], [157] 
765_766del 255 Val255Lys fs STOP10 HPT-JT [158] 
815A>G 272 Asn272Ser # sporadic PTA [159] 
1124-1125dup 376 Asn376Leu fs STOP10 sporadic OF [160] 
1135G>A 379 Asp379Asn HPT-JT [157] 
1239delA 413 Gln413His fs STOP15 HPT-JT [133] 
aLocation of mutations are annotated based on the cDNA of CDC73, assuming that +1 nucleotide corresponds to 
the A from the ATG translation initiation codon. dup, duplication; del, deletion; ins, insertion; > substitution 
mutation. * indicate mutations identified also in somatic cells.  
b+1 codon is the ATG translation initiation codon.  
c predicted effect of the identified gene mutation at the protein level. Splice [d], donor splice site; Splice [a], 
acceptor splice site; fs, frame shift; number after STOP annotation indicates at which codon position after the 
mutation comes the premature stop codon. # marks missense mutations.  
d Clinical manifestation of the disease. HPT-JT, hyperparathyroidism-jaw tumor syndrome; PTC, parathyroid 
carcinoma; PTA, parathyroid adenoma; OF, ossifying fibroma; FIHP, familial isolated primary 
hyperparathyroidism.  
 
 
that is frequently linked to both sporadic and familial incidents of parathyroid cancer (PTC) 
[133]. Hereditary forms of PTC are often connected to the hyperparathyroidism-jaw tumor 
(HPT-JT) syndrome. Multiple mutations in the CDC73 gene were identified in the families of 
the patients with HPT-JT syndrome, and these mutations were found to predispose the 
carriers to parathyroid cancer [151]. Until the year 2010, the total number of 77 different 
mutations in the CDC73 gene was described in both sporadic and familial disease incidents 
[132]. I summarized mutations of the CDC73 gene that were found in the germline of 
affected patients in the table below (Table 1). Identified gene variations were most frequently 
mapped as point mutations or frame-shift insertion and deletions that created a premature 
stop codon in one of the first exons of the gene [132]. The mutations were frequently present 
in the N-terminal domain of the protein and resulted either in loss of the protein due to 
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nonsense-mediated decay of the aberrant mRNA, or in expression of a C-terminal truncated 
forms of Cdc73 [132]. Interestingly, the missing C-terminal part shares the highest homology 
to the yeast Cdc73 and was found to be responsible for interaction of the Cdc73 homologue 
with RNA PolII and the Paf1 complex [131][161]. Such truncation leads to reduction of 
binding of the entire complex to PolII and its recruitment to chromatin [131], [161].  
 
Table 2. Mutations in the CTR9 gene found in the Wilms tumor families. Table was prepared based on [162]. 
aLocation of mutations are annotated assuming that +1 nucleotide corresponds to the A from the ATG 
translation initiation codon. > substitution mutation; 1194+2 and 1194+3 indicate intronic sequences +2 and +3 
nt after the end of the previous exon.  
b+1 codon is the ATG translation initiation codon.  
c predicted effect of the identified gene mutation at the protein level. Splice [d], donor splice site; 1194+2T>C 
and 1194+3A>C result in an in-frame deletion.  
d Clinical manifestation of the disease. All patients developed Wilms Tumor.  
 
 
An alternative explanation of the deleterious consequences of the mutation was that the 
C-terminal truncated form of parafibromin lost its nuclear localization signal (NLS) [161]. 
Loss of recruitment of parafibromin to chromatin was suggested to cause activation of genes 
encoding cell cycle regulators and pro-survival factors, what explains the tumor suppressor 
function of the Cdc73 homologue [162]. In line with the findings presented above, 
overexpression of the parafibromin gene, but not the mutant allele found in the cancer 
patients leads to repression of the gene encoding a cell cycle regulator Cyclin D1 [162]. In 
addition to mutations resulting in truncations of the protein, 11 missense mutations were also 
identified [132]. Most of them are present in the N-terminal region of the protein and their 
molecular consequences are unknown. Mutations in CDC73 are not only limited to 
parathyroid tumors. Patients with HPT-JT syndrome, in addition to parathyroid cancer, 
develop tumors in other tissues including uterus and kidneys [163]. 
The gene encoding for a human homologue of the Ctr9 subunit has been also identified as a 
tumor suppressor gene [164]. Mutations in the CTR9 gene were found in selected Wilms 
tumors – a form of pediatric kidney cancer. The Wilms tumor develops usually in very young 
children from embryonic cells that undergo uncontrolled proliferation and differentiation due 
Mutationa Codonb Predicted effectc 
Clinical 
manifestationd Reference 
106C>T 36 Q36STOP Wilms tumor [162] 
1194+2T>C Splice [d] 320-398del Wilms tumor [162] 
1194+3A>C Splice [d] 320-398del Wilms tumor [162] 
 33 
to defects in regulation of cellular development. The authors of this comparative study 
identified three nonsense mutations that were associated with development of the tumor (see 
Table 2). More interestingly, they also found two splice site mutations that lead to the exon 
skipping, resulting in loss of two out of sixteen tetratricopeptide repeat domains that build the 
Ctr9 protein (see Table 2). Finally, upon comparison of the genetic material from the tumor 
and another patient’s tissue, the authors concluded that most likely both of the CTR9 alleles 
need to be mutated to result in carcinogenesis and inheritance of only one of them did not 
cause tumor development [164]. I addition to the Wilms tumor, several reports linked loss of 
the locus encoding for the human Ctr9 protein in breast cancer, neuroblastoma, and 
pancreatic cancer [165].  
In turn, other subunits of the Paf1 complex were reported to play an oncogenic role. 
Duplications of the human PAF1 gene were found in patients with pancreatic and ovarian 
cancer [165]. Intriguingly, this observation points towards the opposite role of two 
components of the same complex - Ctr9 and Paf1 in the pancreatic tumors. The oncogenic 
potential of the PAF1 gene was also directly confirmed, since the overexpression of the 
human Paf1 leads to cellular transformation and tumor formation in vitro and in vivo [166]. 
Duplications of the human LEO1 locus were also found to be associated with several types of 
cancer [165]. On the molecular level, human Leo1 was suggested to interact with components 
of the Wnt signaling pathway, which regulates expression of genes controlling cell fate and 
homeostasis [167]. 
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4 Rationale 
 
In fission yeast, the majority of small RNAs associated with the Ago1 protein constitute 
siRNAs mapping to non-coding centromeric transcripts, and RNAs derived from the 
ribosomal RNA. However, a small portion of endogenous siRNAs that map to protein coding 
genes was also shown to be loaded onto the Ago1 protein [168]. The authors of this study 
suggest that 2% of the Ago1-bound small RNAs comes from degradation products of cellular 
mRNAs and named this class of Dcr1-independent small RNAs primal RNAs (priRNAs). 
PriRNAs are believed to associate with Ago1 and drive the initial step of the siRNA 
amplification loop, leading to deposition of H3K9 methylation. Additionally, convergent 
genes or overlapping transcripts can also serve as a source of dsRNA and undergo processing 
into primary small RNAs. It was observed that upon overexpression of Dcr1, the number of 
small RNAs mapping to such genomic loci heavily increased [169]. 
From the cellular perspective, small RNAs mapping to protein coding genes and constitutive 
heterochromatic siRNAs differ from each other only in terms of abundance. Hypothetically, 
with all the RNAi factors in place, such mRNA-targeting siRNAs could induce spontaneous, 
unregulated formation of heterochromatin throughout the genome and impose a danger on 
cellular gene expression levels.  
Figure 3. We hypothesized that small RNA-mediated heterochromatin formation in fission yeast is 
under control of a repressive factor. We aimed at identifying this repressor by a mutagenesis screen 
approach. See section 4 for detailed description. 
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Since no compelling and consistent evidence for such nucleation events to happen in wild 
type cells had been available, we hypothesized that yeast employed a repressive mechanism 
or factor in order to protect the gene expression from the consequences of endogenous small 
RNAs (Figure 3). We reasoned that by designing an appropriate experimental setup testing 
for the siRNA-mediated in trans gene silencing, we could perform a mutagenesis screen and 
identify the putative repressor.  
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5 Results 
5.1 Forward genetic screen - design and results 
 
In order to identify the suppressors of siRNA-mediated heterochromatin formation in trans, 
we designed a forward genetic screen that we named sms for small-RNA-mediated silencing. 
In the screening approach, we used a reporter strain sms0, which carried a functional ade6+ 
gene at the trp1+ locus on chromosome II (Figure 4A). At the endogenous nmt1+ locus on 
chromosome I, we inserted a construct encoding an RNA hairpin targeting 250 nucleotides of 
the ade6+ gene (ade6-hp), which was expressed from the promoter of the adh1+ gene and 
terminated by the terminator of the endogenous nmt1+ gene (Figure 4B). Additionally, the 
sms0 strain carried at the endogenous ade6+ locus a mutant ade6-704 allele that encoded a 
non-functional form of the Ade6 protein. We chose to insert the ade6+ reporter at the tpr1+ 
locus, because it had been shown before that under conditions when the HP1 protein Swi6 is 
overexpressed, siRNA-mediated heterochromatin silencing of a ura4+ reporter gene can be 
induced in this genomic location [80].  
Use of the ade6+ gene as a reporter provides a great advantage for performing a silencing 
screen, because the activity of this gene can be easily assayed based on the color of the yeast 
colonies grown on Yeast Extract (YE) indicator plates that contain limiting amounts of 
adenine. If the ade6+ gene is silent or mutated, cells grown on such plates are red; in 
contrast, when the ade6+ gene is fully active – cells appear white (Figure 5A, Figure 5B).   
By deep sequencing of small RNAs isolated from the sms0 strain we confirmed that the ade6-
hp construct produced small RNAs complementary to the ade6+ mRNA in high quantities 
(Figure 6A). These small RNAs showed characteristic length and preference for the U base at 
the starting position, which is known to be a signature for siRNAs loaded onto Ago1 (Figure 
6B). Despite the evidence for siRNA production, colonies of the sms0 strain were white on 
adenine-limiting plates (Figure 5B, Figure 6D) and the ade6+ mRNA levels in the sms0 
strain remained unchanged, as compared to the strain without the ade6-hp (Figure 6C). The 
aforementioned observations confirmed the fact that small RNAs cannot induce repression of 
the ade6+ reporter in trans in the wild type cells. Furthermore, overexpression of the HP1 
protein Swi6 in the sms0 strain did not lead to induction of ade6+ reporter silencing (Figure 
6D). In order to identify mutations that would enable siRNA-mediated repression of the 
ade6+ gene in trans, we subjected the sms0 strain to ethylmethansulfonate (EMS) treatment 
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(Figure 7). EMS is a chemical mutagen which alkylates guanine residues in DNA, leading 
predominantly to transition mutations from G:C to A:T pairs. Upon EMS treatment, we 
selected colonies that demonstrated red color. In a screen based on the ade6+ silencing assay, 
loss-of-function mutations in the adenine synthesis pathway would also result in a red 
coloration of the cells, and therefore constitute false-positive hits. In order to eliminate 
false-positive results, red colonies isolated upon EMS treatment were tested for growth in the 
absence of adenine. As a result of this secondary screen, which was followed by four rounds
Figure 4. Scheme representing genomic locations of the source of hairpin-derived small RNAs and 
their target loci in the sms0 strain. A wild type ade6+ gene was inserted upstream of the trp1+ gene on 
chromosome II to create a reporter locus. Endogenous ade6 locus on chromosome III carries a mutant ade6-
m704 allele, which gives rise to non-functional product due to single point mutation: Thr645Ala. ade6-hp 
construct linked to noureseothricin resistance cassette (Nat) was inserted into nmt1+ locus on chromosome I 
B Ade6-hp cassette encodes for a hairpin encompassing 250nt long fragment of the ade6+ gene from the 
base pair 621 to the base pair 870. The hairpin loop sequence comes from the full-length intron of the cox4+ 
gene. The expression of the hairpin is driven from the adh1+ gene promoter and terminated with nmt1+ 
terminator sequence.  Asterisk denotes the site of point mutation in the ade6-m704 allele. Green arrows mark 
locations of the primers used for PCR in ChIP experiments (see Figure 12.). ORF, open reading frame. 
 38 
  
of backcrossing, we obtained ten independent mutants that we named sms1 to sms10 (Figure 
8A). Five of the identified mutants (sms1, sms3, sms4, sms6, sms8) showed ade6+ silencing 
that was dependent on the presence of Dcr1, as the red cell phenotype disappeared when the 
dcr1+ gene was deleted (Figure 8B). The Dcr1-dependent phenotype was consistent with the 
fact, that the same five mutants showed H3K9me2 accumulation over the ade6+ gene (Figure 
8C).  
In order to identify the mutations responsible for the observed silencing phenotype, we 
subjected genomic DNA isolated from the sms1 to sms10 strains to whole-genome next-
generation sequencing (Figure 9A). In the Dcr1-dependant mutants we identified missense 
and nonsense mutations in the following genes: SPBC651.09c, SPAC664.03, 
Figure 5. ade6+ silencing assay. A If the ade6+ gene is active, cells grow white on Yeast Extract (YE) 
medium. If ade6+ gene is mutated or silenced – cells appear red. B The ability of ade6+ hairpin-derived 
small RNAs to silence the trp1+::ade6+ reporter gene was tested by the ade6+ silencing assay using plates 
with decreasing adenine concentrations. Cells carrying the ade6+ gene at the endogenous location, as well 
as the trp1+::ade6+ reporter locus were spotted in ten-fold serial dilutions on YE (See Figure 4). As a 
negative control cells expressing ura4+-targeting hairpin were used. As a positive control cells carrying the 
mutant ade6-m704 allele were also spotted.  
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SPBC13E7.08c, and SPBC17G9.02c (Figure 9B, Table. 3). These genes encoded for 
homologues of four out of five protein subunits of the S. cerevisiae RNA polymerase-
associated factor 1 (Paf1) complex. Since the genes SPAC664.03, SPBC13E7.08c, and 
SPBC17G9.02c had not been described in S. pombe so far, we named them after their S. 
cerevisiae homologues paf1+, leo1+ and cdc73+, respectively. The SPBC651.09c gene, 
which encodes for the homolog of S. cerevisiae Rtf1 had already been named as prf1+ [96]. 
In the remaining five mutants showing the Dcr1-independent red phenotype, mutations were 
mapped to ade6+ and ade7+ genes. These false positive hits were weak loss-of-function 
alleles that were able to survive the secondary screen in the absence of adenine.   
In summary, we have identified five mutations that enabled in trans siRNA-mediated 
heterochromatic silencing in Dcr1-dependent manner in S. pombe. We obtained the mutants 
through an EMS mutagenesis screen approach followed by whole-genome sequencing. All of 
the identified mutations were mapped to genes encoding homologues of subunits of the Paf1 
complex, implicating a repressive role of the Paf1 complex in in trans silencing.  
 
5.2 Validation of the screen results 
 
After identifying the mutant alleles potentially responsible for the silencing phenotype, we 
went on to validate our results by reconstituting the point mutations in the paf1+, leo1+, 
cdc73+ and prf1+ genes in the sms0 strain. All the mutants confirmed the red colony 
phenotype in the silencing assay when the ade6-hp construct was present, and no silencing 
was observed in the absence of the ade6-hp construct (Figure 10A). The ade6+ repression 
was more stable and potent once we picked red colonies for each mutant and propagated 
them in a second silencing assay experiment (Figure 10B). As expected, we could also 
confirm reduced ade6+ mRNA levels in the reconstituted mutants by an RNA expression 
The fifth subunit of the Paf1 complex is called Tpr1. Although in our screen we had not 
recovered any mutations in the tpr1+ gene, we observed that in the strain where the analysis 
endogenous tpr1+ gene had been tagged with 3xFLAG tag on the C-terminus, 
siRNA-mediated repression of the ade6+ reporter was also occurring (Figure 11).  
Tagging of the cdc73+gene with the 3xFLAG also caused the red cell phenotype. We 
concluded that tpr1::3xFLAG and cdc73::3xFLAG act as hypomorphic alleles,  possibly 
affecting the function of the Paf1 complex.  
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Figure 6. ade6-hp-derived siRNAs cannot silence the expression of the ade6+ gene. A Production of 
small RNAs from the stem of the ade6-hp in the sms0 strain was confirmed by next-generation deep 
sequencing. B Histograms illustrating size and the first nucleotide distribution for the sense and antisense 
small RNAs originating from the ade6-hp construct. siRNAs targeting the ade6+ ORF are produced 
efficiently in the wild type strain. siRNAs mapping to the sense and antisense strand of the adh1+ promoter 
and cox4+ intron were also detected. Note that cox4+ siRNAs are almost as abundant as ade6+ siRNAs. C 
ade6+ mRNA levels were measured by RT-qPCR and normalized to act1+ mRNA. Expression of 
ade6+-targeting small RNAs did not lead to repression of the trp1+::ade6+ reporter. Note that ade6+-m704 
trp1::ade6+ strain carries two alleles of the ade6 gene and therefore exhibits two fold higher ade6+ mRNA 
levels. One representative biological replicate is shown. D The inability of ade6+-targeting small RNAs to 
induce silencing of the ade6+ gene was confirmed by the silencing assay at various adenine concentrations. 
Cells carrying the ade6+ gene at the endogenous location, as well as at the trp1+ reporter locus were spotted 
in ten-fold serial dilutions on YE in ten-fold serial dilutions on YE plates. As a negative control cells  
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These results further supported our hypothesis that the Paf1 complex acts as a suppressor of 
the small-RNA-mediated repression of gene activity in trans in fission yeast.  
 
5.3 siRNA-mediated gene repression is due to heterochromatin formation 
 
On centromeric repeats, siRNA-directed gene silencing leads to formation of silent 
chromatin, which is associated with the accumulation of histone H3 lysine-9 methylation 
(H3K9) and leads to reduced transcriptional activity. By performing a chromatin 
immunoprecipitation (ChIP) experiment in the Paf1 complex mutant strains, we detected high 
levels of H3K9 methylation at the trp1+::ade6+ locus in the presence of the ade6-hp (Figure 
12A). We also observed reduced transcriptional activity at the trp1+::ade6+ locus, which 
was demonstrated by lowered H3K36 tri-methylation levels along the ade6+ gene body 
(Figure 12B), as well as reduced PolII occupancy at the end of the gene (Figure 12C). 
Therefore, we could further confirm that the reduction in ade6+ expression in all the Paf1 
complex mutant strains is due to de novo formation of heterochromatin.  
As mentioned above in Section 5.1, the sms0 strain that we used for the screen carries, in 
addition to the functional ade6+ allele at the trp1+ locus, a mutated ade6-m704 allele at its 
endogenous location (Figure 4). Since the mutant allele differs only by a point mutation from 
the wild type ade6+ alele, small RNAs produced from the ade6-hp are also complementary 
to the ade6-m704 transcript. We therefore speculated that siRNA-mediated de novo 
heterochromatin formation would also occur at the ade6-m704 genomic location. As 
expected, we observed high enrichment of the H3K9me2 mark over the ade6-m704 allele in 
all the reconstituted mutants (Figure12D). This further confirmed the in trans nature of the 
heterochromatin formation phenomenon we identified. Importantly, we also detected high 
levels of H3K9 methylation at the ade6-hp locus, indicating that the ade6+-targeting small 
RNAs direct heterochromatin formation in the Paf1 complex mutants also in cis (Figure 
12E). Expression of the nmt1+::ade6-sh+ construct is driven from the adh1+ promoter, and 
it encodes for a hairpin containing a cox4+ intron sequence in the place of the loop (Figure 
4B).   
expressing a ura4+-targeting hairpin were used. As a positive control, cells carrying the mutant ade6-m704 
allele were spotted. Note that overexpression of Swi6 did not lead to establishment of silencing. 
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Interestingly, despite the fact that functional siRNAs targeting both strands of the cox4+ 
intron were detected in high quantities in the sms strains (Figure3B), we did not observe 
accumulation of H3K9 methylation at the cox4+ coding sequence (Figure 12F).  Next, we 
wanted to confirm that in trans silencing was a sequence-independent phenomenon that could 
be used to silence other euchromatic genes. To this end, we created a strain expressing small 
RNAs targeting the endogenous ura4+ gene from the ura4+ hairpin (ura4-hp) construct 
integrated at the nmt1+ locus, and then introduced the paf1-Q264Stop mutation (Figure 13A). 
To test the expression of the ura4+ gene we performed a silencing assay on medium 
containing 5-FOA, which is toxic to yeast cells when the ura4+ gene is active. Paf1 mutant 
cells expressing small RNAs targeting the ura4+ gene grew on the plates with 5-FOA
Figure 7. sms forward genetic screen designed to identify putative repressor of the siRNA-mediated 
transcriptional gene silencing. Scheme depicting the workflow of EMS mutagenesis screen performed in 
this study. Parental strain sms0 was treated with EMS and plated on the YE plates. In the secondary screen, 
red colonies were picked and tested for growth on adenine-depleted medium to eliminate false positive hits 
with mutations in the adenine synthesis pathway. In order to identify clones in which trp1+::ade6+ 
silencing is dependent on siRNAs we deleted dcr1+ in a tertiary screen. Subsequently, upon four rounds of 
backcrossing, positive clones were subjected to whole-genome sequencing in order to map the mutations 
causing the red phenotype.  
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Figure 8. sms screen identifies five independent mutants showing siRNA-dependent repression of the 
ade6+ gene by accumulation of H3K9 methylation. A sms screen gave rise to 10 independent clones 
showing red phenotype on YE plates. Cells carrying an ade6-M210 allele and a heterochromatic copy of the 
ade6+ reporter (otr1R::ade6+) were used as a positive control B Five mutants showed silencing phenotype 
that was dependent on the presence of Dcr1. C Accumulation of the H3K9 dimethyl mark at the 
trp1+::ade6+ gene was tested by ChIP. Enrichments were calculated relative to the ‘no antibody’ control. 
To control for background signal and for ChIP efficiency, scores were normalized to enrichments over the 
adh1+ gene. 
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whereas paf1+ cells did not, suggesting that in the presence of the paf-Q264Stop mutant 
allele, siRNAs induced silencing of the endogenous ura4+ gene, as anticipated (Figure 13 
A). We could also observe silencing of the ade6+ gene at its endogenous location, when 
ade6-hp-derived small RNAs were expressed in the Paf1 mutant strain (Figure 10C).  
We subsequently confirmed that siRNAs generated from a source different than a hairpin 
construct could also effectively silence genes in trans in a Paf1 mutant strain. Using a 
tethering system described before [35] we induced heterochromatin formation and small 
RNA production at the ura4+::5BoxB locus. ura4+-targeting siRNAs produced from this 
locus are necessary to establish heterochromatin formation in cis, but they cannot mediate 
heterochromatin nucleation at the second, euchromatic copy of the ura4+ allele in trans in 
wild type cells [35]. In a paf1-Q264Stop strain, siRNAs generated from the ura4+::5BoxB 
locus could initiate repression of the second, euchromatic ura4+ copy. Notably, 
siRNA-mediated ura4+ repression in trans was more pronounced, when the gene encoding 
for the Eri1 nuclease was deleted. This observation is in agreement with the fact that the 
number of siRNA produced from heterochromatic loci was enhanced upon deletion of the 
eri1+ gene.  
Taken together, we showed that the Paf1 complex controls small RNA-mediated gene 
repression and heterochromatin formation both in cis and in trans, and that this repression 
can occur on different target genes independent of their sequence or chromosomal location.  
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5.4 Genetic requirements for silencing 
 
In order to further characterize heterochromatin formation that is repressed by Paf1 complex, 
we performed a series of gene deletions in a strain carrying the ade6+::trp1 reporter, the 
nmt1+::ade6-hp construct and the paf1-Q264Stop allele to test the genetic requirements for 
maintenance of the ade6+ silent state. We observed that, in addition to being Dcr1-dependent 
(Figure 8B), the ade6+ repression was dependent on Rdp1 and other components of the 
RDRC complex, as well as on Ago1 and members of the RITS and ARC complexes 
(Figure11). Since the silencing was lost in all these canonical RNAi pathway mutants, we 
concluded that continuous production of small RNAs is necessary for maintenance of the 
ade6+ repression. Triman (Tri) is a 3’ exonuclease that was suggested to take part in  
Figure 9. Causative mutations in Paf1 complex were identified using whole-genome next-generation 
sequencing. A Resequencing of EMS-mutagenized S. pombe strains. From outside to inside, the tracks show 
the genomic location, the average coverage per window of 10kb (black line, scale from zero to 30), the 
number of sequence variations identified prior to filtering in all strains per window of 10kb (blue bars, scale 
from zero to 90) and the five mutations that passed the filtering and overlapped with Paf1C genes (red lines, 
the two mutations in Paf1 are too close to be resolved individually) B Mutations from Dcr1-dependent 
clones were mapped to genes encoding homologues of the S. cerevisiae Paf1 complex. Scheme representing 
location of the missense and nonsense mutations is shown. Domains of the highest conservation are marked 
in gray.  
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Table 3 Mutations in the sms hits mapped by whole genome sequencing. 
processing of Ago1-bound precursors of siRNAs and pri-RNAs, in order to shorten them to 
the length suitable for Ago1 binding [170]. Deletion of the Tri gene (tri+) resulted only in a 
mild derepression of the ade6+ gene. This result indicates that Tri does not contribute 
strongly to siRNA-mediated de novo formation of heterochromatin by the hairpin-derived 
small RNAs.  
In addition, we could confirm that siRNA-directed silencing in the paf1-Q264Stop strain was 
also dependent on the components of the SHREC complex, on the Clr4 methylthranseferase 
and other subunits of the CLRC complex (Figure 14). Finally, the HP1 proteins Swi6 and 
Chp1, which are vital for formation of constitutive yeast heterochromatin, were also required 
for the silencing. These observations further confirm that siRNA-mediated gene silencing 
that we observe when Paf1 complex function is impaired occurs through establishment of 
heterochromatin.  
 
5.5 Impact of the Paf1 complex mutations on global gene expression.  
 
A number of studies performed mainly in budding yeast and mammalian cells suggested 
multiple roles of the Paf1 complex in regulation of transcription by RNA Polymerase II 
(Section 3.7). To assess the consequences of interfering with such a broad-acting complex, 
Clone 
Dcr1-
dependency 
H3K9me2 
accumulation Mapped mutations 
sms1 + + SPBC651.09c (472 Gln to UAA); Prf1 
sms2 - - ade6+ 
sms3 + + SPAC664.03 (104 Gly to Arg); Paf1 
sms4 + + SPBC13E7.08c (157 Trp to UGA); Leo1 
sms5 - - ade7+ 
sms6 + + SPBC17G9.02c (313 Gly to Arg); Cdc73 
sms7 - - ade6+ 
sms8 + + SPAC664.03 (264 Gln to STOP); Paf1 
sms9 - - ade7+ 
sms12 - - ade7+ 
Column 2 indicates whether the silencing phenotype was Dcr1-dependent. Column 3 indicates whether the 
H3K9me2 mark was detected at the trp1+::ade6+ reporter locus. In Dcr1-dependent mutants, we mapped 
mutations in the genes SPBC651.09c, SPAC664.03, SPBC13E7.08c, and SPBC17G9.02c, which encode for 
homologues of the budding yeast Paf1 complex. 
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we looked globally at changes in gene expression by genome-wide RNA expression profiling 
with tiling microarrays. In our analysis, we included the paf1+ strain sms0, all five point 
mutations identified in the screen, as well as full deletions of paf1+ and leo1+ genes. We 
obtained genome-wide expression profiles for two biological replicates for each strain, and 
compared them by performing a Principal Component Analysis (PCA). Principal Component 
(PC) 1 and 2 explained 41.5% and 16.4 % of the variance between samples, and the 
remaining PCs represented 57.9 % of the variance. An analysis of the loadings indicated that 
the remaining PCs all captured at least in part non-reproducible effects in the experiment, 
such as the differences between replicate sets. Therefore, we decided to focus in our analysis 
on the first two PCs and choose them for the visualization (Figure 15A). Comparison of 
samples based on PC1 and PC2 (Figure 15A) revealed that the cdc73-G313R and paf1Δ cells 
are most different from the paf1+ cells. All the remaining mutants clustered together with the 
Figure 10. Mutations in the subunits of the Paf complex cause siRNA-dependent repression of the 
ade6+ gene. A Validation of the sms screen results. Individual point mutations in Paf1 complex subunits 
were reconstituted in the sms0 parental strain. Obtained mutants were tested by the ade6+ silencing assay. 
As a control, strains without the nmt1+::ade6-hp construct were generated. B ade6+ silencing assay 
repeated with red colonies picked from A. Note that induced silencing is very stable. C Whole genome 
expression profiling with tiling microarrays was used to confirm the repression of the trp1+::ade6+ gene 
caused by siRNAs in the identified mutants of the Paf1 complex. Normalized signal intensity is shown in the 
linear scale. 
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wild type samples, generally suggesting that these mutations of the Paf1 complex have very 
little consequence on gene expression. Indeed, comparisons of mean steady state RNA 
expression values between wild type and mutant samples further support the conclusion that 
transcription was not strongly affected in these mutants (Figure 15B).  
Based on the comparison with the data obtained for the paf1Δ mutant, we concluded 
that paf1-G104R, paf1-Q264Stop, rot1-Q472Stop and leo1-W157Stop might represent 
separation-of-function alleles that do not cause severe alterations on the gene expression 
level, and presumably, do not impair the function of Paf1 complex in regulation of 
transcription by RNA PolII significantly.  
 
5.6 Leo1 as a bona-fide repressor of siRNA-directed heterochromatin formation 
 
It drew our attention that in the visualization of the PCA, leo1Δ strain clusters together with 
Paf1 complex point mutants, rather than with the other full deletion strain – paf1Δ (Figure15 
A). Furthermore, the leo1+ deletion caused only mild changes in gene expression at the 
global level (Figure 16A). This suggests that the Leo1 subunit of the complex may elicit a 
special, separate function. Such a function could, for instance, involve direct suppression of 
siRNA-mediated heterochromatin formation by preventing the interaction of the RNAi 
machinery with RNA PolII. Consistent with the result obtained by PCA, we noticed that 
siRNAs were able to induce repression of ade6+ reporter in the leo1Δ strain, whereas in the 
paf1Δ strain the ade6+ gene remained desilenced (Figure 16B). In support of our hypothesis, 
we also noticed that the prf1Δ, paf1Δ, tpr1Δ, and cdc73Δ mutants showed very severe growth 
defects, but the leo1Δ deletion did not cause retarded colony growth (Figure 16B).  
In summary, computational analysis of the genome wide expression profiles and the small 
RNA expression profiles pointed towards a separate role that Leo1 could play in the Paf1 
complex. This observation was reflected by the phenotypic differences between the 
individual Paf1 mutants. Therefore, we concluded that Leo1 could function as the actual 
repressor of small RNA-mediated formation of heterochromatin in trans.  
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5.7 Formation of facultative heterochromatin 
 
As described in details in Section 4, the reasoning behind performing our screen for a 
repressor of small-RNA-mediated silencing was that such repressors could function in the 
cell in order to prevent priRNAs and primary siRNAs from inducing heterochromatin 
formation and gene silencing in a random, uncontrolled manner.  
To test our initial hypothesis and to identify loci that would be susceptible to 
priRNA-mediated heterochromatinization, we compared the aforementioned gene expression 
profile for the leo1Δ mutant strain with a genome-wide small RNA expression profile 
obtained by deep sequencing (Figure 17A). We expected such facultative heterochromatin 
loci to show reduced gene expression combined with an increase in siRNAs that would 
originate from the small RNA amplification loop triggered by the priRNAs or the 
endogenous primary siRNAs.  
Being a proof of principle, all the three loci that are homologous to the ade6-hp: 
nmt1+::ade6-hp+, trp1+::ade6+, and ade6-704 fulfilled our criteria (Figure 17A). 
Additionally, we observed the same effect on the genes neighboring the ade6+ siRNA 
targets, suggesting spreading of heterochromatin over the adjacent regions for a distance up 
to 6 kbp (Figure 18).  
Despite the fact that the ade6-sh construct contained only 250 bp of the ade6+ gene, in Paf1 
mutants, we consequently observed accumulation of siRNA targeting both the plus and the 
Figure 11. C-terminal tagging of the Paf1 complex subunits results in creation of hypomorphic alleles 
and causes ade6+ silencing. Silencing assay was performed with strains where subunits of the Paf1 
complex were C-terminally tagged with 3xFLAG-Tag. Tagging renders Cdc73 and Tpr1 partially non-
functional and results in siRNA-mediated silencing of the trp1+::ade6+ reporter.  Note that full deletions of 
cdc73 and trp1 are deleterious to cell growth (Fig. 16.), whereas cells carrying the tagged alleles grow 
normally.  
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Figure 12. Mutations in the Paf1 complex cause siRNA-directed H3K9 methylation and 
transcriptional repression of the ade6+ gene. A ChIP experiment illustrating the H3K9me2 enrichment at 
the trp1+::ade6+ reporter locus in the indicated mutants. Enrichments were calculated relative to the values 
for the clr4Δ mutant strain and normalized to the values for the adh1+ gene. Mean of 3 biological replicates 
is shown. Error bars represent standard error of mean (s.e.m.). B and C Results of ChIP experiments for 
H3K36me3 and RNA PolII occupancy at the ade6+. To control for background signal and for differences in 
ChIP efficiency. Values were normalized to the enrichments over the snu6+ gene. For the H3K36me3 ChIP, 
scores were normalized to the total histone H3 enrichments. Mean of 3 independent biological replicates is 
shown. P-values were calculated using the one-tailed Student’s t-test. D and E Same as (A), but the 
H3K9me2 enrichment was measured at the ade6-m704 locus and nmt1+::ade6-hp+ locus. F ChIP 
experiment illustrating the H3K9me2 enrichment at the cox4+ ORF and cox4+ intron sequence in the 
indicated mutants of the Paf1 complex. Enrichments were calculated relative to the values for the clr4Δ 
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minus strand of the entire ade6+ ORF (Figure 17B). This strongly indicated that the primary 
siRNAs encoded within the hairpin triggered the RNAi amplification loop, in which highly 
abundant secondary siRNAs were being produced. We also observed spreading of secondary 
siRNA production into adjacent genes, which was accompanied by the spreading of the 
H3K9me2 mark over these regions, as measured in a ChIP experiment in the leo1Δ strain in 
comparison to the leo1+ strain (Figure 19). Interestingly, in the pool of the small RNAs 
originating from these genes, we detected also siRNAs that were mapping to intronic 
sequences (please note the rpl2302+ gene), suggesting that secondary siRNA production 
could possibly be dependent on transcription of nascent transcripts by Rdp1 (Figure 18). 
Taken together, we observed that the siRNA-induced gene silencing in the Paf1 mutants 
leads to formation of a bona fide heterochromatic domain by spreading from the targets of the 
ade6-hp. The assembled domain is several kb long and exhibits all the hallmarks of 
heterochromatin, i.e. reduction in gene expression, accumulation of H3K9 methylation mark 
and production secondary small RNAs.  
We also detected a small number of loci independent from ade6-hp targets that showed weak 
signature of siRNA-mediated silencing (Figure 17A, Tab. 7), yet when we compared the data 
obtained for different mutants, we were unable to recover the same loci in different Paf1 
mutant strains. This suggests that, if the observed decrease in gene expression was indeed 
caused by the priRNAs and facultative heterochromatin formation, these target genes were 
silenced in a random manner. Therefore, we concluded that during mitotic growth in standard 
conditions there are no specific sites strongly primed for silencing by small RNAs.   
5.8 Establishment and maintenance of silencing 
 
During reconstitution of the Paf1 mutant strains, we observed that in a population of freshly 
generated mutants not all of the clones initially exhibited full repression of the ade6+ 
reporter (full red phenotype), and therefore, remained white or pink on the low adenine 
indicator plates. However, when we repeated the ade6+ silencing assays with red colonies 
selected for each of the obtained mutants, we observed that once the silent state was 
established through a number of mitotic divisions, repression was very stable in every case 
(Figure 20A, 20B, Figure 10B). We quantified this observation by scoring the red, white and 
pink colonies originating from a parental red clone for all the mutants. This analysis 
confirmed that descendants of the red colony maintained the silencing of ade6+ state of the 
reporter with a frequency of at least 90% (Figure 20A). Notably, the paf1-Q264Stop mutant 
 52 
showed the highest maintenance rate from all the strains. In order to quantify the frequency 
of initiation of heterochromatin formation in mitotic cells we repeated the experiment with 
descendants of white colonies for each strain (Figure 20B). This time, the frequency varied 
substantially between the strains. For instance, we observed that establishment of the silent 
state was the most frequent in the leo1-W157Stop mutant (Figure 20B). In contrast, the paf1-
Q264Stop mutant strain, which showed the highest heterochromatin maintenance rate was not 
very efficient in establishing of the silent state, with only approximately 10% of colonies that 
showed the ade6+ repression (Figure 20B). 
 
5.9  Propagation of silencing through meiosis 
 
We then went on to investigate rates of establishment and maintenance of the silent ate at the 
trp1+::ade6+ reporter locus during meiosis. We analyzed this by performing a series of 
crosses. First, we crossed a red clone of the paf1-Q264Stop strain with the wild type strain 
(both of the strains were carrying the ade6-hp hairpin construct). We confirmed that the silent 
state was very efficiently maintained over the meiotic division, and we observed as well that 
only the progeny cells carrying the mutant Paf1 allele were able to keep the reporter gene 
silent (Figure 20C). Thus, we concluded that, just like in the case of mitotic cells, 
heterochromatic silencing can be efficiently transmitted through meiosis, but the mutation in 
the Paf1 is necessary for its maintenance. (Figure 20B). We then repeated this cross, but this 
time we used a white clone of the paf1-Q264Stop strain and crossed it with the paf1+ strain 
(both of the strains were carrying the ade6-hp hairpin construct). Interestingly, we observed 
that initiation of the siRNA-mediated repression was more efficient in the meiotic cells than 
during the mitotic growth (Figure 20B). We analyzed progeny of several tetrads coming from 
this cross and saw that that in 70% of all crosses, at least one of the two progeny cells that 
carried the mutant Paf1 allele turned on the silencing of the ade6+ reporter (Figure 20D). 
Besides, we noticed again that only the progeny cells that inherited the Paf1 mutant allele 
were able to keep the ade6+ gene silent. Therefore, we concluded that mutation in the Paf1 
complex is a prerequisite for both establishment and maintenance of the siRNA-directed 
heterochromatin. As described in the section 5.7, hairpin-derived small RNAs triggered the 
production of highly abundant secondary siRNAs targeting the entire ade6+ locus in the Paf1 
mutants (Figure 17B, Figure 18). We went on to test whether these ade6+ secondary siRNAs  
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Figure 13. siRNA-mediated silencing in Paf1 complex mutants is independent of the location and 
sequence of the target gene. A A construct encoding for a ura4+-targeting hairpin (ura4-hp) was 
introduced at the trp1+ locus on chromosome I. Synthetic siRNAs expressed from the hairpin construct 
target the endogenous ura4+ gene located on chromosome III. On the right: paf1-Q264Stop cells and paf1+ 
cells carrying the nmt1+::ura4-hp construct were spotted on plates containing 5-FOA for a ura4+ silencing 
assay. 5-FOA is toxic to cells expressing the ura4+ gene. Note that in the paf1-Q264Stop strain the silent 
state was maintained for several generations on non-selective medium. B Tethering of the RITS complex to 
mRNA expressed from the endogenous ura4+ locus induces de novo synthesis of ura4+ siRNAs (Bühler, 
Verdel, & Moazed, 2006). These ura4+ siRNAs can establish heterochromatin at the ura4+ locus in cis, but 
not in trans on the second ura4+ allele (leu1D::ura4+, chromosome II). paf1+ was mutated and ura4+ 
repression was assessed by FOA silencing assays. Hairpin symbols downstream of the ura4+ ORF denote 
BoxB sequences. Upon transcription BoxB RNA forms stem loop structure when that is bound by the λN 
protein. C ade6+ silencing assay was performed on YE medium. It demonstrates that also the endogenous 
ade6+ gene is repressed, if ade6-hp siRNAs are expressed in paf1-Q264Stop cells. Two biological replicates 
are shown.  
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 were also sufficient for the maintenance of the silent state. To this end, we crossed the 
trp1+::ade6+ paf1-Q264Stop ade6-hp+ strain (red) with  the trp1+::ade6+ paf1-Q264Stop 
(white) strain. To our surprise, we observed that most of such crosses gave red progeny and 
this silencing phenotype was maintained for hundreds of subsequent mitotic divisions, even 
though the ade6-hp was not present (Figure 21A). These results show that silencing of the 
ade6+ gene was stably maintained in the absence of the source of primary siRNAs, likely 
due to the secondary siRNAs produced form the entire ade6+ ORF in the 
siRNA-amplification loop.  In summary, our results showed that under conditions when the 
Paf1 repressive function was impaired, siRNA-directed heterochromatin was maintained very 
efficiently through meiotic division. Additionally, establishment of the silent state happened 
much more frequently when cells underwent a meiotic division than in mitotic cells. 
Importantly, the mutations in the Paf1 complex were necessary for both establishment of the 
silencing and for its subsequent maintenance. Finally and most importantly, secondary 
siRNAs produced from the repressed loci were sufficient to maintain the heterochromatic 
silencing through generations. This conclusion strongly argues for the fact that siRNA-
mediated heterochromatin formation in trans that I described here is an epigenetic 
phenomenon triggered by the hairpin-encoded siRNAs. The silent state can be maintained 
Figure 14. siRNA-directed silencing of the ade6 gene depends on the same factors that are required 
for centromeric heterochromatin formation. ade6+ silencing assay on YE medium performed with paf1-
Q264Stop nmt1+::ade6-hp+ trp1::ade6+ strain in which indicated factors had been deleted. dcr1Δ strain 
was used as a control. RITS, RNA-induced transcriptional silencing complex; ARC, Argonaute siRNA 
Chaperone Complex; RDRC, RNA-Dependent RNA Polymerase Complex; CLRC, Clr4-methylatransferase 
Complex; SHREC, Snf2/Hdac-containing Repressor Complex; HP1, Heterochromatin Protein 1; Tri, Triman 
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independently of the hairpin-derived siRNAs, with the pool of secondary siRNAs serving as 
the carrier of epigenetic information.  
 
 
 
 
Figure 15. Point mutations in the subunits of the Paf1 complex have little effect on gene expression 
globally. A Genome-wide expression profiling using tiling microarrays was performed for two biological 
replicates of the indicated strains. Obtained expression profiles were used to conduct Principal Component 
Analysis (PCA). Principal component 1 and 2 were chosen for visualization. Note that the wild type strain 
clusters together with the mutant strains, whereas the paf1Δ and cdc73-G313R are the most distant from the 
other point mutation strains. Note as well that leo1Δ strain clusters together with other point mutations rather 
than with the paf1Δ strain. B Scatter plots illustrating pairwise comparisons of mean gene expression values 
for the Paf1 complex mutants and the wild type strain. Note that the paf1Δ strain shows the most pronounced 
changes in RNA steady state levels. Mean gene expression values were calculated for two biological 
replicates.  
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5.10 Identification of putative endogenous targets through meiotic division 
 
Prompted by the interesting observation that the establishment of the ade6+ silencing in 
naïve paf1-Q264Stop cells occurs very efficiently when the cells are propagated through 
meiosis (Figure 20 D), we hypothesized that putative targets of the endogenous siRNAs  
would be also more prone to silencing during or after the meiotic division. We reasoned that 
we could look at the colonies derived from single clones obtained by spore dissection in order 
to identify any genes that were primed for silencing. We crossed the leo1Δ strain with the 
leo1+ strain and looked at the progeny of this cross after few days of growth standard 
laboratory conditions. Interestingly, we observed that some of the tetrads gave rise to small 
leo1Δ progeny colonies and for some others the leo1+ and the leo1Δ progeny were of the 
same size (Figure 21B).   
 
5.11 Mechanism of repression 
 
Next, we sought after identifying the mechanistic details of the Paf1-mediated repression of 
heterochromatin assembly in order to learn about its mechanism. In S. cerevisiae, the Paf1 
complex has been implicated in regulation of the transcription process on multiple levels, 
Figure 16. Leo1 subunit of the Paf1 complex is a bone fide repressor of siRNA-mediated 
heterochromatin formation.  A Scatter plot illustrating a comparison of the mean gene expression values 
for leo1Δ and leo1+ strains. Mean gene expression values were calculated for two biological replicates. B 
ade6+ silencing assay performed on YE medium with strains in which genes coding for the subunits of the 
Paf1 complex were fully deleted. Note that siRNA-mediated silencing of the trp1+::ade6+ reporter gene 
was established only in the leo1Δ strain. Note as well that all strains except for the leo1Δ exhibit severe 
growth defects on rich YES medium.  
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including promoting transcription elongation, termination, and RNA 3’-end processing (See 
section 5.2.5, Figure 22A). In the paf1-Q264Stop mutant, we detected a small reduction in 
H3K36 tri-methylation and an increase in PolII occupancy over the reporter gene, pointing 
towards the involvement of the complex in regulation of transcription in S. pombe (Figure 
22B, 22C). To dissect which of the Paf1 functions are most critical to prevent RNAi-
mediated heterochromatin assembly, we took a genetic approach and performed a set of 
deletions. By deleting and mutating the genes encoding for the elongation factors Tfs1 and 
Spt4, termination factors Ctf1 and Res2, as well as histone methyltransferases Set1 and Set2 
[103], [171], [172], we interfered with transcription elongation, termination, or co-
transcriptional histone modifications, respectively  (Figure 22A). 
We observed siRNA-mediated silencing of the ade6+ reporter in the ctf1-70 and to a smaller 
degree in the res2Δ mutant cells, but no repression was detected in the other mutants (Figure 
22D, 22E).  Importantly, silencing in these two strains was not as potent, and the propagation 
of the silent state was not as stable as in the paf1-Q264Stop mutant. Instead, the ctf1-70 and 
res2Δ cells showed variegation of the red phenotype, indicating a bi-stable silencing state that 
could spontaneously undergo de-silencing in the progeny cells during colony growth.  
The ctf1-70 gene encodes for a truncated form of the mRNA cleavage and polyadenylation 
specificity factor Ctf1. In a mutant strain harboring this allele, RNA PolII fails to terminate 
properly at the polyadenylation signal, yet the nascent transcript is still properly processed 
downstream of it, and released from the site of transcription [173]. We then went on to test 
the importance of transcript release for the siRNA-directed silencing specifically. In order to 
uncouple release of the transcript from cleavage by the endogenous factors, we inserted a 
52-nucleotide hammerhead ribozyme (Rz), preceded by a 75-nucleotide long polyA tail 
template downstream of the endogenous ade6+ ORF (ade6-Rz) (Figure 23A). A newly 
transcribed RNA containing such ribozyme undergoes self-cleavage and can be released from 
chromatin independent of the subsequent transcription termination signal. In a control strain 
we used an identical ade6-Rz construct, but the catalytic site of the ribozyme was mutated by 
a single nucleotide substitution (ade6-Rzm). Such mutation abolishes the self-cleavage event 
and as a result, the ade6-Rzm mRNA is dependent on the endogenous transcription 
termination machinery for transcript release.  We observed that silencing of ade6-Rz was less 
efficient and the repression was rather poorly propagated through generations in the paf1-
Q264Stop strain, whereas the ade6-Rzm allele was very effectively silenced (Figure 23B). 
This indicates that the retention of the nascent transcript on chromatin contributes to 
subjecting a gene for siRNA-mediated repression. Taken together, we conclude that 
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impairment of transcription termination and nascent transcript release is the underlying cause 
for siRNA-directed heterochromatin assembly in the Paf1 mutant cells. The fact that 
improper transcription termination, observed in ctf1-70 mutant cells, was not enough to 
induce efficient and stable silencing, is further confirmed by the identification of impaired 
nascent transcript release as a contributing factor. We, therefore, postulate that identified Paf1 
mutations lead to defects in both transcription termination and transcript release and the 
combinatorial effect of these two roles is a cause for observed strong repression. This allowed 
us to identify Paf1 complex mutants in our screen, in contrary to factors like Ctf1 that 
regulate only one of these events (Figure 22).  
 
 
 
 
Figure 17. Nucleation of ectopic heterochromatin by endogenous siRNAs. A Comparison of differential 
gene expression and differential expression of small RNAs for the leo1Δ/leo1+ pair of strains. Differential 
gene expression was obtained from genome-wide expression profiling data generated with tiling 
microarrays. Small-RNA-expression profiling was performed by next-generation deep sequencing, and 
differential small RNA expression was calculated for siRNAs mapping to the antisense strand. Gene 
neighboring the siRNA target loci: trp1+::ade6+, ade6-m704, nmt1+::ade6-hp+ are marked in red, blue 
and green, respectively. Elements of the hairpin construct:  cox4+ intron sequence and adh1+ promoter are 
marked in black and yellow, respectively. Log2 scale was used. B Profiles of small RNAs mapping to the 
ade6+ gene. Small RNA profiles for all point mutants were obtained by next-generation deep sequencing. 
Read counts were normalized to the size of the individual libraries and depicted in log2 scale. Profile for the 
wild type strain is shown in gray, profiles for the mutants are shown in indicated colors. The region marked 
with dashed lines refers to the hairpin-encoded ectopic small RNAs. Note that secondary small RNAs 
mapping to the entire ORF on both sense and antisense strands were detected.  
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6 Discussion and outlook 
 
The results presented in this dissertation demonstrate that in fission yeast, under conditions 
when the Paf1 complex function is impaired, siRNAs can efficiently mediate transcriptional 
gene silencing in trans. The siRNA-induced repression can be directed against euchromatic 
genes independent of their genomic location, and involves de novo formation of functional 
heterochromatin. The silent state fulfills all the criteria of a bona fide heterochromatic 
domain, like the accumulation of H3K9 methylation, generation of target-derived secondary 
small RNAs, and reduction of the transcriptional activity at the target gene (Figure 10, Figure 
12, Figure 18). We showed that mutation of the Paf1 complex is required for both the 
establishment and the maintenance of the repression (Figure 20). Importantly, the silent state 
was transmitted through meiosis and subsequently inherited through several hundred mitotic 
divisions in the absence of the primary siRNA source (Figure 21). This observation 
demonstrates the epigenetic nature of the phenomenon and raises the possibility of stable 
transgenerational silencing of selected target genes ‘at will’, providing an exciting scientific 
finding and novel technological implications at the same time.  
 
6.1 The Paf1 complex represses epigenetic gene silencing 
 
One of the most exciting results presented in my thesis is that under the condition when the 
Paf1 function is impaired, the silent chromatin state of the ade6+ locus can be efficiently 
transmitted through meiosis and hundreds of mitotic cell divisions, even if the 
hairpin-derived primary small RNAs are not provided any longer (Figure 21). The 
heterochromatic state is maintained in the progeny cells due to secondary siRNAs originating 
from the siRNA amplification cycle established at the target locus (Figure 3, Figure17). This 
self-reinforcing positive feedback loop comprises of small RNA production and deposition of 
H3K9 methylation. Thus, RNAi-directed transcriptional gene silencing induced in the Paf1 
mutant cells complies even with the strictest definitions of epigenetic gene silencing [1], 
[174].  
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6.2 Potential conservation of the repressive role of the Paf1 complex  
 
Despite the high evolutionary conservation of the RNAi pathways and their components, the 
function of small RNAs in stable transcriptional silencing of protein coding genes has not 
been unanimously confirmed. However, several biological phenomena show intriguing 
resemblance to the small RNA-mediated transgenerational gene silencing that we observe 
when the Paf1 complex function is impaired. 
One of most notable examples is the phenomenon of paramutation observed first in plants 
[175]. In maize, expression of the B locus responsible for plant pigmentation is regulated by 
the chromatin state of its enhancer. Interestingly, upon crossing two maize plants, one 
carrying the silent copy of the gene and one carrying the active copy of the gene, the active 
allele becomes repressed in trans by the presence of the silent allele during the embryonic 
development of the heterozygous progeny. This leads to the non-mendelian inheritance of the 
pigmentation phenotype. It is unclear why the active enhancer undergoes hetero- 
chromatinization, but it is known that this process depends on small RNAs and the RNAi 
Figure 18. The ade6-m704 locus produces secondary siRNAs when the function of the Paf1 complex is 
impaired. Small RNA profile at the ade6-m704 locus was obtained by next-generation deep sequencing for 
the leo1+ and leo1Δ strains. Read counts were normalized for the size of the sequencing libraries and 
represented in log2 scale. Sense reads are depicted in red, antisense reads in blue. Gray bar indicates ectopic 
small RNAs produced from the ade6-hp. Note that siRNAs mapping to the intron of the rpl2302+ gene were 
also detected.  
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 machinery [175]. Most intriguingly, the enhancer sequence functions as a source of 24 nt 
long small RNAs, regardless of whether it is present in active or silent chromatin form. It is 
tempting to speculate that the difference between the two alleles lies in the occupancy of 
active or functional Paf1 complex, which, when present, represses formation of 
heterochromatin on the enhancer locus and keeps the gene active. Examples of mechanisms 
resembling the paramutation phenomenon have been also described in Drosophila and mice 
[176]. In a recent study Baulcombe and colleagues identified a mutant plant background, in 
which de novo induced RNA-directed DNA methylation and TGS can be epigenetically 
propagated to the progeny plants with an increased stability [177]. Interestingly, if the mutant 
plants are propagated for several generations, the induced silent state also shows an effect 
similar to paramutation. The authors propose that their finding can be applied in the future to 
generate epigenetic transgenic plants without the need for constant modifications of their 
genome. 
 
Transgenerational gene silencing induced by small RNAs has also been reported in 
C.-elegans [67], [178]. In a phenomenon named RNAe, for RNA-induced epigenetic 
silencing, transcriptional silencing of a reporter gene is induced by the PIWI protein PRG-1 
and piRNAs, or by the RDE-1-bound 21-U RNAs (Described in section 3.1.4). Both of these 
pathways lead to the generation of secondary 22G-RNAs and involve the RdRP activity. 
Figure 19. Heterochromatin spreads from the ade6-m704 locus when the function of the Paf1 complex 
is impaired. ChIP experiment illustrating the H3K9me2 mark enrichment at the genes neighboring the 
ade6-m704 locus in leo1+ and leo1Δ strains (see Fig. 18. for the scheme of locus architecture). Enrichments 
were calculated relative to the values for clr4Δ mutant strain and normalized to the values for the adh1+ 
gene. Error bars represent standard deviation. Mean of two biological replicates is shown. 
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22G-RNAs are bound by the worm specific Argonaute protein WAGO-9 (also known as 
HRDE-1), and the worm nuclear Argonaute protein NRDE-3 [179]. Upon loading with small 
RNAs, WAGO-9 translocates to the nucleus where it targets the nascent transcripts of RNA 
PolII and mediates transcriptional gene silencing through H3K9 methylation. Members of the 
NRDE pathways (See section 3.1.4): NRDE-1, NRDE-2 and NRDE-4, as well as the HP1 
homolog HPL-2, are required for the establishment and maintenance of this repression [179], 
[180]. The silent state can be efficiently transmitted through multiple generations [67], 
however, it is not dependent on PRG1 or on the primary piRNAs that maintain the silencing. 
It was also suggested that to some extent RNAe shows the properties of paramutation, 
however, unlike in plants, the paramutagenic properties of the silent allele depend on the 
gender of the parent through which it was inherited [67]. This remarkable stability of the 
silent state and dependence on production of secondary siRNAs resemble the repression 
induced by ade6-hp-derived siRNAs when the Paf1 complex function is impaired (Figure 18, 
Figure 21). No mechanistic details of RNAe were reported so far, so the putative involvement 
of the Paf1 complex and the role of transcription kinetics in this small RNA-mediated 
transcriptional silencing remain to be uncovered.  
 
Finally, in line with our hypothesis on the role of Paf1 complex in preventing small RNA 
mediated gene silencing, the Paf1 complex was suggested to act as a protector of the 
pluripotent state of mouse Embryonic Stem Cell (ESC) [181], [182]. The authors showed that 
Paf1 complex associates with the promoters of key pluripotency genes, including Oct4, Sox2 
and Klf4.  This association contributes to maintenance of the active chromatic state at these 
loci. Depletion of the Paf1 complex leads to decreased expression of pluripotency genes, 
formation of repressive chromatin state, and cellular differentiation. We speculate that this 
process might also be under control of small RNAs and RNA-directed heterochromatin 
formation. Intriguingly, in this scenario the Paf1 complex would selectively dissociate from 
some, but not all the PolII transcribed genes. Conservation of the Paf1 repressive function 
and the existence of small RNAs targeting the pluripotency genes remain to be confirmed in 
the future. An inherent difficulty of these experiments comes from the fact that Paf1 complex 
is essential for the viability of mouse cells.  
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6.3 The Leo1 subunit is a bona fide repressor of silencing.  
 
The genome-wide expression profiling analysis (Figure 17A) and the ade6+ silencing assay 
in the leo1Δ mutant both point towards the distinct role for the Leo1 subunit in the Paf1 
complex. In fact, several studies performed in budding yeast described slightly distinct 
phenotypes of the mutants of individual Paf1 complex subunits. These differences indicate 
that the individual subunits might play separate roles in the cell. (See section 3.2.4). For 
instance, the budding yeast Leo1 was found to be dispensable for proper H3K36 and H3K4 
methylation levels, which is likely to contribute to the less severe growth phenotype of leo1Δ 
mutants. Whether this is the case for the S. pombe Paf1 complex remains unknown.  
We found striking differences in silencing and growth phenotypes between the strains 
harboring full deletions of the leo1 and the paf1 genes (Figure 16B). We postulated that the 
Leo1 subunit acts as the actual repressor of the siRNA-directed heterochromatin formation 
and this hypothesis made us speculate that maybe the point mutations within the other 
subunits result in disruption of the Leo1 binding to the complex. Intriguingly, the Leo1 
subunit of the hPAf11 complex was implied to function as a direct contact point to the PolII 
[99]. Assuming that the complex architecture is conserved between fission yeast and human, 
mutations causing loss of the Leo1 subunit could result in detachment of the complex and its 
dissociation from chromatin. These hypotheses remain to be tested by in vitro biochemical 
analysis of the complex integrity, as well as by in vivo functional studies.  
The budding yeast Leo1 was also suggested to contribute to the RNA binding properties of 
the Paf1 complex, which in turn was crucial for stable association with chromatin and with 
the transcription elongation machinery [183]. Therefore, mutations of the putative Leo1 RNA 
binding site could result in dissociation of the remaining subunits from chromatin as well. 
The special function of the Leo1 subunit in the context of siRNA-mediated silencing remains 
to be determined.  
A very recent study found Leo1 in a screen for suppressors of heterochromatin spreading in 
fission yeast [184]. Subsequently, the authors confirmed that the remaining components of 
the Paf1 complex, but not other factors regulating transcription elongation and known 
Paf1-related chromatin modifications, also function as negative regulators of the spreading. 
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Figure 20. Establishment and maintenance of the siRNA-directed heterochromatin through mitotic 
and meiotic divisions. A and B Establishment and maintenance of heterochromatin at the trp1+::ade6+ 
locus in the Paf1 complex mutants was assessed upon approx. 30 mitotic divisions, based on the phenotype 
in the silencing assay on YE plates. White and red parental colonies were used for establishment (A) and 
maintenance (B) assay, respectively. C Maintenance of the silent state at the trp1+::ade6+ locus upon 
meiotic division was assessed by crossing of the indicated strains. Progenies of five tetrad dissections are 
shown. Red paf1-Q264Stop cells were used for the cross. White progeny colonies are paf1+. D 
Establishment of the silent state at the trp1+::ade6+ locus upon meiotic division was assessed by crossing 
the indicated strains. Progenies of 24 tetrad dissections are shown. White (naïve) paf1-Q264Stop cells were 
used for the cross. Note that silencing of the trp1+::ade6+ gene was frequently established upon meiosis. 
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The study proposes a model, in which Leo1 recruits the histone H4 lysine 16 (H4K16) 
acetyltransferase Mst1 to actively transcribed chromatin, and by this antagonizes the 
spreading of heterochromatin onto neighboring regions. The model is supported by the 
observation that deletion of the leo1+ gene results in a decrease in H4K16 acetylation and 
loss of the Mst1 binding to chromatin. Although this mechanism is generally in agreement 
with our findings, the aforementioned study does not provided compelling evidence for the 
role of H4K14 acetylation mark in negative regulation of silent chromatin. To strengthen 
their hypothesis, the authors could check whether using a temperature-sensitive allele of Mst1 
would cause a similar spreading effect in the presence of the Paf1 complex [185]. Since Mst1 
is an essential protein, creating a catalytically-dead mutant likely would have similar 
deleterious consequences. However, two mutant alleles of the histone H4 were reported, 
H4K16R which abolishes the acetylation and H4K16Q, which mimics the acetylated state 
[186]. By combining these mutations with the leo1+ deletion, one could test more directly 
whether the H4K16 acetyl mark is a cause, or a consequence of heterochromatinization of 
boundary regions. Finally, the authors do not exclude the possibility that the spreading of 
heterochromatin is actually due to the activity of the RNAi machinery. In fact they observed 
that the spreading phenotype is suppressed when the leo1Δ mutation is combined with 
deletions of genes encoding for the RITS complex components Chp1 and Tas3. Although 
mutations of the RITS complex cause defects in centromeric silencing, which could have an 
effect on the spreading by itself, this result points towards a putative role of the RNAi 
machinery in the spreading of heterochromatin repressed by Leo1.   
 
6.4 Inefficient transcription termination and silencing 
 
We proposed a model according to which the Paf1 complex represses formation of 
siRNA-mediated facultative heterochromatin by ensuring proper transcription elongation, and 
transcript termination and release (Figure 22, Figure 23, Figure 24). Contribution of the Paf1 
complex to multiple stages of transcription seems to be a key feature of the repressor, since 
deletion of factors affecting only individual stages gave rise to a much weaker and unstable 
silencing phenotype (Figure 22). This multilevel effect was probably what contributed to the 
strongest phenotype we were selecting for in our screen, and allowed us to identify the Paf1 
complex, but not other factors like Ctf1, which regulate only one for these events.  
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There is strong evidence for the link between inefficient transcription termination and 
licensing of genes for siRNA-mediated repression. Most importantly, it was shown that if the 
termination signal of a euchromatic ura4+ gene was impaired, siRNA-directed nucleation of 
heterochromatin could be efficiently induced at this locus [169]. The authors propose that the 
presence of termination and polyadenylation signals close to the coding sequence causes 
efficient transcript release and makes genes refractory to siRNA-directed repression. In a 
study conducted in plants, several mutations in the cleavage and polyadenylation factors were 
identified in a screen for factors enhancing small RNA-mediated silencing. These mutations 
subject target genes to RNA-directed repression, possibly by causing impaired 3’ end 
formation and read-through transcription of the transgene [187]. Intriguingly, the authors 
point out that both mis-terminated and mis-spliced transcripts could be recognized as aberrant 
and become sources and targets for small RNAs. Their hypothesis supports well our model, 
as problems with RNA splicing and termination would increase the time nascent transcripts 
spend on chromatin and expose them as a platform for the RITS complex binding.  
Figure 21. siRNA-induced silencing of the trp1+::ade6+ gene can be transmitted through meiosis in an 
epigenetic manner. A Maintenance of heterochromatin at the trp1+::ade6+ locus in the absence of the 
ade6-hp-derived ectopic small RNAs was assessed by crossing of the indicated strains. Progenies of four 
tetrad dissections were struck on YE plates. Note that progenies show red phenotype despite the fact that 
source of initial siRNAs is missing. ade6-hp+ annotations marks colonies carrying the hairpin construct. h+ 
and h- denote mating types. B Progenies of tetrad dissection obtained by crossing of a leo1Δ strain with a 
leo1+ strain. leo1Δ  and leo1+ annotation indicate respective genotypes of the progeny colonies. Note that, 
despite being isogenic, leo1Δ progenies exhibit different growth phenotype. 
 67 
We observed that secondary small RNAs matching the cox4+ intron sequence were produced 
from the hairpin transcript, but they did not cause accumulation of the H3K9 methylation 
over the cox4+ gene (Figure 12). It would be therefore interesting to test whether these small 
RNAs could induce ectopic heterochromatin formation at the cox4+locus in a strain where 
the splicing machinery was impaired. Intriguingly, in the yeast Cryptococcus neoformans, 
inefficient splicing and stalling of the spliceosome results in the production of small RNAs 
from the defective transcripts and subjects them to transcriptional silencing [188]. In this 
manner, foreign genetic elements with poor or inadequate splicing signals can be repressed 
by C. neoformans.  
Deficiency of some splicing factors was suggested to impair RNAi-mediated heterochromatin 
assembly at the centromeric repeats S. pombe [189]. Later studies contradicted this result and 
explained that the silencing defects might be due to inefficient splicing of mRNA encoding 
for the RNAi pathway components [190]. In fact, several of the RNAi pathway genes, 
including ago1+, arb1+ and arb2+ contain introns. It was shown that the silencing defects 
observed upon impairment of splicing could be alleviated by replacing the RNAi pathway 
genes with their cDNA equivalents [190]. Requirement for splicing factors in 
heterochromatin formation implies that it might be more difficult than anticipated to 
understand the role of efficient splicing in protecting the euchromatic and will require more 
careful experimental design.  
The link between silencing and inefficient transcription termination provides a hint on why 
centromeric non-coding repeats can serve as targets for transcriptional gene silencing by 
small RNAs, despite the fact that they are also transcribed by RNA PolII [39]. It was 
suggested that centromeric transcripts frequently undergo aberrant and inefficient 
transcription termination due to collision of the transcribing polymerase with the replication 
machinery [191]. Interestingly, the authors of this study also point towards the role of the 
RNAi machinery in actual transcription termination and release of PolII from mis-terminated 
genes. This hypothesis is in agreement with our general model, implicating the role of slowed 
down transcription kinetics and transcript retention ‘on chromatin’. However, it does not 
address the repressive function of the Paf1 complex. An alternative explanation would be that 
the Paf1 complex interacting with PolII on centromeric repeats is post-transcriptionally 
modified, and this modification affects its activity or causes dissociation from chromatin. 
There is no direct evidence for this hypothesis, yet several observations point to this 
direction. First of all, the components of the Paf1 complex were shown to be post-
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Figure 22. Repression occurs due to inefficient transcription termination. A Schematic representation of 
the stages of transcription process in which the Paf1 complex was suggested to play an important role. B and 
C Results of ChIP experiments to assess accumulation of the H3K36me3 mark and RNA PolII occupancy at 
the ade6+ locus in paf1+ and paf1-Q264Stop strains, in the absence of ade6-hp construct. In order to control 
for signal background and for differences in ChIP efficiency, scores were normalized to the enrichments 
over snu6+ gene. For the H3K36me3 ChIP, scores were normalized to the total histone H3 enrichments. 
Mean of three biological replicates is shown. Error bars represent standard error of mean (s.e.m.). P-values 
were calculated using one-tailed Student’s t-test. D ade6+-silencing assay on YE plates using the 
nmt1+::ade6-hp+ tpr1+::ade6+ strain, in which indicated factors had been deleted or mutated. Lower panel 
shows close-up pictures of ctf1-70 mutant. Note the variegating colonies indicating the bi-stable silencing 
state. paf1-Q264Stop strain was used as a positive control. E Establishment (top) and maintenance (bottom) 
of heterochromatin at the trp1+::ade6+ locus in the ctf1-70 and res2D mutants were assessed upon approx. 
30 mitotic divisions White and red parental colonies were used to assess establishment and maintenance, 
respectively. n, number of scored colonies. 
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transcriptionally modified both in the fission and the budding yeast [192–194]. Furthermore, 
many connections link the Paf1 complex to regulation of the cell cycle as well. Most notably, 
the Cdc73 subunit was identified in a screen for regulators of the yeast cell cycle in the 
budding yeast, and the fission yeast Cdc73 was found in a global analysis of proteins that 
acquire cell-cycle dependent modifications [192]. It was proposed in the past that siRNA 
production and the subsequent reinforcement of silencing at centromeric repeats occurs in a 
cell cycle-dependent manner [195]. Thus, one could imagine that a crosstalk between these 
two processes exists. Paf1 binding to centromeric DNA could be regulated by cell cycle and 
have a direct consequence in making the centromeric chromatin permissive for the RNAi 
factors, small RNA production and transcriptional silencing.  
An alternative model of siRNA-mediated transcriptional silencing could also be drawn. A 
study using a mass spectrometry approach detected an interaction between the Cdc73 subunit 
of the Paf1 complex and the putative histone H3 lysine 9 demethylase Epe1 [186]. Thus, the 
Paf1 complex could protect the active chromatin state of protein coding genes by continuous 
recruitment of Epe1, which would remove any H3K9 methylation induced by the endogenous 
primary siRNAs. Mutations in the Paf1 complex would disrupt this interaction and prevent 
Epe1 recruitment, allowing siRNA-mediated nucleation of heterochromatin and 
establishment of the self-reinforcing loop. In line with this idea, it has been recently shown 
that in the epe1Δ strain, heterochromatin can be stably maintained and inherited [196], [197]. 
However, contrary to our model, in the epe1Δ mutant, heterochromatin can be stably 
maintained in the absence of the RNAi machinery. This discrepancy speaks against this 
alternative mechanistic interpretation. Furthermore, a molecular mechanism in which the 
Paf1 mutations cause loss of the Epe1 demethylase does not explain the fact that mutations in 
the factors mediating transcription termination give rise to the similar silencing phenotype as 
the Paf1 complex mutants (Figure 22). Therefore, is more likely that putative recruitment of 
Epe1 would rather contribute to the role of the Paf1 complex as a repressor of 
siRNA-mediated heterochromatin formation, than be the main cause of it.  
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6.5 Possible approaches to test conservation of Paf1 complex function  
 
As mentioned in the Section 8.2, studies of putative conservation of small-RNA-mediated 
transcriptional gene silencing upon depletion of the Paf1 complex are inherently difficult in 
higher eukaryotes, because all of the components of the complex are essential for cell 
viability. Therefore, in order to elucidate the role of hPaf1 in transcription and epigenome 
regulation, one needs to employ approaches more complicated than complete gene deletions.  
 
hPaf1 complex has been implicated in maintenance of the pluripotent state of ESC. To test 
the positive effect of hPaf1 complex on expression of the pluripotency genes, we could 
generate various conditional knockout alleles in mouse ESC lines and assess the pluripotency 
and differentiation potential upon depletion of the complex. To this end, one can employ the 
genome editing technologies aforementioned in the Section 3.1.5. Importantly, as complete 
ablation of the hPaf1 complex is likely to be deleterious for cell survival, it will be crucial to 
find a time window when we could assay gene expression and ideally small RNA expression 
Figure 23. Efficient transcript release contributes to escape from siRNA-mediated silencing. A 
Schematic representation of the ribozyme constructs inserted at the endogenous ade6+ locus. ade6+ ORF is 
followed by a sequence encoding for a synthetic polyA signal. A 52nt-long sequence encoding for a wild 
type (ade6-Rz) or mutant (ade6-Rzm) self-cleaving hammerhead ribozyme was inserted downstream. ade6-
Rzm differs from ade6-Rz by one nucleotide, which introduces a mutation in the active site and renders the 
ribozyme inactive. Ribozyme-encoding sequence is followed by a terminator sequence from the adh1+ 
gene. B paf1-Q264Stop strain carrying the ade6-Rz and ade6-Rzm alleles was spotted in ten-fold serial 
dilutions on YE plates for the ade6+ silencing assay. Red colonies from the middle panel were selected for 
second silencing assay to assess the efficiency of heterochromatin maintenance (most right panel). Note that 
both ade6-Rz constructs produce functional ade6+ mRNA (white color of the cells in the paf1+ cells). 
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as well. This would allow us to test the model proposed in this study directly. Alternatively, 
we could also try to perform the experiments in heterozygous cell lines, assuming that 
depletion of one allele will have a sufficient effect on the protein levels of the Paf1 complex 
without causing cell death.  
Mutations in genes encoding the Paf1 complex have been linked to tumorigenesis. Several 
mutations that correlated with the occurrence of the disease (See. Table 1 and Table 2) were 
identified in the CDC73 and CTR9 genes. In case of the hereditary tumors, it was suggested 
that the patients were carriers of one mutated allele (See Table 1), and inactivation or loss of 
the second one caused the development of cancer [163]. In some cases development of the 
tumors was caused by a second mutation event but in a different tumor suppressor gene 
[163]. Although this approach would be highly speculative, we could assume that the 
expression of such mutated alleles lead to production of a defective form of the Paf1 
complex. The expression of this allele would still allow cell survival, causing only a partial 
loss-of-function phenotype. Thus, we could reconstitute some of these mutations in order to 
impair the function of the Paf1 complex.  
Finally, we could also test whether impaired transcription termination and transcription 
kinetics would subject genes to small-RNA-mediated repression also in human cells without 
interfering with the Paf1 complex expression levels. During influenza virus infection in 
human cells, the viral protein NS1 interacts with the cleavage and polyadenylation factor of 
the host and causes inefficient release of the nascent transcript by inhibiting the transcript 
cleavage event [198]. By this mechanism, the virus can promote transcription of its own 
genome. In a separate study, the NS1 protein has been suggested to interact with the Paf1 
complex, affecting efficient transcription elongation and by this suppressing the expression of 
antiviral response genes [199]. If both of these functions were correctly described, 
overexpression of the NS1 protein should affect the kinetics of transcription termination and 
elongation. Thus, we could provide the cells with a potent source of small RNAs and 
combine it with the overexpression of NS1 and by this we would likely circumvent the 
problem of the lethality caused by knockouts or knockdowns of the Paf1 complex genes. 
Overexpressing NS1 could be relatively easily used to test the model we proposed for the 
fission yeast in the human cells in the future.  
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6.6 Implications for mechanistic studies 
 
The results obtained in our study provide a novel experimental setup that can be used to 
address some fundamental mechanistic questions in an unprecedented way. We show that a 
potent source of siRNAs is required to establish the silencing (Figure 10, Figure 14). 
Afterwards, the function of primary siRNAs can be taken over by the secondary siRNAs, but 
the silencing is still highly dependent on Dicer and other RNAi machinery components 
(Figure 14). By performing a series of crosses, we showed that the heterochromatin 
maintenance could be uncoupled from the constant expression of the primary siRNAs from 
the hairpin. We believe that this clean and elegant experimental design can be used to 
determine other requirements for heterochromatin establishment and maintenance. Until now, 
these experiments were performed in a laborious way, involving deletion and reconstitution 
of the clr4+ methylatransferase gene, or relied on treatment of the cells with a histone 
deacetylase inhibitor that could be insufficient or elicit pleiotropic effects [200], [201]. 
Furthermore, by using gene specific hairpins, with our new approach we can study 
heterochromatin independently of the repetitive nature of the centromeric repeats and their 
partial complementarity to other heterochromatic loci. We can also test the requirements for 
the length and sequence of a minimal siRNA source, or avoid the redundancy of multiple 
maintenance pathways at the mating type locus [32].  
 
As mentioned above, expression of the ade6-sh+ construct is driven from the adh1+ 
promoter, and it encodes for a hairpin containing the cox4+ intron sequence in the place of 
the loop (Figure 4B). Despite the fact that small RNAs targeting both strands of the cox4+ 
intron and the adh1+ promoter were made, they did not induce accumulation of the H3K9 
methylation mark on either of these genes (Figure 12). Production of cox4+ intron-derived 
secondary siRNAs, but not siRNAs mapping to the rest of the transcript were also observed 
by another group, which used a similar hairpin construct [169]. This finding seems to be the 
closest indication of the interaction between siRNAs and the nascent RNA that is required for 
silencing and heterochromatin formation, rather than an interaction with the underlying DNA 
sequence or the mature transcripts, To prove this hypothesis, careful experiments will be 
required; for instance, starting with designing a hairpin targeting the intronic sequence 
directly or designing splice site mutants that would retain the intron in the cox4+ transcript 
without affecting the stability of the mRNA. In addition, this observation indicates that the 
small RNAs mapping to the hairpin locus are also secondary siRNAs produced by Rdp1, as 
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the cox4+ intron sequence is only present in one orientation, but sequenced small RNAs are 
mapping to both strands and are present in equally high amounts.  
 
 
  
Figure 24. Proposed model for Paf1-mediated repression of siRNA-directed heterochromatin 
formation. A Paf1C facilitates rapid transcription and release of the nascent transcript from the DNA 
template. Because the kinetics of transcription termination and transcript release is faster than 
siRNA-mediated binding of the RNAi machinery and recruitment of the H3K9 methyltarsferase Clr4, 
heterochromatin formation cannot be induced. B In the Paf1C mutants, transcription elongation, termination, 
and the release of the nascent transcript from chromatin are slowed down. This results in an accumulation of 
RNA polymerases associated with nascent transcripts, providing a time window in which siRNA-guided 
RITS complex can bind nascent transcripts and recruit the CLRC complex. Consequently, highly stable and 
repressive heterochromatic domain that produced secondary siRNAs is assembled. 
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6.7 Formation of facultative heterochromatin 
 
As outlined in Section 4.3, we initiated this study to identify putative repressors of 
siRNA-mediated transcriptional silencing in trans. We reasoned that a yeast cell would 
employ such repressive mechanism to protect gene expression from the consequences of 
endogenous, low abundant small RNAs. We identified the Paf1 complex as the sought-after 
repressor and we hypothesized that under the condition when the Paf1 complex function is 
impaired, priRNAs and other dsRNA-derived primary RNAs should induce heterochromatin 
formation on protein coding genes even more efficiently.  
 
Although we identified a number of loci that underwent mild repression in different Paf1 
complex mutants, we failed to detect silencing repeatedly at the same genomic location in 
different strains (Table 7, Figure 17A). This result is in agreement with our observation that a 
stable source of small RNAs is required for establishment of heterochromatin (Figure 11). 
Since priRNAs were derived from degradation products of cellular mRNAs, they would 
make a low abundant source of siRNAs that is not potent enough to establish 
heterochromatin at corresponding euchromatic locations. Alternatively, it could be that 
priRNAs and endogenous small RNAs were able to induce silencing but in a random manner 
and the strong silencing effect could not be observed because we performed the experiment 
in a mixed population of cells. Dcr1 was suggested to be a limiting factor for siRNA 
generation and it was reported that overexpression of Dcr1 protein increases drastically the 
levels of primary siRNAs [80], [169]. Thus, combining the Dcr1 overexpression with Paf1 
complex mutation could increase the population of endogenous small RNAs potentially 
required to initiate heterochromatin formation.  
 
Several genes have been reported to be targets of RNAi-mediated facultative heterochromatin 
formation in cells grown at varied growth conditions [202]. We suspected that these loci 
could be inherently primed for repression already under normal conditions and that we could 
induce heterochromatin formation at these loci in the Paf1 mutant strains. Since that was not 
the case, we concluded that no genes were specifically primed for silencing by 
siRNA-mediated formation of heterochromatin in S. pombe under standard laboratory growth 
conditions. Consistently, we have not observed the signature of heterochromatin 
establishment at the convergent gene pairs, as was previously suggested [203], [204] 
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Another likely explanation for the fact that we did not identify any genes that had undergone 
silencing by endogenous small RNAs is that such small RNAs were able to mediate 
heterochromatin formation; but this heterochromatic repression was weak or could not be 
propagated for long. If this was the case, repeating the expression profiling in the conditions 
where maintenance of heterochromatin was more potent could increase the chance of success. 
Recently, two groups reported that upon removal of the putative histone demethylase Epe1, 
epigenetic inheritance of the silent chromatin state independent of small RNAs was enhanced 
[196], [197]. Combining the epe1+ deletion with the impairment of the Paf1 complex could 
lead to a more stable propagation of heterochromatin and allow us to identify possible targets 
of endogenous primal RNAs. Following this logic, deletion of other factors that negatively 
regulate heterochromatin formation like Mst2 [205] or Eri1[35], [206] could also cause more 
potent maintenance. Finally, as it was reported that in trans silencing of homologues 
sequences could be enhanced by overexpression of the Swi6 protein [80], we could also try 
overexpressing Swi6 in the Paf1 complex mutant strain. 
 
Results presented in the section 5.9 demonstrate that if the naïve cells with an active copy of 
the ade6+ gene undergo meiosis, the efficiency of the RNAi-mediated nucleation of 
heterochromatin at the reporter gene is notably increased (Figure 20). Although this 
observation serves more as indirect evidence, we noticed that the mutant progeny from a 
cross of the leo1+ strain with the leo1Δ strain differ in size (Figure 21B), even though all 
crosses should have produced an isogenic set of four progeny colonies. We speculate that 
these phenotypic differences are a consequence of the fact that upon meiosis, endogenous 
ectopic heterochromatin formation in the leo1Δ progenies is more potent than during mitotic 
growth. However, the euchromatic genes become targets of the RNAi in a random fashion, 
which causes different growth phenotypes in genetically identical cells. This observation 
might serve as a starting point to further analyze the progeny of the leo1+and leo1Δ crosses, 
for instance, by RNA-sequencing or small RNA profiling. In order to identify such 
endogenously silenced genes, RNA isolation and sequencing might need to be performed 
directly from the colonies obtained from the crosses, under conditions resembling the ‘single 
cell’ RNA sequencing experiment. This approach could help to avoid dilution of the effect 
induced upon meiosis during long-propagation of the mutant cells.  
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6.8 Potential applications 
 
In our analysis we did not identify genes that would be silenced by endogenous siRNAs in 
the Paf1 complex mutants. This speaks in favor of using the mutation of the Paf1 complex as 
a tool to induce targeted transgenerational gene expression changes in various organisms. In 
case of creating knockout transgenic plants, applying our finding would, in theory, alleviate 
the need to edit the genome every time when a new gene needs to be removed. Instead, since 
the mutations in the Paf1 complex seem to have very minor effects on the global gene 
expression and cellular fitness (Figure 15, Figure 16B), one could use a Paf1 mutant plant 
and provide a potent source of small RNAs to induce gene silencing. Most importantly, the 
silent state could then be propagated to the next generations without the need for constant 
supply of the primary siRNA source. Furthermore, the gene silencing is also reversible, as it 
does not imply any changes in the sequence of the target gene.  
In our model system, the silent state is maintained thanks to the secondary small RNAs, 
which are produced in the efficient amplification loop by Rdp1 at the target locus. Thus, it 
might be that effective transgenerational silencing could only be applied in organisms with 
RDRP activity. In worms and plants, RDRPs have been well described [207]. Especially in 
plants there is a great potential for applying this approach as there is strong evidence for the 
existence of the self-reinforcing loop that involves siRNA production, DNA methylation and 
H3K9 methylation and for its role in the maintenance of silencing [60]. Evolutionary studies 
did not reveal the presence of genes encoding for RdRP homologues in vertebrates and it 
remains uncertain whether they carry any non-viral genes encoding RdRP activity. 
Furthermore, it remains unclear whether mechanisms coupling the small RNA-mediated 
target recognition with establishment of a heterochromatic domain are also present in 
mammals. If so, one could speculate that in mammalian cells, transient presence of small 
RNAs could induce heterochromatin formation and establish transcriptional silencing, which 
could then be reinforced by more classic heterochromatin factors and propagated through 
mitotic divisions independent of the small RNAs, with the help of DNA methylation, histone 
modifications, chromatin readers and HP1s[1].  
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8 Abbreviations 
 
Ago Argonaute 
ARC Argonaute siRNA chaperone complex 
Aub Aubergine 
bp base pair 
ChIP chromatin immunoprecipitation 
CLRC Clr4-Rik1-Cul4 complex 
CPSF cleavage/polyadenylation specificity 
CstF cleavage stimulation factor 
CTD C-terminal domain 
CTGS co-transcriptional gene silencing 
DCL Dicer-like 
Dcr1 S. pombe Dicer 
DRB 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole  
DSIF DRB sensitivity-inducing factor 
dsRNA double-stranded RNA 
EMS ethyl methanesulfonate 
ESC embryonic stem cells 
EZH2 Enhancer of Zeste 2 
FACT facilitates chromatin transcription 
FIHP familial isolated primary hyperparahthyroidism 
GW glycine-tryptophane 
H2BK123 histone H2B lysine 123 
H3K27 histone H3 lysine 27 
H3K36 histone H3 lysine 36 
H3K4 histone H3 lysine 4 
H3K79 histone H3 lysine 79 
H3K9 histone H3 lysine 9 
H3K9me histone H3 lysine 9 methylation 
H3K9me2 histone H3 lysine 9 dimethylation 
H3K9me3 histone H3 lysine 9 trimethylation 
H4K16 histone H4 lysine 16 
H4K16Q histone H4 lysine 16 substitution with glutamine 
H4K16R histone H4 lysine 16 substitution with arginine 
HDAC histone deacetylase 
hp hairpin 
HP1 heterochromatin protein 1 
HPT-JT hyperparathyroidism-jaw tumor syndrome 
imr innermost repeats 
kb kilo base 
miRNA micro RNA 
NLS nuclear localization signal 
NRDE nuclear RNAi-defective 
NS1 non-structural protein 1 
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nt nucleotide 
OF ossifying fibroma 
ORF open reading frame 
otr outermost repeats 
Paf1 RNA Polymerase II-associated factor 1 
piRNA Piwi-interacting RNA 
PIWI P-element induced wimpy testis 
PolII RNA Polymerase II 
PolIV RNA Polymerase IV 
PolV RNA Polymerase V 
polyA polyadenine tail 
pre-miRNA precursor microRNA 
pri-miRNA primary microRNA 
PTA parathyroid adenoma 
PTC parathyroid carcinoma 
pTEFb positive transcription elongation factor 
PTGS post-transcriptional gene silencing 
RdDM RNA-directed DNA methylation 
RDE RNAi-defective 
RDRC RNA-directed RNA polymerase complex 
RdRP RNA-directed RNA polymerase 
RISC RNA-induced silencing complex 
RITS RNA-induced transcriptional silencing complex 
RNAe RNA-induced epigenetic silencing 
RNAi RNA interference 
RNASe III ribonuclease III 
RT-qPCR real-time quantitative PCR 
Ser-2 serine 2 
Ser-5 serine 5 
Ser-7 serine 7 
SHREC Snf2/HDAC-containing repressor complex 
siRNA small interfering RNA 
snoRNA small nucleolar RNA 
splice [a] splice acceptor site 
splice [d] splice donor site 
TALEN transcription activator-like effector nuclease 
TE transposable element 
TGS transcriptional gene silencing 
Tri Triman 
TSS transcription start site 
UTR untranslated region 
WAGO worm-specific Ago 
WT wild type 
YE yeast extract 
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9 Experimental Procedures 
9.1 Methods 
 
All the experiments and analysis were conducted as described in the Methods section of the 
published manuscript that can be found in the Section 10 [2]. 
 
9.2 Strains 
 
Table 4 Yeast strains used in this study. 
Name Genotype Ref 
SPB155 h- leu1-32 ura4-D18 ade6-704 b 
SPB389 h-  leu1-32  ura4-D18 a 
SPB462 h-  leu1-32, ura4-D18 nmt1+::ade6-hp+ a 
SPB426 h- leu1-32 ura4-D18 ade6-704  trp1+::ade6+ a 
SPB464 h- leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2163 h-  sms1 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2164 h-  sms2 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2165 h-  sms3 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2166 h-  sms4 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2167 h-  sms5 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2168 h-  sms6 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2169 h-  sms7 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2170 h-  sms8 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2171 h-  sms9 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2172 h-  sms10 leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2173 h-  sms1 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2174 h-  sms2 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2175 h-  sms3 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2176 h-  sms4 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2177 h-  sms5 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2178 h-  sms6 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2179 h-  sms7 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2180 h-  sms8 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2181 h-  sms9 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2182 h-  sms10 dcr1D::hph leu1-32 ura4-D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2047 h- paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2127 h- dcr1D::hph paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2128 h- ago1D::TAP-kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2129 h- tas3D::TAP-kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2130 h- chp1D::TAP-kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2131 h- arb1D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2132 h- arb2D::TAP-kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2133 h- rdp1D::TAP-kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ a 
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nmt1+::ade6-hp+ 
SPB2134 h- hrr1D::TAP?-kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2135 h- cid12D::TAP-kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2136 h- clr4D::hph paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2137 h- rik1D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-M210  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2138 h- raf1D::TAP?-kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2139 h- raf2D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2141 h- clr1D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2142 h- clr2D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2143 h- clr3D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2144 h- mit1D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2145 h- swi6D::hph paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2147 h- chp2D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2146 h- stc1D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2148 h- ers1D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-M210  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB2150 h- tri1D::kan paf1-Q264stop::LEU2 leu1-32 ura4-D18 ade6-704  trp1+::ade6+ 
nmt1+::ade6-hp+ 
a 
SPB1788 h+ leu1-32 ura4D18 ade6-M210 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2063 h+ paf1-Q264stop::kan leu1-32 ura4-D18 ade6-m210  trp1+::ade6+ a 
SPB2016 h- prf1D::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1953 h- paf1D::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1955 h- leo1D::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1956 h- tpr1D::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1957 h- cdc73D::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB2020 h- paf1+::kan leu1-32 ade6-M210 nmt1+::ura4-hp+ a 
SPB2021 h- paf1-Q264stop::kan leu1-32 ade6-M210 nmt1+::ura4-hp+ a 
SPB2002 h- paf1+::LEU2 ura4+::5BoxB-hphR leu1D::ura4-intron(StuI)-natR  a 
SPB2003 h- paf1-Q264Stop::LEU2 ura4+::5BoxB-hphR leu1D::ura4-intron(StuI)-natR  a 
SPB2004 h- paf1+::LEU2 ura4+::5BoxB-hphR tas3+::lN-kanR leu1D::ura4-intron(StuI)-natR  a 
SPB2005 h- paf1-Q264Stop::LEU2 ura4+::5BoxB-hphR tas3+::lN-kanR leu1D::ura4-intron(StuI)-
natR  
a 
SPB2029 h- paf1+::LEU2 eri1D::ble ura4+::5BoxB-hphR tas3+::lN-kanR leu1D::ura4-intron(StuI)-
natR 
a 
SPB2030 h- paf1-Q264Stop::LEU2 eri1D::ble ura4+::5BoxB-hphR tas3+::lN-kanR leu1D::ura4-
intron(StuI)-natR 
a 
SPB2022 h-  paf1+::kan leu1-32  ura4-D18  a 
SPB2023 h-  paf1-Q264Stop::kan leu1-32  ura4-D18 a 
SPB2024 h-  paf1+::kan leu1-32  ura4-D18 nmt1+::ade6-hp+ a 
SPB2025 h-  paf1-Q264Stop::kan leu1-32  ura4-D18 nmt1+::ade6-hp+ a 
SPB2039 h-  paf1-Q264Stop::kan leu1-32  ura4-D18 nmt1+::ade6-hp+ a 
SPB1995 h- prf1-3xFLAG::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1996 h- paf1-3xFLAG::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1997 h- leo1-3xFLAG::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1998 h- tpr1-3xFLAG::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
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SPB1999 h- cdc73-3xFLAG::kan leu1-32 ura4D18 ade6-704 trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1960 h- paf1-G104R::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1961 h- paf1+::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1962 h- paf1-G104R::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+  a 
SPB1963 h- cdc73-G313R::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1965 h- cdc73-G313R::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+  a 
SPB1966 h- prf1-Q472Stop::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1967 h- prf1+::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1968 h- prf1-Q472Stop:: kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+  a 
SPB1969 h- leo1-W157Stop::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1970 h- leo1+::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1971 h- leo1-W157Stop::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+  a 
SPB1972 h- paf1-Q264Stop::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ a 
SPB1973 h- paf1-Q264Stop::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ a 
SPB2009 h- paf1-G104R::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ 
(heterochromatic) 
a 
SPB2010 h- cdc73-G313R::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ 
(heterochromatic) 
a 
SPB2011 h- prf1-Q472Stop::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ 
(heterochromatic) 
a 
SPB2012 h- leo1-W157Stop::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ 
(heterochromatic) 
a 
SPB2013 h- paf1-Q264Stop::kan leu1-32 ura4-D18 ade6-704  trp1+::ade6+ nmt1+::ade6-hp+ 
(heterochromatic) 
a 
SPB2276 h- leu1-32 ura4-D18 shade6-250/natMX paf1-Q264Stop::kan ade6+::ade6-polyA(75)-Rzm-
Tadh1 
a 
SPB2277 h- leu1-32 ura4-D18 shade6-250/natMX paf1-Q264Stop::kan ade6+::ade6-polyA(75)-Rz-
Tadh1 
a 
SPB2318 h+ leu1-32 ura4-D18 shade6-250/natMX ade6-M210 trp1+::ade6+ set2D::kan a 
SPB2353 h+ leu1-32 ura4-D18 shade6-250/natMX ade6-M210 trp1+::ade6+ set1D::kan a 
SPB2355 h- leu1-32 ura4-D18 shade6-250/natMX ade6-704  trp1+::ade6+ ctf1-70::hph a 
SPB2357 h- leu1-32 ura4-D18 shade6-250/natMX ade6-704  trp1+::ade6+ res2D::hph a 
SPB2358 h+ leu1-32 ura4-D18 shade6-250/natMX ade6-M210 trp1+::ade6+ spt4D::kan  a 
SPB2359 h+ leu1-32 ura4-D18 shade6-250/natMX ade6-M210 trp1+::ade6+ tfs1D::kan a 
SPB2286 h- leu1-32 ura4-D18 shade6-250/natMX ade6+::ade6-polyA(75)-Rzm-Tadh1 a 
SPB2287 h- leu1-32 ura4-D18 shade6-250/natMX ade6+::ade6-polyA(75)-Rz-Tadh1 a 
 
a this study 
b obtained from  Katja Ludin/Jürg Kohli 
 
9.3 Plasmids  
 
Table 5 Plasmids used in this study. 
Name Description Ref 
pMB417 pNatMXARTade6-hp a 
pMB1344 pJET1.2-paf1-Q264stop-LEU2(s.c) b 
pMB1313 pFA6a-paf1-G104R-kanMX b 
pMB1314 pFA6a-cdc73-G313R-kanMX b 
pMB1318 pFA6a-prf1-Q472Stop-kanMX b 
pMB1319 pFA6a-leo1-W157Stop-kanMX b 
pMB1320 pFA6a-paf1-Q264Stop-kanMX b 
 
a kind gift from Tetsushi Iida 
b generated in this study 
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9.4 Oligonucleotides used for RT-qPCR 
 
Table 6 Oligonucleotides used in this study as primers for RT- qPCR analysis 
Name Sequence Target Comment 
mb6582 ATAAGGTATAACGACAACAAACG ade6+ promoter forward 
mb6583 GCATACGCTAAAATCAATATAGC ade6+ promoter reverse 
mb6584 CGAAAAACAGGTTGTAGGGATCC ade6+ CDS forward 
mb6585 GAATTTGCTGCATCCAAGATGATGC ade6+ CDS reverse 
mb6586 AAACATTGGCTTACGACGGTCG ade6+ CDS forward 
mb6587 GAACGAACTTTTCAACATAAAGCG ade6+ CDS reverse 
mb6588 TTCCACAACTCATGCGTTGATGG ade6+ CDS forward 
mb6589 GATGCAAAGTTGCACCGGGAATGG ade6+ CDS reverse 
mb6590 TCACCGCACACCAGATCGCATGG ade6+ CDS forward 
mb6591 ATACCAGGCAAATGAGCGGCACC ade6+ CDS reverse 
mb6592 CCCTTTTGGCTGCTATGGAGAGC ade6+ CDS forward 
mb6593 CTATGCAGAATAATTTTTCCAACC ade6+ CDS reverse 
mb6730 GCATTGAAGTTTAAGATAACATTGG ade6+ terminator forward 
mb6731 TAACATAGCCAAACATAATGCGG ade6+ terminator reverse 
mb555 TCCTCATGCTATCATGCGTCTT act1+ CDS forward 
mb556 CCACGCTCCATGAGAATCTTC act1+ CDS reverse 
mb557 CTGGCCAGCTTATTCAACTTCAT fbp+ CDS forward 
mb558 GATTTCGTCGAGATCTTTTTTCATG fbp1+ CDS reverse 
mb2202 CATGGAAATTGCAGTGATGGTAGT ade6+ CDS, wt and mutant allele forward 
mb2203 TGAATGGTCTCAGTTGTAGGATAAGC ade6+ CDS, wt and mutant allele reverse 
mb6373 GCTTGCCCAACTTCTCAGT hairpin, binds the targeting seq. forward 
mb6374 AGTTTGTCATAGCAGCTTAATGGT hairpin, binds the loop seq. reverse 
mb6416 CCATTCAAAAGGATAATGTTTGA ade6-m704 CDS only forward 
mb6417 CATGGCAAGGGTTTGAGCACGCTG ade6+ CDS, wt and mutant allele reverse 
mb6415 CCATTCAAAAGGATAATGTTTGT ade6+ CDS, wt allele only forward 
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The Paf1 complex represses small-RNA-mediated
epigenetic gene silencing
Katarzyna Maria Kowalik1,2*, Yukiko Shimada1,2*, Valentin Flury1,2, Michael Beda Stadler1,2,3, Julia Batki4 & Marc Bu¨hler1,2
RNA interference (RNAi) refers to the ability of exogenously intro-
duced double-stranded RNA to silence expression of homologous
sequences. Silencing is initiated when the enzyme Dicer processes
the double-stranded RNA into small interfering RNAs (siRNAs).
Small RNA molecules are incorporated into Argonaute-protein-
containing effector complexes, which they guide to complementary
targets tomediate different types of gene silencing, specifically post-
transcriptionalgenesilencingandchromatin-dependentgenesilencing1.
Although endogenous small RNAs have crucial roles in chromatin-
mediated processes across kingdoms, efforts to initiate chromatin
modifications in trans by using siRNAs have been inherently dif-
ficult to achieve in all eukaryotic cells. Using fission yeast, here we
show that RNAi-directed heterochromatin formation is negatively
controlled by the highly conserved RNA polymerase-associated fac-
tor 1 complex (Paf1C). Temporary expression of a synthetic hairpin
RNA in Paf1C mutants triggers stable heterochromatin formation
athomologous loci, effectively silencinggenes in trans.This repressed
state is propagated across generations by the continual production
of secondary siRNAs, independently of the synthetic hairpin RNA.
Our data support a model in which Paf1C prevents targeting of na-
scent transcripts by the siRNA-containingRNA-induced transcrip-
tional silencing complex and thereby epigenetic gene silencing, by
promoting efficient transcription termination and rapid release of
theRNAfrom the site of transcription.We showthat although com-
promised transcription termination is sufficient to initiate the forma-
tionofbi-stableheterochromatinby trans-acting siRNAs, impairment
of both transcription termination and nascent transcript release is
imperative to confer stability to the repressed state. Our work un-
covers a novelmechanism for small-RNA-mediated epigenome reg-
ulation and highlights fundamental roles for Paf1C and the RNAi
machinery in building epigenetic memory.
In the fission yeast Schizosaccharomyces pombe, a functional RNAi
pathway is required for the formation and stable propagation of con-
stitutive heterochromatin found at pericentromeric repeat sequences.
S. pombe contains single genes encoding for an Argonaute and a Dicer
protein, called ago11 and dcr11, respectively. Centromeres of ago1D
or dcr1D cells have markedly reduced histone 3 lysine 9 (H3K9)meth-
ylation, which is a hallmark of heterochromatin, and defective chro-
mosomesegregationandheterochromatic gene silencing2.Ago1 is loaded
with endogenous smallRNAscorresponding toheterochromatic repeats,
and interacts withChp1 andTas3 to form the RNA-induced transcrip-
tional silencing (RITS) complex3. Current models propose that Ago1-
boundsmallRNAstargetRITS tocentromeresviabase-pairing interactions
with nascent, chromatin-associated non-coding transcripts. Conse-
quently, RITS recruits the RNA-dependent RNApolymerase complex
(RDRC) to initiate double-stranded RNA synthesis and siRNA amp-
lification, as well as the cryptic loci regulator complex (CLRC) to facil-
itatemethylation of histoneH3K9 (ref. 4). Chp1 reinforces the hetero-
chromatin association of RITS by bindingmethylatedH3K9with high
affinity5, thereby creating a positive-feedback loop between siRNA
biogenesis, RITS localization and H3K9 methylation. Hence, siRNA-
programmedRITS acts as a specificity determinant for the recruitment
of other RNAi complexes and chromatin-modifying enzymes to cen-
tromeres.However, anoutstandingquestion iswhether synthetic siRNAs
can also function in this context, and thereby be used to trigger de novo
formation of heterochromatin, particularly outside of centromeric re-
peats, to stably silence gene expression at will1.
Small RNAs have crucial roles in endogenous chromatin-mediated
processes also in plants,Caenorhabditis elegans,Drosophila melanoga-
ster and ciliates. Their role in chromatin silencing can also be extended
tomammalian cells, although themechanisms and physiological path-
ways are less clear1,6. Yet, efforts to initiate chromatin modifications
in trans by using siRNAshave been inherently difficult to achieve in all
organisms. In plants, this is because the ability of siRNAs to induce
DNA methylation at gene promoters is context-dependent and sens-
itive to pre-existing chromatin modifications7. And although siRNAs
have been shown to promote DNAmethylation in trans on homolog-
ous reporter transgenes in tobacco andArabidopsis8, it is unclearwhether
this is a general phenomenon for endogenous promoters. Inmamma-
liancells, the introductionof siRNAsorhairpinRNAshas been reported
to promote the modification of DNA and histones9–11. However, most
small RNAs seem tomediate post-transcriptional gene silencing exclu-
sively, and siRNA-mediated silencing of transcription does not neces-
sarily require chromatin modification12,13. Consequently, the potential
of synthetic siRNAs to trigger long-lasting gene repression in mam-
malian cells is debated. Similarly, although studies in S. pombe have
shown that RNA-hairpin-derived siRNAs can promote H3K9 methy-
lation in trans at a small number of loci14,15, it is inefficient, locus-
dependent, and the silent state observed is weak and highly unstable14.
Rather, endogenousprotein-codinggenes seemtobe refractory to siRNA-
directed repression in trans in wild-type cells (Extended Data Figs 1
and 2). Therefore, it has been proposed that the ability of siRNAs to
direct de novo formation of heterochromatin in trans is under strict
control by mechanisms that have thus far remained elusive.
To identify putative suppressors of siRNA-mediated heterochroma-
tin formation,we designed a small-RNA-mediated silencing (sms) for-
ward genetic screen. We constructed a reporter strain (sms0), which
expresses anRNAhairpin (ade6-hp) that is complementary to 250 nu-
cleotides of ade61 (Fig. 1a andExtendedData Fig. 1).We chose ade61
as a reporter because ade6 mutant cells form red colonies on limiting
adenine indicator plates, whereas ade61 cells appear white. Although
the ade6-hpconstruct generated siRNAs complementary to ade61mes-
senger RNAs, no red colonies were visible, demonstrating that ade61
siRNAs cannot silence the ade61 gene in trans in sms0 cells (Extended
Data Figs 1b and 2). To screen for mutants that would enable ade61
siRNAs to act in trans, we mutagenized sms0 cells with ethylmethan-
sulfonate (EMS). This revealed five smsmutants that are highly suscep-
tible to denovo formationof heterochromatin and stable gene silencing
by siRNAs that are acting in trans (Extended Data Fig. 3).
*These authors contributed equally to this work.
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To map the mutations in sms mutants, we re-sequenced the ge-
nomes of sms0 and backcrossed sms mutants using whole-genome
next-generation sequencing.Wemappedmissense or nonsensemuta-
tions in the genes SPBC651.09c, SPAC664.03, SPBC13E7.08c and
SPBC17G9.02c (ExtendedData Fig. 3), whose homologues in budding
yeast encode for protein subunits of the Paf1 complex. We therefore
named SPAC664.03, SPBC13E7.08c and SPBC17G9.02c after the S. cer-
evisiae homologues paf11, leo11 and cdc731, respectively. SPBC651.
09c has already been named as prf11 (ref. 16). To validate these as the
causative mutations, we reconstituted the candidate point mutations
in Paf1, Leo1, Cdc73 and Prf1 in sms0 cells. All five point mutations
recapitulated the sms mutant phenotype in cells expressing ade6-hp
siRNAs (Fig. 1b, c). As expected from the red colour assays, ade61
mRNAlevelswere reduced inallmutant strains. siRNA-mediatedade61
silencing was also observed in cells that express a carboxy-terminally
33Flag-tagged version of the fifth Paf1C subunit Tpr1, which acts as a
hypomorphic allele (Extended Data Fig. 4). Therefore, we have iden-
tified mutant alleles for the homologues of all five subunits of Paf1C
that enable siRNAs to induce gene silencing in trans.
Wenext analysedwhether other genes could alsobe silenced in trans
in the Paf1C mutants. We first selected the endogenous ura41 gene,
as this has been shown to be refractory to silencing by siRNAs acting
in trans14,15,17. The paf1-Q264Stopmutation was introduced in a strain
expressing ura41 siRNAs from a ura41 hairpin integrated at the
nmt11 locus15. ura41 repression was monitored by growing cells on
media containing 5-fluoroorotic acid (5-FOA), which is toxic toura41
expressing cells. As expected, paf11 cells did not grow on 5-FOA-
containing media, indicating that the ura41 gene is expressed. How-
ever, paf1-Q264Stop cells formed colonies on 5-FOAcontainingmedia,
demonstrating siRNA-directed silencing of the endogenous ura41
locus (Extended Data Fig. 5a). Similarly, siRNAs generated at the het-
erochromaticura41::5BoxB locus18were able to silence a leu1D::ura41
reporter in trans in paf1-Q264Stop but not paf11 cells (Extended Data
Fig. 5b), demonstrating that siRNAs generated fromsources other than
RNA stem–loop structures also direct trans-silencing in paf11mutant
cells. Finally, we also observed silencing of the endogenous ade61 gene
when ade6-hp siRNAs were expressed from the nmt11 locus in paf1-
Q264Stop cells (Extended Data Fig. 5c). In summary, Paf1Cmutations
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enabled siRNA-directed silencing in trans at all euchromatic loci that
we tested.
The foregoing results indicated that de novo formation of hetero-
chromatinwasmediatedby trans-acting siRNAs. Indeed, Paf1Cmutants
showedhighH3K9methylation at all ade61 siRNA target loci (Fig. 1d
andExtendedData Fig. 6a–c), demonstrating that Paf1Cprevents trans-
as well as cis-acting siRNAs from directingmethylation of H3K9. Fur-
ther corroborating the formation of bona fide heterochromatin at the
ade61 target locus, ade61 repression was dependent on components
of SHREC (Snf2/histone deacetylase (HDAC) repressor complex) and
CLRC, as well as the heterochromatin protein 1 (HP1) proteins Swi6
and Chp2, which are known to facilitate constitutive heterochromatin
formation at centromeres (Fig. 1e). Finally, the formation of hetero-
chromatin reduced transcriptional activity of the ade61 gene as evi-
denced by reducedH3K36 tri-methylation andRNApolymerase (Pol)
II occupancy (Extended Data Fig. 6d, e). From these results we con-
clude that siRNAs can initiate the formation of heterochromatin and
gene silencing, but that this is under strict negative control by Paf1C.
This explains previous unsuccessful attempts to induce stable hetero-
chromatin formation in trans using synthetic siRNAs.
Consistent with the formation of an epigenetically distinct chro-
matin domain at the siRNA target loci, cells in a population of freshly
generated Paf1Cmutants were either fully red or fully white. The latter
gradually became redwith increasingnumbers ofmitotic divisions, and
once established, the silent state was remarkably stable (Fig. 1b, c). The
fact that not all cells in a population of naive Paf1Cmutant cells turned
red immediately allowed us to determine the frequency of initiation of
heterochromatin formation quantitatively. This analysis revealed that
silencing in mitotic cells was efficiently established in leo1-W157Stop
mutant cells,whereas cdc73-G313R cellswere the least efficient (Fig. 2a).
Descendants of a red colony switched to the white phenotype only
sporadically in all Paf1Cmutants, demonstrating that maintenance of
heterochromatin is very robust in these cells (Fig. 2b). Interestingly,
siRNA-directed de novo formation of heterochromatin was most effi-
cient in meiosis. In 70% of all crosses between a naive paf1-Q264Stop
mutant (white) and a paf11 cell, at least one of two paf1-Q264Stop
spores had initiatedade61 repression (red) (Fig. 2c andExtendedData
Fig. 7).We also observed highly efficient propagation of the silent state
through meiosis, but only in descendants of spores that inherited the
Paf1Cmutation (Fig. 2d).Thus, siRNAs are sufficient to initiate the for-
mation of very stable heterochromatin when Paf1C function is impaired.
Notably, assembly of heterochromatin at the ade61 target gene was
accompanied by the production of novel ade61 siRNAs that are not
encoded in the ade6-hp and that accumulated to high levels (Fig. 2e).
Thus, primary ade6-hp siRNAs trigger the production of highly abun-
dant secondary ade61 siRNAs inPaf1Cmutants. To test whether con-
tinuous production of siRNAs is necessary for sustaining the repressed
state,wedeleted genes encoding forRNAi factors and found thatade61
silencing was completely abolished in all canonical RNAi mutants.
Deletionof tri11 resulted inmoderate derepressionofade61 silencing,
suggesting aminor contributionof this exonuclease to siRNA-mediated
heterochromatin silencing (Fig. 1e). To testwhether secondary siRNAs
produced at the ade61 target locus are sufficient to maintain hetero-
chromatin,we crossed a trp11::ade61 paf1-Q264Stopade6-hp1 strain
(red) with a trp11::ade61 paf1-Q264Stop (white) strain. These crosses
regularly produced spores that gave rise to red cells even in the absence
of thenmt11::ade6-hp1 allele. The redphenotypewas still visible after
replica plating, demonstrating that heterochromatin canbemaintained
in the absence of the primary siRNAs for hundreds of mitotic cell divi-
sions (Fig. 2f). These results demonstrate that siRNAs can induce an
epigenetic change in gene expression in meiotic and mitotic cells, and
that secondary siRNAproduction is sufficient topropagate the repressed
state for many mitotic cell divisions independently of the primary
siRNAs that triggered the epigenetic switch.
The highly conserved Paf1C is well known for promoting RNA Pol
II transcription elongationandRNA39-endprocessing (Fig. 3a). Paf1C
also governs transcription-coupled histonemodifications and has con-
nections to DNA damage repair, cell cycle progression, and other pro-
cesses19. Given this broad function, we assessed the effect of our Paf1C
mutations on genome expression. This analysis revealed that paf1-
G104R,paf1-Q264Stop,prf1-Q472Stopand leo1-W157Stop impair repres-
sion of heterochromatin formation, without affectingRNA expression
globally (Supplementary Information and Extended Data Fig. 8). This
is consistent with our observation that ade61 expression is unaffected
in Paf1Cmutants in the absence of siRNAs (Fig. 1b).We did, however,
detect a reduction in H3K36 tri-methylation and an increase in RNA
Pol II occupancy on the ade61 gene in paf1-Q264Stop cells (Fig. 3b, c).
This is consistent with the role of Paf1C in promoting transcription,
and suggests that decelerated transcription kinetics in Paf1C mutants
enables siRNA-directed epigenetic gene silencing. To dissect which of
Paf1C’s activities aremost critical topreventRNAi-mediatedheterochro-
matin assembly,we interferedwith transcription elongation, termination
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or co-transcriptional histone modification directly by mutating genes
encoding elongation factors (Tfs1 and Spt4), termination factors (Ctf1
and Res2), or histone methyltransferases (Set1 and Set2)20,21 (Fig. 3a).
We observed siRNA-mediated initiation of ade61 silencing in ctf1-70
and res2D cells, butnot in tfs1D, spt4D, set1D and set2D cells (Fig. 3d–f),
demonstrating that impaired transcription terminationbutnot elonga-
tion is sufficient to allow siRNA-directed repression.Notably, although
impaired transcription termination in ctf1-70 and res2D cells was suf-
ficient to initiate silencing, the silent state was less stable than in paf1-
Q264Stopmutant cells (Fig. 3e, f). This explains why our screen did not
reveal mutations in transcription termination factors.
In ctf1-70 cells, although RNA Pol II fails to terminate, the nascent
RNA is still properly processed and released from the site of transcrip-
tion21. This probably accounts for the less stable silencing in ctf1-70 cells
and suggests that themore severe phenotype of Paf1Cmutants is due to
the combined effects of impaired termination and nascent transcript
release. Therefore, we tested whether artificially releasing the nascent
transcript from the site of transcription partially alleviates siRNA-
mediated heterochromatin formation in Paf1C mutant cells. To this
end,we inserted a 52-nucleotidehammerhead ribozyme (Rz), preceded
by a templated polyA (A75) tail, downstream of the ade61 open read-
ing frame (ade6-Rz) to induce self-cleavage of nascent ade61 tran-
scripts (Fig. 3g). Indeed, initiation of silencing at the ade6-Rz locuswas
inefficient and the repressed state was poorly propagated in paf1-
Q264Stopmutant cells. By contrast, silencingwas very effective in cells
that contain a single base change in the catalytic site of the ribozyme
(ade6-Rzm) that abolishes self-cleavage (Fig. 3h). Thus, retaining the
nascent transcript onchromatin is critical to stabilize the repressed state.
These results are consistent with a kinetic model for Paf1C function
anddemonstrate that proper transcription termination is crucial to pre-
vent de novo formation of heterochromatin by siRNAs (ExtendedData
Fig. 9). This is further supported by the recent observation that ter-
mination sequences in the 39 untranslated region of the ura41 gene
inhibit the ability of siRNAs to promote heterochromatin formation17
and is reminiscent of enhanced silencing phenotype (esp) mutations in
Arabidopsis thaliana, which are in genes that encode for members of
the cleavage polyadenylation specificity factor and cleavage stimulation
factor complexes22. Importantly, our results show that impairment of
both transcription termination and nascent transcript release is imper-
ative to confer stability to the repressed state, although compromised
transcription termination is sufficient to initiate the formation of bi-
stable heterochromatin by trans-acting siRNAs.
Besides Dcr1-dependent siRNAs, Ago1 associates with Dcr1-inde-
pendent small RNAs referred to as primal RNAs (priRNAs). priRNAs
seem to be degradation products of abundant transcripts and could
potentially trigger siRNA amplification and uncontrolled heterochro-
matic gene silencing23. Therefore, we speculated that the physiological
function of Paf1C is to protect the genome from spurious priRNA-
mediated heterochromatin formation. To investigate this we analysed
whether Paf1C mutants would disclose genomic regions that could be
potentially assembled into facultative heterochromatin by endogenous
small RNAs. On the basis of our results, loci at which facultative het-
erochromatin forms inanRNAi-dependentmanner are expected to show
reduced RNA expression with a concomitant increase in siRNA pro-
duction. As expected, thenmt11::ade6-hp1, trp11::ade61 and ade6-
704 loci fulfilled this criteria (Extended Data Fig. 10a). Moreover, we
observed repression and siRNA production for genes flanking these
loci, indicating spreading of heterochromatin into neighbouring genes,
whichoccurredup to 6 kilobases (kb)upor downstreamof the ade6-hp
siRNA target sites. Indeed, we observed H3K9 methylation in this re-
gion in leo1D cells specifically (Extended Data Fig. 10b, c). In addition
to these regions, we observed siRNA-directed silencing signatures at
different, non ade61-linked genomic loci, indicating that Paf1C may
indeed function to protect the genome from illegitimate repression of
protein coding genes by endogenous priRNAs. However, we did not
recover the same sites repeatedly in the different Paf1C mutants
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(Supplementary Table 1). This indicates that initiation of silencing at
these sites occurred stochastically and that there are no specific sites
primed for the formation of facultative heterochromatin inmitotic cells
that are grownunder standard laboratory conditions.Therefore,wecon-
clude thatPaf1Cprotectsprotein-codinggenes fromunwanted long-term
silencing that might occur by chance, thereby restraining phenotypic
variation and conferring epigenetic robustness to the organism.
In summary, we discovered that synthetic siRNAs are highly effec-
tive in directing locus-independent assembly of heterochromatin that
can be stablymaintained throughmitosis andmeiosis onlywhenPaf1C
activity is impaired. A remarkable observation of our study is that the
newly established heterochromatin was inherited for hundreds of cell
divisions across generations in Paf1Cmutant cells, even in the absence
of the primary siRNAs that triggered the assembly of heterochroma-
tin. This phenomenon complies with the classical definition of epige-
netics24 (that is, that it is heritable even in the absence of the initiating
signal) and highlights fundamental roles of Paf1C and the RNAi ma-
chinery in building up epigenetic memory. This mechanism is also re-
miniscentofRNA-mediated epigenetic phenomena inhigher eukaryotes
suchasparamutation25 andRNA-induced epigenetic silencing (RNAe)26.
RNAe is a phenomenon in which small RNAs of the C. elegans Piwi
pathway can initiate transgene silencing that is extremely stable across
generations even in the absence of the initiating Piwi protein. Yet, not
all Piwi pathway RNAs trigger RNAe (ref. 27). Similarly, generation of
siRNAs is necessary but not sufficient for paramutation in maize28.
Thus, Paf1C may also have a regulatory role in paramutation and/or
RNAe. Notably, Paf1C is known to help maintain expression of tran-
scription factors required for pluripotency in human and mouse em-
bryonic stem cells and prevent expression of genes involved in lineage
specification29,30, which may also involve small RNAs and chromatin
regulation.
The ability to induce long-lasting and sequence specific gene silen-
cing by transient delivery of synthetic siRNAs without changing the
underlying DNA sequence will not only enable fundamental research
on mechanisms that confer epigenetic memory, but may also open up
new avenues in biotechnology and broaden the spectrum of the poten-
tial applications of RNAi-based therapeutics. Epigenetic control over
gene expression is of particular interest in plant biotechnology, as this
would circumvent the generation of genetically modified organisms.
Online ContentMethods, along with any additional Extended Data display items
andSourceData, are available in theonline versionof thepaper; referencesunique
to these sections appear only in the online paper.
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METHODS
Strains and plasmids. Fission yeast strains were grown at 30 uC in YES medium.
All strains were constructed following a PCR-based protocol31 or by standard mat-
ing and sporulation. Plasmids and strains generated in this study are shown in Sup-
plementary Tables 2 and 3.
EMS mutagenesis, hit selection and backcrossing. Exponentially growing sms0
(SPB464) cellswerewashedand resuspended in50mMK-phosphate buffer (pH7.0)
and treated with EMS (final concentration 2.5%) for 150min. An equal volume of
freshly prepared 10% sodium thiosulfate was then added. Cells were washed with
water and subsequently resuspended in YES. EMS treatment resulted in,50% cell
viability. To screen formutants inwhich ade61 expressionwas silenced, cells were
spreadonYEplates.About 350,000 colonieswere examined and pink colonieswere
selected for further evaluation. Positive hits were backcrossed four times with the
parental strains SPB464 or SPB1788, depending on mating type.
Silencing assays. To assess ura41 expression, serial tenfold dilutions of the re-
spective strains were plated on PMGc (non-selective, NS) or on PMGc plates con-
taining 2mgml21 5-FOA. To assess ade61 expression, serial tenfold dilutions of
the respective strains were plated on YES and YE plates.
Assessment of initiation versus maintenance of ectopic heterochromatin for-
mation.Mutant strains were seeded on YE plates and single-cell-derived red or
white colonies were selected. Colonies were resuspended in water and 100–500
cells were seeded on YE plates, which were then incubated at 30 uC for 3 days.
Images of the plateswere acquired after onenight at 4 uCand colonieswere counted
automatically usingMatlab (TheMathWorks) and ImageJ Software (National In-
stitutes of Health).
RNA isolation and cDNA synthesis.RNA isolation and cDNA synthesis was per-
formed as described previously32.
Quantitative real-time PCR. Real-time PCR on cDNA samples and ChIP DNA
was performed as described33 using a Bio-Rad CFX96 Real-Time System using
SsoAdvanced SYBRGreen supermix (Bio-Rad). Primer sequences are given inSup-
plementary Table 4.
Chromatin immunoprecipitation.Chromatin immunoprecipitation (ChIP) exper-
imentswereperformedaspreviously described33withminormodifications. Inbrief,
S. pombe cells were fixed with 1% formaldehyde for 15min and then lysed in buffer
containing 50mMHEPES/KOH, pH7.5, 140mMNaCl, 1mMEDTA, 1%Triton
X-100, 0.1% sodium deoxycholate, 1mM phenylmethylsulfonyl fluoride (PMSF)
and protease inhibitor cocktail. Chromatin was sheared with a Bioruptor (Diage-
node).The followingantibodieswere used in this study: histoneH3K9me2-specific
mouse monoclonal antibody fromWako (MABI0307), histone H3-specific rabbit
polyclonal antibody from Abcam (ab1791), histone H3K36me3-specific rabbit
polyclonal antibody fromAbcam (ab9050), andRNApolymerase IImousemono-
clonal antibody from Covance (8WG16).
Small RNA sequencing.Total RNAwas isolated from exponentially growing cells
using the hot phenolmethod34. The RNAwas fractionated using RNeasyMidi col-
umns (Qiagen) following theRNAcleanupprotocol provided by themanufacturer.
The flow-through fractionwas precipitated (‘small RNA’ fraction).Aliquots (25mg)
of the small RNAfractionwere separatedby17.5%PAGEand the 18–28-nucleotide
population purified. Libraries were prepared using the Illumina TruSeqTM small
RNApreparation protocol (RS-930-1012). The 145–160-nucleotide populationwas
isolated and the library sequenced on an Illumina HiSeq2000. Small RNA reads
were aligned as described previously32 with two mismatches allowed.
Whole-genome sequencing.Cells fromanovernight culturewere collected,washed
once with water and flash frozen in liquid nitrogen. Cells were spheroplasted in
spheroplast buffer (1.2Msorbitol, 100mMKHPO4, pH7.5, 0.5mgml
21 zymolyase
(ZymoResearch), 1mgml21 lysing enzyme from Trichoderma harzianum (Sigma)).
GenomicDNAwas isolated using theDNeasy Blood andTissueKit (Qiagen). Bar-
coded genomic DNA libraries for Illumina next-generation sequencing were pre-
pared from 50 ng genomic DNA using the Nextera DNA Sample Preparation Kit
(Illumina). Libraries were pooled equimolarly and sequenced on one lane of a
HiSeq2000 machine (Illumina). Basecalling was done with RTA 1.13.48 (Illumina)
software and for the demultiplexingCASAVA_v1.8.0 (Illumina)was used. For each
strain, between 8.7 and25.5million (meanof 14.2million) 50-nucleotide readswere
generated and aligned to the Schizosaccharomyces pombe 972h- genome assembly
(obtained on 17 September 2008 from http://www.broad.mit.edu/annotation/
genome/schizosaccharomyces_group/MultiDownloads.html) using ‘bwa’ (ref. 35,
version 0.7.4) with default parameters, but only retaining single-hit alignments
(‘bwa samse -n 1’ and selecting alignments with ‘X0:i:1’), resulting in a genome
coverage between 26 and 85-fold (mean of 44-fold). The alignments were con-
verted toBAMformat, sorted and indexedusing ‘samtools’ (ref. 36, version0.1.19).
Potential PCRduplicateswere removed using ‘MarkDuplicates’ from ‘Picards’ (http://
picard.sourceforge.net/, version1.92). Sequencevariantswere identifiedusingGATK
(ref. 37, version 2.5.2) indel realignment and base quality score recalibration using
a set of high confidence variants identified in an initial step as known variants, fol-
lowed by single nucleotide polymorphism (SNP) and INDEL discovery and gen-
otyping for each individual strainusing standardhard filtering parameters, resulting
in a total of 270–274 sequence variations (mean of 280) in each strain compared to
the reference genome (406 unique variations in total over all strains). Finally, var-
iationswere filtered to retainonly high quality singlenucleotide variations (QUAL
$ 50) of EMS type (GjC to AjT) with an alellic balance$ 0.9 (homozygous) that
were not also identified in the parental strain (sms0), reducing the number of var-
iations per strain to a number between 2 and 8 (mean of 4.6).
Expression profiling. RNA was isolated from cells collected at an attenuance (D)
of 600nm of 0.5 (D600 nm5 0.5) using the hot phenol method34. The isolated RNA
was processed according to theGeneChipWholeTranscriptDouble-StrandedTar-
get AssayManual fromAffymetrix using the GeneChip S. pombe Tiling 1.0FR. All
tiling arrays were processed in R38 using bioconductor39 and the packages tiling-
Array40 andpreprocessCore. ThearrayswereRMAbackground-corrected, quantile-
normalized, and log2-transformedon the oligonucleotide level using the following
command: expr,2log2(normalize.quantiles(rma.background.correct(exprs(read-
Cel2eSet (filenames,rotated5TRUE))))).Oligonucleotide coordinateswere inter-
sected with the genome annotation and used to calculate average expression levels
for individual genomic features (excluding thosewith,10oligonucleotides) aswell
as broader annotation categories. In the latter case, multimapping oligonucleo-
tideswere counted only once per category (avoidingmultiple counts from the same
oligonucleotide).
Gene nomenclature. The proteins PAF1p, CDC73p, RTF1p, LEO1p and CTR9p
form a stable complex in S. cerevisiae (Paf1C). The systematic IDs of the genes en-
coding the S. pombehomologues of these proteins are SPAC664.03, SPBC17G9.02c,
SPBC651.09c, SPBC13E7.08c and SPAC27D7.14c, respectively. The CTR9 homo-
logue SPAC27D7.14c is currently annotated as Tpr1. The RTF1 homologue
SPBC651.09c is currently annotated as PAF-related factor 1 (prf11), because rtf11
is already used for an unrelated gene (SPAC22F8.07c). Therefore, we refer to
SPAC664.03, SPBC17G9.02c, SPBC651.09c, SPBC13E7.08c and SPAC27D7.14c
as paf11, cdc731, prf11, leo11 and tpr11, respectively, in this paper.
Statistics.A one-tailed Student’s t-test was used, with P, 0.05 as the significance
level. No statistical methods were used to predetermine sample size.
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heterochromatic RNA transcripts.Mol. Cell 47, 215–227 (2012).
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Extended Data Figure 1 | Design of the ade61 RNA hairpin (ade6-hp)
construct that expresses abundant sense and antisense (primary) siRNAs.
a, The RNA stem–loop construct consists of a 250-nucleotide-long ade61
fragment, followed by a cox41 intronic sequence and the reverse complement
of the ade61 fragment. The promoter sequence of the adh11 gene drives
expression of the RNA hairpin. Transcription of the construct is terminated by
the termination signals of the nmt11 gene. The construct was provided by
T. Iida. b, c, Small RNA sequencing revealed that the RNA stem is converted
into sense and antisense siRNAs covering the 250-nucleotide stretch from the
ade61 open reading frame (nucleotides 621–870). Furthermore, sense and
antisense siRNAs mapping to the cox41 intronic and adh11 promoter
sequences are also generatedwhen this construct is expressed in wild-type cells.
ORF, open reading frame. Asterisk denotes the point mutation (Thr645Ala) in
the ade6-704 loss of function allele. Green arrows indicate forward and reverse
primers that were used for PCR in ChIP experiments. d, Schematic diagram
depicting origin and target(s) of synthetic ade6-hp siRNAs. The ade6-hp
expression cassette (a) was inserted into the nmt11 locus on chromosome I by
homologous recombination. The ade6-hp-containing plasmid was linearized
with PmlI, which cuts in the middle of the nmt11 terminator sequence, and
transformed into ade6-704 cells. Thereby, the ade6-hp construct was inserted
downstream of the nmt11 gene. The nourseothricin (Nat)-resistance
cassette linked to the ade6-hp construct allowed selection of positive
transformants. It also allows assessment of spreading of repressive
heterochromatin that is nucleated by the ade6-hp siRNAs in cis (see Extended
Data Fig. 7b). A wild-type copy of the ade61 gene was inserted upstream of
the trp11 gene on chromosome II by homologous recombination. Because
the endogenous ade6-704 allele is non-functional, positive transformants
could be selected by growth in the absence of adenine. In Paf1C mutant cells,
ade6-hp-derived siRNAs either act in cis to assemble heterochromatin at
the nmt11 locus (chromosome I), or in trans to direct the formation of
heterochromatin at the trp11::ade61 (chromosome II) and ade6-704
(chromosome III) loci.
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Extended Data Figure 2 | Silencing assays demonstrating the inability of
synthetic siRNAs to act in trans in Paf1C wild-type cells. a, ade61 silencing
assayswere performedwith cells expressing synthetic ade6-hp siRNAs, ura4-hp
siRNAs or no siRNAs. The ability of ade6-hp siRNAs to silence either the
endogenous ade61 gene or the trp11::ade61 reporter gene was assessed at
different adenine concentrations. ade6-704 cells were used as positive control.
b, c, ade61 mRNA levels were determined by quantitative RT–PCR and
normalized to act11mRNA. One representative biological replicate is shown.
Error bars, s.d. d, ade61silencing assays demonstrating that neither the
endogenous ade61 gene nor the trp11::ade61 reporter gene becomes
repressed by trans-acting ade6-hp siRNAs, even upon overexpression of the
heterochromatin protein Swi6.
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Extended Data Figure 3 | Sms forward genetic screen identifies five true
positive hits that enable siRNAs to methylate H3K9 at the ade61 gene in
trans. a, Workflow of the EMS mutagenesis screen. We mutagenized sms0
cells, which express abundant siRNAs complementary to the ade61 gene
(indicated by green hairpin), with EMS (primary screen). Subsequently, we
tested the positive red colonies for growth in the absence of adenine to select
against loss-of-function mutations in the adenine biosynthesis pathway
(secondary screen). In hits that remained positive after the secondary
screen, dcr11 was deleted to identify truly siRNA-dependent hits (tertiary
screen). Formapping of causativemutations bywhole-genomenext-generation
sequencing, positive hits were backcrossed four times. b, sms1-10mutants show
the red ade61 silencing phenotype on YE plates, which segregated through
four successive backcrosses for all 10mutants. The ade6-M210 loss-of-function
allele and ade61 inserted within centromeric heterochromatin (otr1R::ade61)
serve as positive controls. c, ChIP experiment demonstrating methylation of
H3K9 at the ade61 target loci in sms1, 3, 4, 6 and 8. One representative
biological replicate is shown. d, ade61 silencing in sms1, 3, 4, 6 and 8 is Dcr1-
dependent. e, Resequencing of EMS-mutagenized S. pombe strains. From
outside to inside, the tracks show the genomic location, the average coverage
per window of 10 kb (black line, scale from 0 to 30), the number of sequence
variations identified before filtering in all strains per window of 10 kb
(blue bars, scale from 0 to 90) and the five mutations that passed the filtering
and overlapped with Paf1C genes (red lines, the two mutations in Paf1 are
too close to be resolved individually). f, Table lists mutations mapped by
whole-genome sequencing. In Dcr1-dependent mutants, we mapped
mutations in the genes SPBC651.09c, SPAC664.03, SPBC13E7.08c and
SPBC17G9.02c whose homologues in budding yeast encode for protein
subunits of the Paf1 complex.
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Extended Data Figure 4 | Mutant alleles for the homologues of all five
subunits of Paf1C enable siRNAs to induce gene silencing in trans. a, ade61
siRNAs reduce ade61 mRNA levels in all Paf1C mutant strains identified
in this study.Whole-genome tiling arrayswere used to assess gene expression in
the mutant cells indicated. y axis is in linear scale. b, C-terminally tagged Tpr1
and Cdc73 are hypomorphic. Full deletions of the tpr11 and cdc731 genes
cause retarded growth phenotypes (Extended Data Fig. 8c). By contrast,
tpr1-3xFLAG and cdc73-3xFLAG grow normally, and display ade6-hp siRNA-
mediated repression of the ade61 gene.
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ExtendedData Figure 5 | Expression of synthetic siRNAs in paf1-Q264Stop
cells is sufficient to trigger stable repression of protein codinggenes in trans.
a, Left, the paf1-Q264Stop mutation was introduced into cells that express
synthetic ura4-hp siRNAs15. Right, wild-type (paf11) and paf1-Q264Stopwere
grown in the presence or absence of 5-FOA. Red arrow indicates paf1-Q264Stop
colonies growing on FOA-containing medium. Note that these colonies
could be propagated in non-selective medium without losing the repressed
state. b, In S. pombe, artificial tethering of the RITS complex to mRNA
expressed from the endogenousura41 locus using the phagelNprotein results
in de novo generation of ura41 siRNAs. These siRNAs load onto RITS and are
necessary to establish heterochromatin at the ura41 locus in cis. However,
like ura4-hp siRNAs, they are incapable of triggering the repression of a second
ura41 locus in trans18. To test whether ura41 siRNAs produced as a result
of Tas3lN tethering to ura41::5BoxB mRNA (chromosome III) can act
in trans to silence a second ura41 allele (leu1D::ura41, chromosome II),
paf11 was mutated and ura41 repression was assessed by FOA silencing
assays.Whereas 5-FOAwas toxic to both paf11 and paf1-Q264Stop cells in the
absence of ura41 siRNAs (Tas3 not fused to lN), FOA-resistant colonies
appeared upon Tas3-lN tethering, demonstrating that siRNAs generated from
the ura41::5BoxB locus can initiate repression of the second ura41 copy
expressed from the leu11 locus. Notably, siRNA-mediated ura41 repression
in trans was more pronounced in the absence of the RNase Eri1. We have
previously shown that the levels of ura41::5BoxB-derived siRNA are higher in
eri1D cells41. We note that trans-silencing of the second ura41 allele
occasionally occurs in paf11 cells in the absence of Eri1 (ref. 18). However, in
contrast to paf1-Q264Stop cells, the repressed state of ura41 is not stably
propagated. Hairpin symbols downstream of the ura41 ORF denote BoxB
sequences. They form stem–loop structures when transcribed and are bound
by the lN protein. c, ade61 silencing assay demonstrating that also the
endogenous ade61 gene is repressed if ade6-hp siRNAs are expressed from the
nmt11 locus in paf1-Q264Stop cells. Silencing assay was performed with
two freshly generated (naive) paf1-Q264Stop mutant strains. A few white
colonies in which heterochromatin has not yet formed are discernable.
Such white colonies were picked to determine heterochromatin initiation
frequencies shown in Fig. 2.
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Extended Data Figure 6 | ade61 siRNAs trigger de novo methylation of
H3K9 at homologous ade61 sequences in cis and in trans. a, ade6-hp RNA
producing locus and siRNA target loci in trans in the sms0 strain. ade6-704
is a loss-of-function allele of the endogenous ade61 gene and serves as a
positive control in the silencing assays. b, c, ade61 siRNAs direct the
methylation of H3K9 at ade6 targets in cis (green) and in trans (red) in
Paf1C mutant cells. H3K9me2 for trp11::ade61 is shown in Fig. 1d.
Quantitative PCR was performed with locus-specific primers. Error bars,
s.e.m.; n5 3 technical replicates. d, e, ChIP experiments to assess ade61
transcriptional activity. H3K36me3 levels were normalized to total H3 levels.
snu61 is transcribed by RNAPIII and serves as background control. Error bars,
s.e.m.; n5 3 independent biological replicates; P values were calculated
using the one-tailed Student’s t-test.
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Extended Data Figure 7 | Pronounced siRNA-directed heterochromatin
formation in trans during meiosis. a, White (naive) cells that had not yet
established heterochromatin at the trp11::ade61 locus were isolated from
populations of freshly generated paf1-Q264Stop strains and crossed with paf11
cells. Both mating partners expressed ade6-hp siRNAs and contained the same
trp11::ade61 reporter. Spores were dissected on YE plates and incubated for
3–4 days at 30 uC. Note the non-Mendelian inheritance pattern of the parental
white phenotype and the high incidence of heterochromatin formation (red
phenotype) in paf1-Q264Stop cells aftermeiosis. b, Spores from 43 tetrads were
dissected in total. Colonies formed by the individual spores (a) were then struck
on YE plates and incubated for 3–4 days at 30 uC, followed by replica-plating
onto YES-G418 and YES1nourseothricin (Nat) plates for genotyping. Thus,
the cells visible on the YE plates have gone through roughly 50–80 mitotic
divisions after mating and sporulation. This analysis shows that de novo
formation of heterochromatin by trans-acting siRNAs during meiosis occurs
more frequently than inmitosis.However, once established, heterochromatin is
remarkably stable in mitotic cells (see also Fig. 2). Notably, growth of some
paf1-Q264Stop descendants was reduced on YES1Nat plates, demonstrating
spreading of heterochromatin into the neighbouring Nat-resistance cassette
that marks the nmt11::ade6-hp1 locus (see Extended Data Fig. 1). Note
that genes repressed by heterochromatin can be derepressed under strong
negative selection. Thus, this observation indicates extraordinary repressive
activity of the heterochromatin that forms in cis at the ade6-hp siRNA-
producing locus. Finally, paf11 cells (no growth on YES-G418 or PMG-LEU)
never turned red, demonstrating the high repressive activity of Paf1. This
explains unsatisfactory results of previous attempts to induce the formation of
stable heterochromatin in trans by expressing synthetic siRNAs.
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Extended Data Figure 8 | Effect of Paf1C mutations on global gene
expression and silencing. a, The effect of the Paf1C mutations on genome
expression was assessed by hybridizing total RNA to whole-genome tiling
arrays. The parental wild-type strain, all Paf1C point mutations discovered in
the screen, and full deletions of the paf11 and leo11 genes were included in
the analysis. To compare the genome-wide expression profiles of the mutants
with thewild-type strain, a principal component analysis (PCA)was performed
on the data obtained for two biological replicates of each strain. Principal
component (PC) 1 and 2 explained 41.5% and 16.4% of the variance between
samples and were selected for visualization, revealing that cdc73-G313R and
paf1D cells are most different from wild-type cells. All the other mutants
clustered together in a group of samples that also includes wild type,
demonstrating that RNA steady-state levels are onlyminimally affected in these
mutants. Note that leo1D is more similar to wild type than paf1D, as well as
that paf1D clusters separately from the Paf1C point mutants. b, Pairwise
comparisons of gene expression between wild-type and paf1 mutant strains.
c, leo1D cells have no growth defect but are susceptible for de novo formation
of heterochromatin by siRNAs acting in trans. These results suggest that
Leo1 might be a bona fide repressor of small-RNA-mediated
heterochromatin formation.
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Extended Data Figure 9 | Kinetic model for Paf1C-mediated repression of
siRNA-directed heterochromatin formation. a, Paf1C facilitates rapid
transcription and release of the nascent transcript from the DNA template.
Because the kinetics of transcription termination and RNA39 end processing is
faster than RITS binding and CLRC recruitment, stable heterochromatin
and long-lasting gene silencing cannot be established. b, In Paf1C mutant cells
identified in this study, elongation of RNA polymerase II, termination of
transcription, and the release of the nascent transcript from the site of
transcription is decelerated. This results in an accumulation of RNA
polymerases that are associated with nascent transcripts, opening up a window
of opportunity for the siRNA-guided RITS complex to base-pair with nascent
transcripts and recruit CLRC. Consequently, highly stable and repressive
heterochromatin is assembled, which is accompanied by the generation of
secondary siRNAs covering the entire locus (not depicted in this scheme).
Notably, our results demonstrate that impaired transcription termination but
not elongation is sufficient to allow silencing. However, to confer robustness to
the repressed state, both transcription termination and release of the RNA
transcript from the site of transcription must be impaired concomitantly.
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Extended Data Figure 10 | Formation of ectopic heterochromatin.
a, Differential gene expression compared to differential antisense siRNA
expression in leo1D. Gene expression profiles were obtained with whole-
genome tiling arrays and small RNA profiles by deep sequencing. Genes
neighbouring the nmt11::ade6-hp1, trp11::ade61 and ade6-704 loci are
marked in colour (see also Supplementary Table 1). b, siRNA readsmapping to
the ade6-704 locus in leo11 and leo1D strains. Red, plus strand; blue, minus
strand. Intronic rpl2302 siRNAs in leo1D cells indicate co-transcriptional
double-stranded RNA synthesis by RDRC before splicing. c, ChIP experiment
showing H3K9me2 enrichments on genes surrounding the ade6-704 locus in
leo11 and leo1D cells. Enrichments were calculated relative to background
levels obtained in clr4D cells andnormalized to adh11. Error bars, s.d.;mean of
n5 2 independent biological replicates.
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M I K E L  Z A R A T I E G U I
RNA interference (RNAi) is a mechanism of gene regulation that uses small RNAs called short interfering RNAs (siRNAs)
to silence the expression of specific targets that 
have complementary nucleotide sequences. 
This can occur through post-transcriptional 
silencing, which degrades the target transcript, 
or through modification of chromatin (the 
complex of proteins, RNA and DNA in which 
DNA is packaged in the cell), which prevents 
transcription from initiating. RNAi always 
causes transcript degradation, but its effect on 
chromatin is bewilderingly inconsistent; only 
some targets in some organisms exhibit RNAi-
mediated chromatin modifications, despite 
the evolutionary conservation of this mecha-
nism. In a paper published on Nature’s web-
site today, Kowalik et al.1 report that the target 
transcript must remain associated with the site 
of transcription for RNAi to act on chroma-
tin, providing a possible explanation for this 
variability.
Researchers can exploit RNAi to inhibit 
any RNA sequence of choice, simply by intro-
ducing a source of siRNA, such as a double-
stranded RNA molecule that can be processed 
to siRNA by the nuclease enzyme Dicer. Dur-
ing transcription, siRNA can hybridize with a 
complementary nascent transcript and induce 
the deposition of silencing chromatin marks, 
leading to the formation of an inheritable 
repressive type of chromatin called hetero-
chromatin. The inheritance of silencing 
chromatin modifications down generations of 
cells is an example of epigenetic memory. 
By forming complexes with Argonaute 
effector proteins, siRNA can locate and silence 
target sequences even if they are located at dis-
tant sites, a process called silencing in trans. 
This phenomenon is crucial for repressing the 
transcription of dispersed repetitive genomic 
elements, such as transposons2, which must 
be silenced to prevent them from ‘jumping’ 
around the genome and introducing harmful 
mutations. However, when researchers try to 
take advantage of this phenomenon to induce 
heterochromatin in mammalian protein- 
coding genes, the process seldom works. 
Instead, it produces erratic results that depend 
in perplexing ways on the target gene and on 
pre-existing chromatin modifications. 
Similarly disappointing results have been 
reported for fission yeast (Schizosaccharo-
myces pombe). The yeast’s siRNA precursors 
cannot induce heterochromatin formation in 
target genes3, although certain non-protein-
coding sequences at the centre of the yeast’s 
chromosomes are robustly silenced by RNAi. 
Reasoning that suppressive mechanisms might 
protect protein-coding genes from RNAi, 
Kowalik and colleagues performed a genetic 
screen in S. pombe, looking for mutations that 
allowed silencing in trans. Strikingly, all the 
mutations they obtained arose in proteins of 
the RNA polymerase-associated factor 1 com-
plex (Paf1C). 
The authors report that several different 
siRNA precursors can reliably induce hetero-
chromatin formation when Paf1C is mutated. 
The silenced DNA regions exhibit all the 
hallmarks of endogenous heterochromatin, 
including decreased transcription, generation 
of target-derived (secondary) siRNA molecules, 
and addition of a methyl group to the amino-
acid residue lysine 9 of the chromatin protein 
histone 3 (a modification known as H3K9me). 
Kowalik et al. found that, once established, 
siRNA-induced heterochromatin can be 
inherited across generations of cells, even in 
the absence of the original siRNA source, as 
long as Paf1C is still mutated. This suggests 
that the cycle of secondary siRNA generation 
and H3K9me deposition that arises after het-
erochromatin initially forms can induce its 
own inheritance (Fig. 1). Silencing marks are 
re-established after each chromatin replication, 
preventing their dilution and satisfying even the 
strictest definitions of epigenetic inheritance.
M O L E C U L A R  B I O L O G Y
RNA interference  
hangs by a thread
The Paf1 protein complex in fission yeast has been found to protect protein-coding 
genes from inhibition by RNA-mediated silencing of transcription, by 
stimulating the release of nascent transcripts from DNA. 
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Figure 1 | Interfering with interference. Short interfering RNA (siRNA) forms complexes with the 
Argonaute 1 (Ago1) protein, enabling it to bind to and cleave complementary transcripts. a, In fission 
yeast, the Paf1 protein complex (Paf1C) promotes both transcript elongation by the enzyme RNA 
polymerase II (Pol II) and 3ʹ-end processing, which consists of the release of Pol II, and cleavage and 
polyadenylation of messenger RNA, releasing the mRNA from the site of transcription. The released 
transcript is silenced post-transcriptionally by siRNA. b, Kowalik et al.1 report that, if mutations 
compromise Paf1C activity, the uncleaved transcript is retained at the site of transcription. Ago1–siRNA 
forms complexes with other proteins, which together mediate the induction of chromatin-silencing 
modifications such as H3K9me, and the initiation of a self-reinforcing cycle of secondary siRNA 
production, in which mRNA is cleaved by siRNA, and the cleaved transcript is processed to siRNA by the 
nuclease enzyme Dicer.
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How does Paf1C prevent RNAi from 
silencing chromatin? The authors tackled this 
question by genetically inhibiting proteins 
involved in each of the three main functions 
regulated by Paf1C: chromatin modifica-
tion; elongation of messenger RNA during 
transcription; and processing of the 3ʹ end 
of mRNA as transcription terminates4. Dur-
ing 3ʹ-end processing, transcripts are cleaved 
and a ‘polyadenine tail’ is added to stabilize 
the mRNA and permit normal translation. 
Interfering with chromatin modification or 
transcript elongation had no effect on hetero-
chromatin formation. However, mutations in 
Ctf1 and Res2, two proteins required for cleav-
age and polyadenylation of mRNA, allowed 
in trans silencing to occur, albeit less efficiently 
than in the Paf1C mutants. 
Conversely, Kowalik et al. demonstrate 
that bypassing 3ʹ-end processing, by using a 
ribozyme molecule that cleaves off and releases 
the nascent transcript from DNA before ter-
mination, prevents in trans silencing even 
when Paf1C is mutated. Thus, it seems that 
the expeditious 3ʹ-end processing of protein-
coding genes protects them from RNAi by 
denying siRNA a docking platform — a nas-
cent transcript still attached to the site of tran-
scription. This process is probably necessary to 
prevent spurious heterochromatin formation 
by run away RNAi activity, because the authors 
observe stochastic formation of heterochro-
matin in abnormal, protein-coding locations 
when Paf1C activity is compromised.
On a fundamental level, these results high-
light the inextricable relationship between 
RNAi and mRNA processing. Both share the 
same targets, which are transcribed by the 
enzyme RNA polymerase II, and the two pro-
cesses share much cross-regulation. It seems 
that the two mechanisms converge in 3ʹ-end 
processing. Almost a decade ago, genetic 
screens searching for enhancers of post-
transcriptional RNAi in plants yielded factors 
involved in 3ʹ-end processing5, a harbinger 
of the effect shown here for transcriptional 
silencing. Strikingly, it seems that Dicer can 
release some nascent transcripts6,7, usurp-
ing the role of the normal cleavage and poly-
adenylation machinery in certain situations. 
Together with the known influence of chro-
matin state on 3ʹ-end processing8, a picture is 
emerging of a network of regulatory activities 
that enhance or prevent chromatin silencing 
in different targets.
But the most exciting implication is the 
potential to leverage this knowledge to induce 
targeted heterochromatin formation in differ-
ent organisms, including humans. Mechanisms 
of RNAi-mediated chromatin modification 
might be universally conserved after all, with 
the variability observed in different targets 
and models stemming from differences in 
the efficiency of nascent transcript release at 
target sequences. In S. pombe, the transcripts 
naturally targeted for RNAi-mediated het-
erochromatin formation exhibit notoriously 
inefficient termination of transcription9, which 
explains why their silencing is independent of 
Paf1C activity. Furthermore, a protein-coding 
reporter gene can be efficiently silenced in 
trans in this yeast if its 3ʹ-end-processing sig-
nals are mutated10. Perhaps, then, we will be 
able to silence genes reliably and inheritably at 
will, by inhibiting transcription termination11 
and simultaneously using a specific RNAi trig-
ger. In this way, RNAi would finally fulfil its 
promise and join other technologies, such as 
CRISPR/dCas9 systems, that enable editing of 
the epigenome. ■
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11 Appendix 
11.1 Supplementary tables 
Table 7 Gene repressed in the Paf1 complex mutants.  
 
Gene ID Chromosome Location Feature type 
Expression 
fold change 
small RNAs 
 yes/no 
change 
in 
mutant 
pr
f1
-Q
47
2S
to
p 
SPNCRNA.1234 chr3 1837499-1840092 long ncRNA -2.836 yes down 
SPNCRNA.10 chr3 1837689-1838380 long ncRNA -2.695 yes up 
SPCC1223.03c chr3 1840594-1843300 pre-mRNA -2.224 no  
SPAC1296.02 chr1 711413-711767 intron -2.217 yes NC 
SPNCRNA.504 chr3 1839578-1840266 long ncRNA -1.930 yes NC 
SPCC1322.13 chr3 1316243-1318070 pre-mRNA -1.834 yes up 
SPCC1223.01 chr3 1834599-1837464 pre-mRNA -1.732 yes up 
SPNCRNA.1235 chr3 1839787-1844115 long ncRNA -1.724 yes down 
SPCC1223.02 chr3 1838335-1839525 pre-mRNA -1.640 yes up 
SPCC1322.14c chr3 1318375-1321275 pre-mRNA -1.279 yes up 
SPCC2H8.02 chr3 827911-828545 5' UTR -0.897 no  
SPCC285.17 chr3 1831913-1834169 pre-mRNA -0.828 no  
SPBC14F5.12c chr2 4182411-4182642 5' UTR -0.812 no  
SPAC1296.02 chr1 711238-712354 pre-mRNA -0.804 yes NC 
SPBC1861.02 chr2 4133286-4133635 3' UTR -0.777 no  
SPAC2H10.04 chr1 5272461-5272835 pre-mRNA -0.746 no  
SPAC4C5.04 chr1 1198224-1198458 5' UTR -0.727 no  
SPNCRNA.511 chr3 2011061-2012433 long ncRNA -0.724 no  
SPCC13B11.01 chr3 1589427-1592889 pre-mRNA -0.709 yes up 
SPBC19C7.12c chr2 2842901-2845922 3' UTR -0.708 no  
pa
f1
-Q
26
4S
to
p 
SPNCRNA.1234 chr3 1837499-1840092 long ncRNA -2.540 yes down 
SPNCRNA.10 chr3 1837689-1838380 long ncRNA -2.456 no  
SPCC1322.13 chr3 1316243-1318070 pre-mRNA -2.366 yes up 
SPAC1296.02 chr1 711413-711767 intron -2.334 yes up 
SPCC1223.03c chr3 1840594-1843300 pre-mRNA -1.972 yes up 
SPCC1223.01 chr3 1834599-1837464 pre-mRNA -1.536 yes up 
SPNCRNA.1235 chr3 1839787-1844115 long ncRNA -1.484 yes NC 
SPNCRNA.504 chr3 1839578-1840266 long ncRNA -1.379 yes NC 
SPCC1322.14c chr3 1318375-1321275 pre-mRNA -1.265 yes up 
SPAC664.03 chr1 1708728-1710347 pre-mRNA -1.225 yes up 
SPCC1223.02 chr3 1838335-1839525 pre-mRNA -1.199 yes up 
SPNCRNA.511 chr3 2011061-2012433 long ncRNA -1.131 no  
SPNCRNA.1254 chr3 2011026-2012559 long ncRNA -1.055 no  
SPAC1296.02 chr1 711238-712354 pre-mRNA -1.019 yes up 
SPBC1861.02 chr2 4133286-4133635 3' UTR -0.992 no  
SPNCRNA.763 chr1 1813439-1815920 long ncRNA -0.975 no  
SPAC2H10.04 chr1 5272461-5272835 pre-mRNA -0.947 no  
SPCC13B11.01 chr3 1589427-1591358 5' UTR -0.892 yes up 
SPNCRNA.17 chr2 1777375-1777788 long ncRNA -0.891 no  
SPBC1271.10c chr2 347590-350376 pre-mRNA -0.879 no  
pa
f1
-G
10
4R
 
SPNCRNA.1234 chr3 1837499-1840092 long ncRNA -1.729 yes NC 
SPNCRNA.10 chr3 1837689-1838380 long ncRNA -1.671 yes up 
SPCC1223.03c chr3 1840594-1843300 pre-mRNA -1.381 no  
SPCC1223.02 chr3 1838335-1839525 pre-mRNA -1.327 yes up 
SPNCRNA.504 chr3 1839578-1840266 long ncRNA -1.212 yes NC 
SPAC1296.02 chr1 711413-711767 intron -1.184 yes NC 
SPNCRNA.1235 chr3 1839787-1844115 long ncRNA -1.170 yes NC 
SPBC13E7.07 chr2 3053333-3055355 3' UTR -1.148 no  
SPCC1322.13 chr3 1316243-1318070 pre-mRNA -1.065 yes up 
SPCC1223.01 chr3 1834599-1837464 pre-mRNA -0.978 yes up 
SPAC2H10.04 chr1 5272461-5272835 pre-mRNA -0.897 no  
SPBC83.10 chr2 1528476-1528831 3' UTR -0.844 no  
SPAC8C9.07 chr1 3654213-3654875 pre-mRNA -0.682 no  
 129 
SPCC1620.10 chr3 2163164-2164505 pre-mRNA -0.678 no  
SPBC1271.10c chr2 347590-350376 pre-mRNA -0.667 no  
SPNCRNA.944 chr1 3876714-3877850 long ncRNA -0.665 no  
SPAC5H10.13c chr1 167766-168809 3' UTR -0.665 no  
SPAC16E8.06c chr1 3508514-3510077 pre-mRNA -0.645 no  
SPAC607.02c chr1 2040405-2040627 5' UTR -0.641 no  
SPBC16E9.02c chr2 1918006-1920215 pre-mRNA -0.635 no  
le
o1
-W
15
7S
to
p 
SPNCRNA.1234 chr 3 1837499-1840092 long ncRNA -2.745 yes down 
SPNCRNA.10 chr 3 1837689-1838380 long ncRNA -2.619 no  
SPCC1322.13 chr 3 1316243-1318070 pre-mRNA -2.513 yes up 
SPAC1296.02 chr 1 711413-711767 intron -2.466 yes NC 
SPCC1223.03c chr 3 1840594-1843300 pre-mRNA -2.262 no  
SPNCRNA.504 chr 3 1839578-1840266 long ncRNA -2.021 yes down 
SPAC186.05c chr 1 5540032-5541502 pre-mRNA -1.969 no  
SPCC1223.02 chr 3 1838335-1839525 pre-mRNA -1.838 yes up 
SPNCRNA.1235 chr 3 1839787-1844115 long ncRNA -1.690 yes down 
SPCC1322.14c chr 3 1318375-1321275 pre-mRNA -1.546 yes up 
SPCC1223.01 chr 3 1834599-1837464 pre-mRNA -1.396 yes up 
SPNCRNA.511 chr 3 2011061-2012433 long ncRNA -1.178 no  
SPNCRNA.1254 chr 3 2011026-2012559 long ncRNA -1.115 no  
SPAC2H10.04 chr 1 5272461-5272835 pre-mRNA -1.107 no  
SPAC1296.02 chr 1 711238-712354 pre-mRNA -1.015 yes NC 
SPAC18B11.03c chr 1 311920-314040 pre-mRNA -0.875 no  
SPAC750.01 chr 1 5555716-5556768 pre-mRNA -0.850 no  
SPNCRNA.585 chr 3 2010261-2010800 long ncRNA -0.826 no  
SPNCRNA.1063 chr 1 5266525-5269973 long ncRNA -0.755 no  
SPNCRNA.17 chr 2 1777375-1777788 long ncRNA -0.753 no  
le
o1
Δ 
SPNCRNA.10 chr 3 1837689-1838380 long ncRNA -1.597 yes up 
SPNCRNA.1234 chr 3 1837499-1840092 long ncRNA -1.588 yes NC 
SPCC1223.03c chr 3 1840594-1843300 pre-mRNA -1.317 no  
SPAC1296.02 chr 1 711413-711767 intron -1.308 yes NC 
SPCC2H8.02 chr 3 827911-828545 5' UTR -1.276 no  
SPNCRNA.1235 chr 3 1839787-1844115 long ncRNA -1.046 yes NC 
SPCC1322.13 chr 3 1316243-1318070 pre-mRNA -1.038 yes up 
SPAC186.05c chr 1 5540032-5541502 pre-mRNA -0.922 no  
SPCC1223.01 chr 3 1834599-1837464 pre-mRNA -0.912 yes up 
SPNCRNA.511 chr 3 2011061-2012433 long ncRNA -0.909 no  
SPNCRNA.504 chr 3 1839578-1840266 long ncRNA -0.895 yes NC 
SPNCRNA.1254 chr 3 2011026-2012559 long ncRNA -0.861 no  
SPAC2H10.04 chr 1 5272461-5272835 pre-mRNA -0.841 no  
SPCC1223.02 chr 3 1838335-1839525 pre-mRNA -0.804 yes up 
SPAC186.05c chr 1 5541139-5541502 5' UTR -0.796 no  
SPBC13E7.08c chr 2 3052520-3055287 pre-mRNA -0.765 no  
SPBC13E7.07 chr 2 3052449-3055355 pre-mRNA -0.697 no  
SPBC83.10 chr 2 1528476-1528831 3' UTR -0.657 no  
SPAC9E9.01 chr 1 4435202-4435509 3' UTR -0.643 no  
SPNCRNA.17 chr 2 1777375-1777788 long ncRNA -0.641 no  
cd
c7
3-
G
31
3R
 
SPNCRNA.1234 chr3 1837499-1840092 long ncRNA -2.353 yes down 
SPCC1322.13 chr3 1316243-1318070 pre-mRNA -2.231 yes up 
SPNCRNA.10 chr3 1837689-1838380 long ncRNA -2.221 no  
SPAC186.05c chr1 5540032-5541502 pre-mRNA -1.771 no  
SPCC1223.03c chr3 1840594-1843300 pre-mRNA -1.727 no  
SPCC794.12c chr3 275261-275513 3' UTR -1.523 no  
SPNCRNA.511 chr3 2011061-2012433 long ncRNA -1.490 no  
SPAC5H10.03 chr1 152573-152909 3' UTR -1.473 no  
SPNCRNA.763 chr1 1813439-1815920 long ncRNA -1.463 no  
SPNCRNA.411 chr2 2901243-2902541 long ncRNA -1.451 no  
SPBC317.01 chr2 3627758-3628658 3' UTR -1.391 yes down 
SPNCRNA.1254 chr3 2011026-2012559 long ncRNA -1.390 no  
SPNCRNA.1264 chr3 2117021-2118767 long ncRNA -1.378 no  
SPCC1223.01 chr3 1834599-1837464 pre-mRNA -1.362 no  
SPNCRNA.523 chr3 2381299-2381802 long ncRNA -1.333 no  
SPNCRNA.716 chr1 1146598-1148060 long ncRNA -1.332 no  
SPNCRNA.1096 chr3 37658-39319 long ncRNA -1.311 no  
SPNCRNA.1561 chr2 2901109-2902665 long ncRNA -1.309 no  
SPNCRNA.889 chr1 3138602-3139458 long ncRNA -1.249 no  
SPNCRNA.1192 chr3 1400016-1400808 long ncRNA -1.234 no  
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This table lists the 20 most repressed genomic features in each of the Paf1 complex mutant strains, based on the 
genome-wide expression profiles generated with tiling microarrays. Column ‘Expression fold change’ shows 
average fold change in expression level between the mutant and the wild type strain (log2 scale). Column ‘Small 
RNAs –yes/no’ indicates whether small RNAs originating from the respective loci were detected in our deep 
sequencing data set from either wild type or the mutant strain. Column ‘Small RNAs – change in mutant’ 
describes whether small RNAs number increases or decreases in the respective mutant strain. ‘NC’ – no change. 
 
 
